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ZUSAMMENFASSUNG
Das Hauptaugenmerk der hier vorgelegten Dissertation richtete sich auf die Aufklärung
von  Struktur-Funktions-Beziehungen  in  der  Ubihydrochinon  :  Cytochrom  c
Oxidoreduktase, dem Cytochrom-bc1-Komplex, aus Saccharomyces cerevisiae.
Der Cytochrom-bc1-Komplex ist eine essentielle Komponente von Elektronen-
transportketten  in  Eukaryoten  und  Prokaryoten,  wo  er  an  verschiedenen
bioenergetischen  Prozessen  wie  der  Atmungskette,  der  Photosynthese  und  der
Stickstoffixierung  beteiligt  ist.  Der  Mechanismus  dieses  Enzyms  ist  in  seinen
Grundzügen  charakterisiert  und  mit  dem  Model  des  modifizierten  Q-Zyklus
beschrieben.  Jedoch  sind  Regulationsprozesse  und  insbesondere  der  molekulare
Mechanismus der Ubichinoloxidation immer noch unverstanden. Weitere ungeklärte
Punkte  betreffen  die  Bewegung  des  Rieske-Proteins,  die  Verzweigung  des
Elektronentransfers, die Besetzung der Ubichinol-oxidierenden Bindungstasche und
den Verlauf von Protonentransferwegen.
Die  Fragestellung  wurde  mittels  einer  Kombination  biophysikalischer
Techniken,  vor  allem  der  Röntgenkristallographie,  untersucht.  Die  aus  den
Proteinstrukturen gewonnen Informationen wurden mit funktionellen Aussagen aus
kinetischen Studien und den Daten spektroskopischer Experimente, insbesondere der
FTIR-Differenzspektroskopie, ergänzt.
Um den molekularen Mechanismus der Katalyse in der Qo-Bindungsstelle zu
untersuchen,  wurde  der  Bindungsmodus  des  Qo-Inhibitors  HHDBT  mittels  der
Röntgenkristallographie bestimmt (Palsdottir et al, 2003). Diese 2.5 Å Kristallstruktur
(PDB-Eintrag: 1P84) erlaubte wichtige Rückschlüsse auf den Katalysemechanismus.
Vorherigen kristallographischen Arbeiten am UHDBT-Inhibitorkomplex waren nicht
erfolgreich und führten nicht zu einer hochaufgelösten Struktur. Unter Verwendung
von Heptyl-HDBT, das eine kürzere Alkyl-Kettenlänge aufweist, wurden erfolgreich
dreidimensionale Kristalle des Komplexes gezüchtet.
Die Bindung von Heptyl-HDBT an das Enzym wurde durch kinetische Studien
in Kollaboration mit Prof. B. Trumpower charakterisiert. Eine wesentliche Information
dabei war, dass dieses Hydroxychinon in seiner ionisierten Form bindet, entgegen
vorherigen Behauptungen, eine ionisierte Verbindung könne nicht in der katalytischen
Substrattasche binden (Zhang et al, 1999). Demnach weisen unsere Studien darauf hin,
dass die pH-Abhängigkeit der alkyl-HDBT Inhibierung durch eine dissoziierbareZusammenfassung
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Gruppe im Komplex, vermutlich den Liganden des [Fe-2S]-Zentrums His181, bewirkt
wird und nicht durch eine Verringerung der Inhibitoreffizienz durch Deprotonierung
der Hydroxylgruppe. Die strukturelle Ähnlichkeit zu Ubichinol und die kompetitive
Hemmung  der  Qo-Bindungsstelle  erlauben  es,  HHDBT  als  Substratanalogon  zu
betrachten.
Die Konformationsänderungen an der Bindungsstelle unterstützen den zuvor
postulierten Protonentransferweg und offenbaren die Plastizität der katalytischen
Bindungsstelle. Glu272
Copb  ist  ein  primärer  Ligand  der  Hydroxylgruppe  von
Stigmatellin, wie im röntgenkristallographischen Strukturmodell gezeigt wurde (Hunte
et  al.,  2000).  Die  Seitenkette  rotiert  von  der  Bindungsstelle  weg,  wenn  die
Hydroxylgruppe des Stigmatellins durch die Carbonylgruppe von HHDBT ersetzt wird
(Palsdottir  et al.,  2003).  Die  beobachtete  Rotation  von  Glu272  bestätigte  den
vorgeschlagenen Protonentransferweg, zusammen mit der wichtigen Beobachtung, dass
das Glu272-Carboxylat in der neuen Orientierung über ein Wassermolekül direkt mit
dem Häm-Propionat A verbunden ist. Vom Propionat A aus können Protonen über ein
kurzes Netzwerk von Wasserstoffbrücken, das strukturelle Wassermoleküle einbindet,
zum  Intermembranraum  transferiert  werden  (Palsdottir  et al.,  2003).  Aus  dem
beobachteten  Bindungsmodus  des  Hydroxychinon-Anions  und  dem
Protonentransferweg wurde ein katalytischer Mechanismus abgeleitet, der sich mit dem
Modell einer einfachen Besetzung der Ubichinol-Oxidationstasche in Einklang bringen
lässt. Die aus der Struktur hergeleiteten funktionellen Rückschlüsse werden diskutiert
(Palsdottir et al., 2003).
Um das vorgeschlagene mechanistische Modell zu überprüfen, wurde die FTIR-
Spektroskopie in Kollaboration mit Dr. P. Hellwig eingesetzt (Ritter et al., 2004). Diese
Studie  zeigte  zum  ersten  Mal,  dass  die  Bindung  der  Inhibitoren  HHDBT  und
Stigmatellin  den   Protonierungszustand  und/oder  die  Orientierung  von  sauren
Seitenketten  beeinflusst.  Des  weiteren  wurde  die  Interaktion  der  Stigmatellin
Carbonylgruppe  mit dem Enzym nachgewiesen.
In  Zusammenarbeit  mit  Prof.  M.  Ullmann  wurden  elektrostatische
Berechnungen  an  den  atomaren  Koordinaten  des  Cytochrom-bc1-Komplexes mit
gebundenem HHDBT in der Qo-Bindungsstelle durchgeführt. Vorläufige Ergebnisse
dieser  theoretischen  Untersuchung,  besonders  im  Hinblick  auf  die
Protonierungswahrscheinlichkeit  funktionell  relevanter  Aminosäurereste  wurden
diskutiert (Diplomarbeit, A. Klingen).Zusammenfassung
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Bei einem Vergleich von Cytochrom-bc1-Komplex Strukturen von Hefe und
Rind, mit verschiedenem Besetzungsgrad der Chinon-Bindungsstellen wurde die
Plastizität der Qo-Bindungsstelle beobachtet. Die Bindung des Qo-Bindungsstellen
Inhibitors  verursacht  folgende  Konformationsänderungen  in  den  Cytochrom  b
Domänen: die cd1 Helix und der ef Loop einschließlich der Seitenkette des Tyr279
bewegen  sich  und  führen  zu  einer  Aufweitung  der  Bindungstasche.  Diese
Konformationsänderungen  gehen  mit  einer  Domino-ähnlichen  Verschiebung  des
Wasserstoffbrückennetzwerkes einher. Die Reorientierung der Aminosäurereste in
Abhängigkeit  der  Besetzung  der  Qo-Bindungsstelle  wurde  unter  funktionellen
Gesichtspunkten diskutiert.
Ein  weiteres  Ergebnis  der  Doktorarbeit  war  die  Optimierung  der
Proteinreinigung im Hinblick auf eine geringere Delipidierung der Proteinprobe und
eine vergrößerte Kapazität. Dabei wurde, verglichen zu den früheren Präparationen, die
Ausbeute verbessert sowie die spezifische Enzymaktivität des gereinigten Proteins
erhöht. Der Lipid-Gehalt wurde durch die geringere Exposition des Proteins gegenüber
Detergenz-haltigen Medien erhöht. So konnten zwei neue Phospholipidmoleküle
reproduzierbar in unterschiedlichen Datensätzen identifiziert werden. Die Position
eines dieser Phospholipide an der Oberfläche der Qo-Bindungsstelle ist der äußeren
Lipidschicht der Doppelmembran zuzuordnen und erlaubte zusammen mit den zuvor
identifizierten Phopholipiden von der Matrixseite eine vertikale Positionierung des
Komplexes in der Membran. Darüber hinaus wird die Bindung eines Cardiolipins an
der Dimergrenzfläche beschrieben.
Die in der Kristallstruktur identifizierten, spezifisch gebundenen Phospholipide,
die  an  Interaktionsflächen  von  Proteinuntereinheiten  auftreten,  weisen  auf  eine
wichtige Rolle für die strukturelle Integrität des Komplexes hin. Eine vergleichende
Analyse  der  Lipidbindungsstellen  in  Strukturen  homologer  Proteine  wurde
durchgeführt und zeigte, dass sie Spezies-übergreifend konserviert sind (Palsdottir und
Hunte, in Druck). Eine Überlagerung der Strukturen des Cytochrom-bc1-Komplexes
aus Hefe und Huhn zeigte konservierte Bindungsstellen für die spezifisch gebundenen
Lipid-  und  Detergenzmoleküle.  Vielleicht  noch  erstaunlicher  sind  die
lipidangereicherten Kavitäten, die beim Vergleich der Strukturen von mitochondrialen
Cytochrom-bc1-Komplexen  mit  den  Röntgenkristallstrukturen  des  Cytochrom-b6f-
Komplex beobachtet wurden. Eine Analyse des Bindungsmodus von fest gebundenen
Lipiden  in  Membranproteinstrukturen  wurde  durchgeführt.  Es  wurden  hierbeiZusammenfassung
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spezifische Bindungsmuster für die Stabilisierung der Interaktionen zwischen den
Phosphodiestergruppen und den Seitenketten der Aminosäurereste identifiziert. Eine
bevorzugte Stabilisierung der  Phospholipide auf der negativen Seite der Membranen
wurde beobachtet. Ein erster Versuch wurde unternommen, um spezifische Motive für
Lipidkopfgruppenbindung zu identifizieren.
Es wurden Prüfstrategien entwickelt, um sowohl den Cytochrom-bc1-Komplex
als auch das Fv-Fragment auf seine Qualität zu überprüfen. Ein magnetic beads pull
down assay wurde für den analytischen Test der Bildung des Ko-Komplexes aus
Antikörper-Fv-Fragmenten und Cytochrom-bc1-Komplexes etabliert. Es wurde eine
detaillierte  strukturelle  Charakterisierung  des  Rieske-Epitops,  das  von  dem  Fv-
Fragment erkannt wird, durchgeführt. Die Spezies-Spezifität in der Erkennung der
antigenen Determinante wurde experimentell bestätigt. Daraufhin wurde ein Projekt in
Zusammenarbeit mit der Arbeitsgruppe von Herrn Prof. B. Ludwig (Diplomarbeit, T.
Kleinschroth) initiiert, mit der Aufgabe das Epitop der Hefe auf ein bakterielles Rieske-
Protein zu übertragen. Das Ziel dieses Projekts ist die Konstruktion eines bakteriellen
Cytochrom-bc1-Komplexes, der sich zur Fv-Fragment-vermittelten, dreidimensionalen
Kristallisation eignet.
Die  Röntgenkristallstrukturen  der  Hefe  Cytochrom-bc1-Komplexe  mit
gebundenen HHDBT oder Stigmatellin in der Qo-Bindungsstelle sind wertvoll, um
Einsichten in den molekularen Mechanismus und die molekulare Architektur des
katalytischen Zentrums zu erhalten. Außerdem ist die strukturelle Analyse dieser hoch
konservierten  Enzyme  wichtig,  um  die  molekularen  Ursachen  menschlicher
Krankheiten zu verstehen, die auf Mutationen im Cytochrom b zurückzuführen sind.
Ebenfalls von großer Bedeutung sind diese Strukturen für die gezielte Entwicklung von
Pestiziden oder pharmazeutischen Wirkstoffen, die gegen das aktive Zentrum der
Komplexe in Parasiten oder Pilzen gerichtet sind. Zielorganismen entwickeln oft eine
Resistenz gegenüber diesen Wirkstoffen.
Basierend auf dem HHDBT Bindungsmodus in der Qo-Bindungsstelle wurde
die Interaktion mit dem Antimalariawirkstoff Atovaquone modelliert. Die strukturellen
Grundlagen von dessen Spezies-spezifischer Wirkung können so diskutiert werden.
Weiterhin dienen Sequenzanalysen in Kombination mit strukturellen Studien der
Untersuchung  von  auftretenden  Resistenzen  gegenüber  der  Inhibitoren  der  Qo-
Bindungsstelle (Kessl et al., 2003).Zusammenfassung
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Die Röntgenstrukturen des Cytochrom-bc1-Komplexes bieten die Grundlage für
detaillierte Struktur-Funktions-Studien zur Beschreibung der molekularen katalytischen
Vorgänge. Sie fördern aufregende Entdeckungen für das tiefere Verständnis der
fundamentalen Prozesse des Lebens, welche durch diesen Typ der Enzyme katalysiert
werden.Abstract
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ABSTRACT
This dissertation is a study of the structure and function of the cytochrome bc1
complex from the yeast Saccharomyces  cerevisiae. This enzyme operates in all
kingdoms of life and is a cornerstone in bioenergetic electron transfer chains, where it
carries out tasks as diverse as respiration, photosynthesis, and nitrogen fixation. This
homodimeric multisubunit membrane protein has been studied extensively for several
decades and the enzyme mechanism is described with the modified protonmotive Q
cycle. Still, the molecular and kinetic description of the catalytic cycle is not complete
and questions remain regarding the bifurcation of electron transfer at the quinol
oxidation (Qo) site, substrate occupancy, pathways of proton conduction, and the
nature of the Rieske protein domain movement.
We used competitive inhibitors to study the molecular architecture at the Qo
site with X-ray crystallography. The structure of the enzyme with the substrate analog
5-n-heptyl-6-hydroxy-4,7-dioxobenzothiazole (HHDBT) bound at the Qo site was
determined  at  2.5  Å  resolution.  Spectroscopic  studies  showed  that  HHDBT  is
negatively charged when bound at the active site. Mechanistic interpretations from
inhibitor binding are in line with single occupancy model for quinol oxidation and
structural analysis supports the proposed proton transfer pathway. For functional
insight into the enzyme mechanism, redox-sensitive protonation changes were studied
by Fourier transform infrared spectroscopy.
The protein purification procedure was optimized for less delipidation and the
isolated  enzyme  was  more  active.  Furthermore,  two  new  phospholipids  were
identified in the X-ray structures, including a cardiolipin. Strikingly, conserved lipid
binding cavities were observed in structural comparison with homologous enzymes.
The functional role of tightly bound phospholipids will be discussed.
Finally, the Qo site is a target for various compounds of agricultural and
pharmaceutical importance. Importantly, the X-ray structures permit detailed analysis
of the molecular reasons for acquired resistance to and treatment failure of Qo site
inhibitors, such as atovaquone, that is used to treat malaria and pneumonia, as
discussed herein.Introduction
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1. INTRODUCTION
1.1 Biological energy conversion and oxidative phosphorylation
The enzymes that drive cellular energy production are highly conserved throughout
the kingdoms of life. Before the atmosphere was enriched with O2, the early anaerobic
life forms displayed a large repertoire of energy transduction mechanisms (see
Schopf, 1994; Berry, 2002). Less variation is observed in the building blocks that
construct the molecular machines that carry out oxidative phosphorylation and
oxygenic  photosynthesis.  The  organelles  that  host  these  essential  bioenergetic
processes, namely mitochondria and chloroplasts, are suggested to be remnants of
ancient bacteria, which were engulfed and integrated by endosymbiosis (see Margulis,
1981). The endosymbiosis hypothesis is supported by the remarkable similarity of the
photosynthetic machinery of cyanobacteria and plant chloroplasts. Likewise, the
mitochondrial enzymes involved in oxidative phosphorylation are highly conserved
(see Saraste, 1999; Schultz and Chan, 2001).
Regardless of metabolic diversity, the common principle in bioenergetics is
the establishment of a chemiosmotic gradient across biological membranes. The
conceptual breakthrough of a protonmotive force, first proposed in the chemiosmotic
hypothesis by Mitchell (1961), terminated the search for an organic compound linking
oxidation of metabolites and ATP production. Instead the protonmotive force was
proposed to comprise electrogenic separation of charges and a pH gradient across
insulating membranes.
In aerobic life, the great majority of cellular energy is produced by oxidative
phosphorylation  which  yields  adenosine  triphosphate  (ATP).  In  eukaryotes,
mitochondria are specialized for this task. An outer membrane and a highly folded
inner mitochondrial membrane enclose the enzyme-saturated matrix (Fig. 1B). The
respiratory electron transfer chain resides in the inner mitochondrial membrane and is
typically composed of four multisubunit membrane protein complexes (complexes I-
IV) (Fig. 1C). Electron transfer through these membrane bound enzymes is achieved
by cofactors of distinct redox midpoint potentials (Em), that are configured to harvest
the free energy from oxidation of metabolites in a process that facilitates proton
translocation.Introduction
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Cytosolic  oxidation  of  carbohydrates,  commonly  known  as  glycolysis,
terminates in the dehydrogenase catalyzed decarboxylation of pyruvate to acetylCoA
(AcCoA), a reaction that takes place in the mitochondrial matrix. AcCoA is also a
terminal product of fatty acid oxidation. Enzymes of the citric acid cycle (i.e. Krebs
cycle)  oxidize  AcCoA  to  CO2  in  stepwise  reactions,  and  thereby  reduce  three
nicotinamide adenine dinucleotide (NADH) and one flavin adenine dinucleotide
(FADH2)  per  cycle.  NADH  is  the  substrate  for  Complex  I  (NADH:ubiquinone
oxidoreductase), whereas FADH2 is intrinsic to the only membrane bound component
of the citric acid cycle, or Complex II (Succinate:ubiquinone oxidoreductase, SQR).
Complex I and II reduce the lipophilic two electron-two proton carrier, ubiquinol,
which is the substrate of the third respiratory complex, the cytochrome bc1 complex
[E.C.1.10.2.2, Ubiquinol: cytochrome c oxidoreductase]. Complex III reduces the
soluble cytochrome c in the intermembrane space, which is the substrate of Complex
IV, or cytochrome c oxidase, that finally reduces oxygen to H2O. Electron transfer
through Complexes I, III and IV is coupled to translocation of protons across the inner
mitochondrial membrane. The established gradient of protons drives ATP production
by the thermodynamically feasible backward flow through Complex V, the reversible
F1-F0 ATP synthase.
The yeast Saccharomyces cerevisiae is a suitable model organism to study the
respiratory chain. It is easy to cultivate, the genome has been sequenced (Goffeau et
al., 1996) and it is accessible to genetic manipulation. Furthermore, it is facultative
anaerob organism, and therefore it is possible to grow respiratory deficient variants on
fermentable carbon sources.
In S. cerevisiae, Complex I is lacking, but its function in reducing ubiquinone
is supplemented by alternative NADH dehydrogenases (de Vries and Grivell, 1988;
Marres  et  al.,  1991;  Small  and  McAlister-Henn,  1998).  These  alternative
dehydrogenses, however, do not translocate protons (see Joseph-Horne et al., 2001).
1.2 The cytochrome bc1 complex catalysis
Cytochrome bc complexes are versatile enzymes found in most niches of life, where
they  operate  in  tasks  as  diverse  as  respiration,  bacterial  nitrogen  fixation,
denitrification, and together with the bacterial reaction center in light driven electron
transfer (see Berry et al., 2000). In thylakoids and cyanobacterial plasma membrane, a
homologous enzyme, cytochrome b6f complex, functions in oxygenic photosynthesis.Introduction
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Fig.1  Oxidative  phosphorylation  in  mitochondria.  A,  schematic  overview  of  an
eukaryotic  cell.  B,  mitochondria,  the  organelles  responsible  for  cellular  energy
production, exhibit different shapes and sizes. 3D imaging of mitochondrial morphology
has extended the schematic “baffle model” to include more complex invaginations of the
inner mitochondrial membrane (IMM). Shown are electron microscopy tomographic
reconstructions of dendritic mitochondrion from chick cerebellum (Frey and Mannella,
2000). The highly folded IMM forms cristae (Palade, 1952), which increase the surface
area for respiration to take place. C, structural overview of oxidative phosphorylation
(OXPHOS). Except for Complex I, the components of OXPHOS have been structurally
characterized by X-ray crystallography: a) structural insight and subunit assignment in
Complex  I  relies  so  far  on  electron  microscopy  and  single  particle  analysis  (e.g.
Zickermann et al., 2003; Peng et al., 2003; Friedrich and Bottcher, 2004). Shown here is
a single particle reconstruction of complex I from the obligate aerob fungi, Y. lipolytica
(kindly provided by M. Bostina), b) X-ray structure of the mitochondrial Complex II is not
available, shown here is a monomer from the X-ray structure of the homologous enzyme
from E. coli (pdb entry 1NEK), c) Complex III from S. cerevisiae mitochondria (pdb entry
1KB9), d) Complex IV from bovine
 heart mitochondria (pdb entry 1V54), e) Complex V
from S. cerevisiae mitochondria (pdb entry 1QO1). In the intermembrane space (IMS) the
soluble electron carrier cytochrome c (cyt c) (from pdb entry 1KYO) is shown. The
lipophilic electron carrier CoQ diffuses within the IMM and connects complexes I, II and
III. The Krebs cycle products NADH and FADH2 fuel the respiratory chain. The purple
arrows show the direction of proton translocation across the membrane.Introduction
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The protonmotive Q cycle was first proposed to describe cytochrome bc1
complex catalysis by Mitchell (1975, 1976). Subsequently, extensive research into the
enzyme mechanism has yielded a reaction scheme termed ‘the modified protonmotive
Q cycle’ (e.g. Crofts and Meinhardt, 1983; Crofts and Wang, 1989; Trumpower,
1990; Crofts, 2003). The overall chemical equation is well understood. In short,
quinone is reduced at the Qi site with uptake of protons from the matrix. In contrast,
protons are released on the intermembrane side when quinol is oxidized at the Qo site
(see Fig. 2). Despite decades of research efforts to understand the enzyme mechanism,
detailed molecular and kinetic description of the reaction cycle, especially at the Qo
site, is still lacking.
Quinol oxidation involves the highly debated bifurcated electron transfer
reaction. One electron is passed via the high potential electron transfer chain, from the
[2Fe-2S]  cluster  to  heme  c1.  Surprisingly,  the  second  electron  travels  a
thermodynamically less favorable route and is recycled within the enzyme. It is
transferred via the two b type hemes to reduce quinone at the Qi site. The resulting
stable semiquinone at the Qi site, is fully reduced after a second quinol molecule is
oxidized at the Qo site.
1.3 Isolation of the cytochrome bc1 complex and supercomplex formation
The first methods to purify the cytochrome bc1 complex were based on bile salt
detergent solubilization and differential ammonium sulfate precipitation (Rieske,
1976; Siedow et al., 1978; Yu et al., 1974). Also, chromatographic approaches, such
as hydroxyapatite chromatography with Triton X-100 (Engel et al., 1980; Riccio et
al.,  1977)  and  anion-exchange  chromatography  of  dodecyl-maltopyranoside
solubilized protein (Berry and Trumpower, 1985) were successfully applied. The
latter procedure has been modified and optimized for preparations from diverse
sources, including animals (Ljungdahl et al., 1987), plants (Berry et al.,  1991),
bacteria (Montoya et al., 1999), and fungi (Hunte et al., 2000; Palsdottir and Hunte,
2003).
Although the components of the respiratory chain are active as isolated
complexes, there is growing evidence for their supramolecular organization in the
membrane, the ‘respirasome’ (Schägger and Pfeiffer, 2000). Early isolation protocols
provided the first evidence that the respiratory chain assembles into supercomplexes.
Complex II and III were co-purified (Yu et al., 1974) and complex III and IV wereIntroduction
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isolated together (Cruciat et al., 2000). Blue native polyacrylamide gel electrophoresis
(BN-PAGE) of digitonin extracts suggested specific assemblies of OXPHOS system
components in both bacterial and mitochondrial membranes (see Schägger, 2002). In
disagreement with results from mutagenesis studies (Bruel et al., 1996), BN-PAGE
analysis  of  mitochondrial  membranes  from  yeast  failed  to  reveal  a  stable
supercomplex between complex II and complex III (Schägger and Pfeiffer, 2000).
However, strong evidence for physical interactions between Complex II, III and IV
comes from inhibitor titration studies. The observed absence of pool function for CoQ
and cytochrome c under physiological conditions suggests that the respiratory chain
forms a functional unit in yeast (Boumans et al., 1998).
1.4 Structural characterization of the cytochrome bc1 complex
From the total of 10 subunits, which construct a monomer in yeast, 3 carry redox
centers  and  are  essential  for  catalysis:  cytochrome  b  with  two  b-type hemes,
cytochrome c1 with the c-type heme, and the Rieske protein, which contains an [2Fe-
2S] iron-sulfur cluster. The first electron micrographs of the cytochrome bc1 complex
showed that the enzyme was a homodimer (see Weiss et al., 1987; Weiss et al., 1990).
A functional unit in catalysis is composed of the soluble Rieske protein domain,
which interacts with cytochrome b and cytochrome c1 from the other monomer. X-ray
structures of the enzyme at a resolution 3 Å or better were available by the late
nineties (Xia et al., 1997; Zhang et al., 1998; Iwata et al., 1998; Hunte et al., 2000).
Importantly, the large-scale domain movement necessary for electron transfer from
Rieske to cytochrome c1 was first visualized in the X-ray structures (Zhang et al.,
1998). The X-ray structure determination of the cytochrome bc1 complex from S.
cerevisiae was facilitated by the antibody Fv fragment 18E11 and yielded 2.3 Å
resolution (Hunte et al., 2000), the highest resolution currently available.
 The cytochrome c oxidase from the soil bacterium Paracoccus denitrificans
was the first example of Fv fragment mediated 3-D crystallization (Ostermeier et al.,
1995; Iwata et al., 1995). The antibody fragment Fv7E2 was first used to crystallize
the four subunit enzyme and its versatility was manifest in subsequent structure
determination of the two subunit catalytic core (Ostermeier et al., 1997). Further
usefulness of antibody-based crystallization enhancers is illustrated in the recent Fab-
mediated X-ray structure determination of the potassium channel KcsA (Zhou et al.,Introduction
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2001), the voltage-dependent potassium channel KvAP (Jiang et al., 2003), and the
ClC chloride channel (Dutzler et al., 2003).
The yeast cytochrome bc1-Fv18E11 co-complex crystallized in space group
C2, with a monomer in the asymmetric unit. The recent structure determination to
2.97 Å resolution of the ternary complex with the substrate cytochrome c co-
crystallized with the Fv-bc1 co-complex, yielded a different crystal packing, with a
dimer in the asymmetric unit (Lange and Hunte, 2002). Interestingly,  a single
cytochrome c was bound per dimer. The X-ray structure of the homodimeric yeast
cytochrome bc1 complex consists of nine subunits per monomer (Fig. 3) with 24
transmembrane helices (TM) (Table 1). The tenth and most basic subunit, Qcr10p, is
removed during the anion exchange chromatography (Hunte  et al.,  2000).  The
bacterial  enzyme  is  structurally  simpler  and  consists  only  of  the  homodimeric
catalytic core (see Berry and Huang, 2003). Similarly, other bacterial respiratory
enzymes, for instance Complex I, are present in the minimal form, and supernumerary
subunits appear to be acquired as recent events in the evolution of the mitochondrial
counterparts (see Brandt et al., 2002). Many of the accessory, i.e. non-catalytic,
subunits are non-essential, but rather appear to guide assembly and/or enforce
stability. This function could be dictated by structure, rather than sequence-specific
traits. For instance, the cytochrome bc1 complex subunit 10 (Qcr10p) in the yeast and
bovine enzymes, lack sequence similarity (Brandt et al., 1994). Still, both subunits
contain one transmembrane helix and charged extramembraneous domains and are
therefore suggested to serve similar structural roles.
Table 1 Subunit composition of the yeast cytochrome bc1 complex.
Subunit Abbr. Topology Function
Cytochrome b Cobp 8 TM Catalytic, essential
Cytochrome c1 Cyt1p 1 TM, IMS Catalytic, essential
Rieske Rip1p 1 TM, IMS Catalytic, essential
Core I Cor1p Matrix Assembly, proteolytic protection, pI~6
Core II Qcr2p Matrix Assembly, proteolytic protection, pI~6
Subunit VI Qcr6p IMS Thermal stability, pI<4
Subunit VII Qcr7p Matrix Biogenesis, essential, pI~6
Subunit VIII Qcr8p 1 TM Biogenesis, essential
Subunit IX Qcr9p 1 TM Thermal stability
Subunit X Qcr10p 1 TM Stability
pI values were only calculated for the peripheral subunits. Functional aspects regarding catalysis, assembly and
stability are discussed in text. Nomenclature, i.e. abbreviations (Abbr.) for subunits, was adapted from the Yeast
Protein Database (YPD).Introduction
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Fig.2 The modified protonmotive Q cycle. A, the functional unit is shown with the three
catalytic subunits: cytochrome b (blue) and cytochrome c1 (yellow) from one monomer,
which interact with Rieske (cyan) from the other monomer. The position of cytochrome c
(red) is shown as refined in the X-ray structure of the ternary complex (pdb entry 1KYO).
The Qo site occupied by stigmatellin (Sti) and the Qi site with ubiquinone (Uq6) bound are
encircled  (magenta).  B, the protonmotive Q cycle is depicted on the right. Ubiquinol
carries protons from the mitochondrial matrix (MA) to the intermembrane space (IMS).
B A
Intermembrane space
Transmembrane
region
Matrix
Fig.3 Structural overview of the yeast cytochrome bc1 complex (Hunte et al., 2000).Introduction
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The 7-8 accessory subunits in the mitochondrial cytochrome bc1 complexes
have proposed roles in regulation, assembly, and stability (di Rago et al., 1997; Zara
et al., 2004) (Table 1). Assembly of the homodimer occurs by congregation of
precomplexes,  guided  by  chaperones  (Cruciat  et al.,  1999).  A  precomplex  of
cytochrome b, subunit 8 (Qcr8p) and subunit 7 (Qcr7p) integrates a subcomplex of the
two core proteins, Core 1 (Cor1p) and Core 2 (Qcr2p) (Lee et al.,  2001). The
peripheral Cor1p and Qcr2p proteins are homologous to the α and β subunits of the
matrix processing peptidases (MPPs), respectively, but have lost MPP activity in
yeast. The core proteins appear important for assembly of the complex (Tzagoloff et
al., 1986; Oudshoorn et al., 1987). Qcr7p and Qcr8p deletion mutants are respiratory
deficient irrespective of temperature (Schoppink et al., 1989; Maarse et al., 1988).
Yeast  deletion  mutants  have  shown  that  absence  of  any  one  of  the  subunits
cytochrome b, Qcr7p, or Qcr8p, induces loss of the other two (Zara et al., 2004).
A  catalytic  function  of  Qcr6p  in  guiding  cytochrome  c docking on the
cytochrome c1 has been proposed (Kim and King, 1983). Furthermore, in the absence
of subunit 6 (Qcr6p), maturation of cytochrome c1 is blocked (Yang and Trumpower,
1994).  Interestingly,  deletion  of  Qcr6p  was  shown  to  promote  supercomplex
formation most likely due to the alleviation of electrostatic repulsion derived from this
highly acidic subunit (Pfeiffer et al., 2003).
Subunit 9 (Qcr9p) deletion negatively affects assembly and stability of the
complex (Phillips et al., 1993). Qcr9p is proposed to stabilize the interactions between
the 3 catalytic subunits, cytochrome b, cytochrome c1 and Rieske (Saint-Georges et
al., 2002). Lower turnover numbers and dissociation of Rieske upon purification of
the enzyme from a Qcr10p deletion strain points to a role of this subunit in conferring
stability to the enzyme (Brandt et al., 1994).
1.5 Tight binding of phospholipids to the cytochrome bc1 complex
The detergent-solubilized cytochrome bc1 complex forms classical type II crystals
(Michel, 1983). The detergent molecules mimic the bilayer and from a cylindrical
micelle, that surrounds the transmembrane region of integral membrane proteins. This
detergent  micelle  is  typically  disordered  and  therefore  not  detected  by  X-ray
crystallography (Roth et al., 1989). Nevertheless, already in the first crystal structure
of a membrane protein, the bacterial reaction center, a few tightly bound N,N-
Dimethyldodecylamine-N-oxide (LDAO) molecules were co-purified and resolved inIntroduction
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the electron density, demonstrating ordered binding to the protein (Deisenhofer et al.,
1985; Deisenhofer and Michel, 1989). Despite the forced delipidation from exposure
to detergent-containing buffers during isolation and crystallization of membrane
proteins, data is accumulating that shows tightly bound lipids that are retained and
refined in the X-ray structures (see Lee, 2003; Palsdottir and Hunte, in press). The
extent of specific binding of these molecules, as well as the functional importance of
lipid binding to membrane proteins provokes ongoing research.
Cardiolipin  is  a  characteristic  phospholipid  of  the  inner  mitochondrial
membrane (see Schlame et al., 2000), which is also composed of phosphatidyl
ethanolamine  (PE),  phosphatidyl  choline  (PC),  phosphatidyl  inositol  (PI),
phosphatidyl serine (PS), and phosphatidyl glycerol (PG) (Zinser et al., 1991). In
addition  to  the  important  role  of  creating  a  permeability  barrier  for  cellular
compartmentalization, as well as sealed integration of integral membrane proteins in
the bilayer, phospholipids and their derivatives have assigned roles in a number of
physiological processes (see Dowhan, 1997; Carman and Henry, 1989). Anionic lipid
headgroups have been proposed to provide proton-conducting pathways at membrane
surfaces (Haines, 1983). Furthermore, emerging evidence suggest roles of lipids in
protein  translocation  (de Vrije  et  al.,  1988),  membrane  protein  topology  (van
Klompenburg et al., 1997), transporter function (Bogdanov and Dowhan, 1995),
membrane protein folding (Bogdanov et al., 1998), thermal stability (Fyfe et al.,
2004), and supercomplex formation (Pfeiffer et al., 2003).
The importance of phospholipids for structural and functional integrity of the
isolated cytochrome bc1 complex is best illustrated by decreased enzyme activity as a
consequence of increased delipidation of the protein (Yu and Yu, 1980; Schägger et
al., 1990). Phospholipid digestion reversibly inactivated the isolated enzyme, which
regained catalytic activity upon addition of a mixture of cardiolipin and phospholipids
(Gomez and Robinson, 1999).
The high resolution X-ray structure of the yeast cytochrome bc1 complex
revealed five tightly bound phospholipid molecules, including a cardiolipin, as well as
one  detergent  molecule  per  monomer  (Lange  et al.,  2001).  The  tightly  bound
cardiolipin was suggested to have a role in the proton uptake pathway at the Qi site,
the  postulated  E/R  pathway  (Lange  et  al.,  2001).  One  of  the  5  identified
phospholipids,  a  phosphatidylinositol,  is  unusual,  because  the  head  group  is
positioned below the estimated membrane plane (Lange et al., 2001). It is referred toIntroduction
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as ‘inter-helical’ because it is wrapped around the transmembrane helix of the Rieske-
protein. The other structurally resolved lipids are thought to represent more faithfully
the surrounding annular bilayer.
The  combination  of  X-ray  structural  analysis,  molecular  genetics  and
biochemical studies provides a powerful strategy to address the functional role of
these tightly bound phospholipids (Lange et al., 2001; Fyfe et al., 2004).
1.6 Properties of the catalytic cofactors in the cytochrome bc1 complex
Early characterization of the cytochromes was based on their redox-specific heme
absorbance in the visible spectrum (Keilin, 1925). The b-type hemes are stabilized by
non-covalent interactions, whereas heme c1 is a true prosthetic group and covalently
linked to cytochrome c1 with thioether bonds from heme c1 vinyl groups to conserved
cysteines. The midpoint potential (Em) of heme c1 is 240 mV in yeast (Sun and
Trumpower,  2003).  Both  b  type  hemes  are  stabilized  between  the  same
transmembrane helices of cytochrome b. However, heme bH is close to the matrix
side, whereas heme bL is closer to the intermembrane space (Fig. 2). Since they
experience different electronic environments, they accordingly exhibit different
midpoint potentials or 120 mV and -30 mV, respectively (Sun and Trumpower, 2003).
The soluble Rieske domain is connected by a ‘linker’ region (residues 81–92)
to the transmembrane anchor (residues 51–80). A phospholipid molecule has been
suggested to have a structural role in stable integration of the transmembrane helix in
the cytochrome bc1 complex (Lange et al., 2001). The soluble domain of the Rieske
protein (residues 93–215) is formed by layers of antiparallel β sheets, which fold into
a compact structure, held by a conserved disulfide bond between residues Cys164 and
Cys180,  at  the  tip  where  the  [2Fe-2S]  cluster  is  bound  (Iwata  et al.,  1996).
Elimination of this disulfide bridge damages the ubiquinol oxidation site (Merbitz-
Zahradnik et al., 2003).
Several strong and conserved bonds interact with the [2Fe-2S] cluster, which
has a high electron midpoint potential (Em,7 ~ 285 mV) that is pH dependent. Variants
with reduced Rieske midpoint potential exhibit decreased catalytic activity, consistent
with ubiquinol oxidation being the rate-limiting step in catalysis (Denke et al., 1998;
Guergova-Kuras et al., 2000). One of the iron atoms of the [2Fe-2S] cluster is
coordinated by  two  histidine ligands,  His161  and  His181,  the  latter  residue  is
proposed to be a direct ligand of quinol. Circular dichroism (CD)-monitored redoxIntroduction
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titrations (Link et al., 1992; Ugulava and Crofts, 1998), protein-film voltammetry (Zu
et al., 2003) and theoretical calculations (Ullmann et al., 2002) agree that when
Rieske is oxidized, the lowest pKa value is ~7.5, or 4 units lower than the pKa values
estimated for the reduced Rieske protein.
The substrate of the yeast cytochrome bc1 complex, Coenzyme Q6 (CoQ6),
exhibits nine different chemical states, with the most stable forms being the fully
protonated ubiquinol (QH2) and the oxidized ubiquinone (Q) (see Chambers, 1988).
These states are interconvertible through semiquinone (SQ) intermediates (Fig.4).
Fig.4 The chemical states of Coenzyme Q. Interconvertible redox states and protonation
reactions. Figure from James et al. (2004).Introduction
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The isoprenoid side chain of CoQ is not essential for Qo site catalysis and can
be replaced with an alkyl group, although this substitution is accompanied by
decreased turnover rates (Yu et al., 1985). Rates of ubiquinol oxidation are found to
increase proportionally with the length of the alkyl side chain until a critical length is
reached and after which the rates decrease again (Yu et al., 1978; Yu et al., 1985).
1.7 Inhibitors as tools to study the molecular mechanism
Site-specific  inhibitors  have  provided  a  bulk  of  data  regarding  the  enzyme
mechanism. Before the X-ray structures were available, kinetic studies on variants
with phenotypes of disturbed enzyme mechanism, together with data on inhibitor
binding, permitted rough assignment of the active sites in a molecular context (see
Brasseur et al., 1996). Widely used inhibitors to study the Qo site include UHDBT (5-
n-undecyl-6-hydroxy-4,7-dioxobenzothiazole)  and  stigmatellin.  The  bifurcated
electron transfer at the Qo site was first realized when the Qi site inhibitor antimycin
was bound and Qo site specific inhibitors were observed to terminate the oxidant-
induced reduction of heme bL (Wikström and Berden, 1972).
Unlike the stably bound and structurally resolved Qi site occupant, X-ray
structural analysis has  failed in  detecting the native Qo site occupant. Instead,
substrate analogs, which serve as competitive inhibitors, are used to analyze the
molecular environment at the binding site. Importantly, EPR studies have served as
diagnostic tools because the paramagnetic Rieske cluster exhibits characteristic
lineshapes with respect to Qo site occupancy (see Brugna et al., 2000; Cooley et al.,
2004). Recently, pulsed EPR analysis provided the first structural characterization of
the interaction of the reduced Rieske [2Fe-2S] cluster with the native occupant at the
Qo  site,  more  specifically  with  the  product  of  the  quinol  oxidation  reaction
(Samoilova et al., 2002).
Three types of Qo site inhibitors can be distinguished; ligands which bind the
proximal domain and perturb the spectroscopic properties of heme bL (Qo-I, e.g.
myxothiazol, MOA-stilbene), molecules which bind to the distal domain and affect
the Rieske [2Fe-2S] EPR lineshape (Qo-II, e.g. UHDBT),  or  compounds  which
exhibit both effects (Qo-III, e.g. stigmatellin) (von Jagow and Link, 1986; Crofts et
al., 1999a). The binding sites for all three classes of inhibitors overlap with respect to
their side chains that tail into a common tunnel, which gradually opens up into the
cavity at the dimer interface. The head groups of type I and type II/III inhibitors, onIntroduction
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the other hand, are stabilized in different positions in the bilobal Qo site, binding
proximal and distal to heme bL, respectively.
Type II/III inhibitors, such as stigmatellin and UHDBT, arrest the [2Fe-2S]
cluster in docking position on cytochrome b (b-position) at a large enough distance to
prevent efficient electron transfer to heme c1 (Zhang et al., 2000). EPR studies have
suggested favored interactions of the distal inhibitors, stigmatellin (von Jagow and
Ohnishi, 1985), UHDBT (Bowyer et al., 1981; Bowyer et al., 1982) and UHNQ
(Matsuura et al., 1983), with the reduced Rieske protein.
Stigmatellin was isolated from the myxobacterium Stigmatella aurantiaca
(Kunze et al., 1984). Its binding to the cytochrome bc1 complex induces a red shift in
the α-band  of  heme b566 and causes a pronounced increase in Rieske midpoint
potential from 290 mV to 540 mV (von Jagow and Ohnishi, 1985). Stigmatellin was
instrumental for high resolution structure determination of the yeast cytochrome bc1
complex, where it fixes the mobile Rieske domain in b-position. The stigmatellin
carbonyl group was within hydrogen bond distance to the Rieske His181 side chain
(Hunte et al., 2000). This interaction was recently confirmed by EPR analysis
(Samoilova  et al., 2002). The stigmatellin side chain is important for efficient
inhibition,  but  not  essential,  as  illustrated  by  alkyl  derivatives  that  still  retain
inhibitory potency (Thierbach et al., 1984). Inhibition with stigmatellin appears to be
pH independent (Zhang et al., 1999). Stigmatellin is a versatile inhibitor that not only
inhibits quinol oxidation in the cytochrome bc1 complex, but also inhibits quinone
reduction in the bacterial reaction center, where it was crystallographically resolved at
the QB site (Lancaster and Michel, 1997).
The alkyl-4,7-hydroxydioxobenzothiazoles (HDBT) were first synthesized as
antimalarial  drugs,  as  described  by  Friedmann  and  coworkers  (1973).  Unlike
stigmatellin, undecyl-HDBT (UHDBT) inhibits the complex in a pH dependent
manner, with decreasing inhibitory potency at alkaline pH (Zhang et al., 1999).
Similar to stigmatellin, UHDBT increases the Rieske midpoint potential, although less
dramatically, or by 70 mV (Bowyer et al., 1982). A pKa of 6.5 has been determined
for the hydroxy group, measured in phosphate buffer containing 1% ethanol, and
deprotonation of the 6-hydroxy group was described with a color change from yellow
to purple (Trumpower and Haggerty, 1980). Effective inhibition of the complex has
been shown for 5-n-alkyl-6-hydroxy-4,7-dioxobenzothiazoles containing 7-15 carbon
alkyl side-chains (Bowyer et al., 1982).Introduction
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1.8 Quinol oxidation reaction
Interpretation of kinetic studies on the cytochrome bc1 complex is complicated by the
fact that duplicates of all reactions and a set of distinct catalytic interfaces have to be
considered, including the large scale domain movement of the Rieske from b- to c1-
position. The thermodynamically favorable, but energetically wasteful, reduction of
Rieske by both electrons of ubiquinol is circumvented by the bifurcated electron flow
at the Qo site, where the second electron enters the lower potential electron transfer
chain.
Which are the regulatory mechanisms behind this bifurcated electron transfer?
Is a semiquinone transiently stabilized as a reaction intermediate or is ubiquinol
oxidation concerted?
Most mechanistic models propose an enzyme-substrate complex with the
Rieske cluster ligand His181 and cytochrome b residue Glu272 as primary ligands of
ubiquinol. The observed pH dependency of quinol oxidation rate in the acidic range
(Brandt and Okun, 1997; Covian and Moreno-Sanchez, 2001) suggests that both
His181 and Glu272 should be deprotonated to participate in formation of the reaction
complex. Also, the probability of forming the reaction complex depends on the
correct positioning of the oxidized Rieske soluble domain. Accordingly, changing the
Ubiquinol HHDBT
StigmatellinIntroduction
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length of the flexible linker region which connects the cluster-containing domain to
the transmembrane helix results in loss of ubiquinol oxidation activity (Nett et al.,
2000; Darrouzet et al., 2000). The position of the Rieske extrinsic domain and
interactions with the Qo site occupant affect the midpoint potential (Darrouzet et al.,
2002; Shinkarev et al., 2002; Cooley et al., 2004). The observed up-shift in midpoint
potential induced by distal inhibitors has been proposed as a gating mechanism to
prevent re-reduction of cytochrome c1 by the semiquinone formed after the initial
coupled proton-electron transfer to the Rieske (Link, 1997). Another interpretation is
based on conformational gating where the Rieske domain is tied up away from the
cytochrome c1 by interactions with the Qo site occupant. Kinetic studies suggest that
the oxidized Rieske protein has higher mobility than does the reduced (Zhang et al.,
2000). Redox-regulated movement of the Rieske is an attractive candidate for gating
quinol oxidation. It is, however, not clear whether the movement of the Rieske
domain is stochastic or a steered molecular motion.
In addition to the large-scale movement of the extrinsic domain from c1- to b-
position, smaller movements of the Rieske head domain docked to cytochrome b have
been proposed (Darrouzet and Daldal, 2002). Studies on variants and observed
compensatory mutations suggest that loops at the cytochrome b surface construct
physical barriers for steering and fine-tuning Rieske movements (Darrouzet and
Daldal, 2003; Brasseur et al., 2004). Furthermore, movement of the Rieske extrinsic
domain was shown to be essential for efficient catalysis, but not required for a single
round of oxidation at the Qo site (Darrouzet and Daldal, 2002).
The complexity of the cytochrome bc1 complex catalysis is illustrated by the
fact  that,  despite  multi-faceted  approach  spanning  several  decades,  important
regulatory  elements  are  still  not  understood.  An  ongoing  dispute  concerns  the
occupancy of the Qo site, with models ranging from a single substrate bound (Crofts
and Wang, 1989; Snyder et al., 1999) to double occupancy (Ding et al., 1992; Ding et
al., 1995b; Brandt, 1996; Brandt, 1998; Bartoschek et al., 2001), including a hybrid
proposal suggesting a moving semiquinone in the bilobal binding site (Hong et al.,
1999; Crofts et al., 2000).Introduction
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1.9 X-ray crystallographic and spectroscopic studies of proton transfer pathways
Maintenance of the proton gradient is a prerequisite for energy transduction. How are
the protons transferred within the hydrophobic membrane spanning domains?
Nagle and Morowitz proposed in 1978 that proton conduction in membrane
proteins takes place through hydrogen bond networks. The available X-ray structures
of energy transducing enzymes now permit combined spectroscopic and structural
dissection, as well as molecular modeling studies, of proton transfer pathways. Proton
conduction by a network of amino acid residues and water molecules has been
proposed for bacteriorhodopsin (Le Coutre et al., 1995), the cytochrome c oxidase
(Riistama et al., 1997; Olkhova et al., 2004), and the photosynthetic reaction center
(Baciou and Michel, 1995; Tandori et al., 1999).
In the cytochrome bc1 complex, ubiquinol carries the protons across the
membrane, but defined pathways for proton conduction must exist to and from the
active sites. The proton exit pathway at the Qo site was first proposed by molecular
dynamics simulations on the 3 Å X-ray structure of the chicken cytochrome bc1
complex  (Izrailev  et al., 1999; Crofts et al.,  1999c).  Subsequently,  the  higher
resolution  structure  of  the  yeast  enzyme  provided  experimental  evidence,
demonstrating a hydrogen bond network, including the heme bL propionate and
structurally resolved water molecules (Hunte et al., 2000) (Fig. 5).
Fig.5 Proposed proton exit pathway from the Qo site. X-ray structural analysis revealed
a  network  of  hydrogen  bonds  (stipled  lines)  which  connect cytochrome b residues,
structural water molecules and the heme bL propionate A (from Hunte et al., 2000).
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X-ray crystallography is the most frequently applied technique to obtain
atomic models of proteins. However, protons are not resolved at the resolution
typically  obtained  for  membrane  proteins.  Information  about  redox-dependent
protonation states of catalytic residues, therefore, needs to be retrieved by other
biophysical techniques. Fourier transform infrared spectroscopy (FTIR) is ideal for
this purpose and has been successfully applied, together with structural information
from X-ray crystallography, to study a number of photosynthetic and respiratory
electron  transfer  complexes.  FTIR  permits  sensitive  measurements  of  redox-
dependent protonation reactions and reliable assignment of bands in the spectra can be
carried out when supplemented with structural information, site-directed mutagenesis
and  isotopically  labeled  compounds.  For  instance, 
13C-labeling  of  the  heme
propionates in cytochrome c oxidase was used to study their protonation states with
FTIR (Behr et al., 1998; Rost et al., 1999; Behr et al., 2000; Hellwig et al., 2002).
FTIR studies have been initiated for cytochrome bc1 complex from R. capsulatus
(Baymann et al., 1999), P. denitrificans (Ritter et al., 2003), bovine (Iwaki et al.,
2003), and, recently, S. cerevisiae (Ritter et al., 2004), as described here.
1.10 Aims of this dissertation
The molecular mechanism and regulatory events in cytochrome bc1 complex Qo site
catalysis are not clear, including controversial models of Qo site occupancy and
electron  transfer  reactions.  Also,  pathways  for  proton  transfer  need  to  be
experimentally validated. Here, X-ray crystallography was the method of choice to
pursue  verification  of  some  of  these  issues  in  structural  context.  Competitive
inhibitors  and  substrate  analogs  were  used  to  analyze  the  Qo  site  molecular
architecture with X-ray crystallography. The structural study presented here was
extended by FTIR analysis to monitor the interactions between inhibitors and the
enzyme in redox-induced difference spectra. Furthermore, the protein preparation was
optimized to increase the lipid content of the isolated enzyme and the binding of
phospholipids to the enzyme was structurally characterized.Results
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2. RESULTS
2.1 Preparation of crystallization grade cytochrome bc1 complex
The purification procedure was scaled-up to accommodate more material and the
exposure to detergent-containing buffers was minimized in order to increase the lipid
content. The modified preparation yielded more active enzyme that was pure and
crystallized readily (Table 2).
1P84.pdb
DDM
solubilization
Membrane preparation
FF DEAE
HyperD DEAE
Anion exchange
chromatography
Size-exclusion chromatography
Fv-cytochrome bc1 co-complex
Co-crystallize with inhibitor
X-ray structure determination
Tightly bound lipids
More active enzyme
Scale-up
Minimize
exposure to
detergent
Scheme 1 Flowchart of the preparation of the yeast cytochrome bc1 complex for X-ray
structure determination. The steps in the purification procedure that were subjected to
modifications including scale-up and less exposure to detergents are boxed red.Results
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2.1.1 Five-fold scale-up of the membrane preparation
The first step in increasing the capacity of the preparation was the physical scale-up of
the glass bead mill system used for cell breakage. In this way, more than one kg of
yeast cells (wet weight) were processed, instead of the previous limit of 250 g per
preparation. A typical yield was ~180 ml membranes from 1300 g cells (wet weight)
or roughly 14 ml/100 g cells, which is similar to the original protocol, where ~20 ml
of membranes were isolated from 100 g cells (Palsdottir and Hunte, 2003). This slight
decrease in membrane yield may be a consequence of less efficient cell breakage
when processing larger volumes, or caused by less efficient design of the large glass
bead mill system. Increasing the membrane volume from 15 ml to 25 ml in 210 ml
extraction buffer resulted in an increase in total protein content from 8.8 mg/ml to
13.5 mg/ml. The observed higher turnover numbers of the cytochrome bc1 complex in
detergent-solubilized membranes (Table 2) may be derived from the higher protein-
to-detergent ratio. More than hundred times the critical micelle concentration (c.m.c.
~0.2 mM) of the non-ionic n-dodecyl-β-D-maltopyranoside (DDM) detergent was
used for solubilization of the protein or a final concentration of ~30 mM. Importantly,
the ratio ~1.15 g DDM per 1 g total protein should be kept constant in all preparations
to ensure reproducibility.
2.1.2 Less exposure to detergent in the purification procedure
Purification of the enzyme is based on two consecutive chromatographic steps using
the weak anion exchange diethylaminoethyl (DEAE) material. This is consistent with
moderately acidic isoelectric points of the extramembraneous subunits (Table 1). The
crude membrane extract was loaded on a DEAE fast-flow (FF) CL-6B resin and the
eluted fractions were applied to a ceramic HyperD DEAE column. Exposure of the
protein to detergents was minimized by decreasing the applied buffer volumes in the
washing and detergent exchange steps. In the first chromatographic step, washing of
the protein when bound to the DEAE sepharose FF column was shortened by 2-fold
(Fig. 6A).
For 3-D crystallization of the complex, the detergent DDM had to be replaced
with n-undecyl-β-D-maltopyranoside (UM) and this was done while the protein was
bound  to  the  HyperD  DEAE  column  material.  The  shorter  alkyl  chain  proved
essential for successful crystallization (Hunte et al., 2000). In the original procedureResults
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15 CVs were applied for detergent exchange. The duration of this detergent exchange
was reduced with respect to exposure to buffer volumes, or 3 column volumes (CVs)
were applied to the scaled-up column that was designed to accommodate twice the
previous yield of isolated enzyme. Also, washing of the protein when bound to the
HyperD DEAE column (e.g. before the detergent exchange), was shortened by a
factor of 2 (Fig. 8A). Specific enrichment of the cytochrome bc1 complex was
observed  as  an  increase  in heme  b to heme c  absorbance  in  redox  difference
absorbance spectra (Fig. 6B).
The enzyme was already enriched when it eluted from the FF column (Fig.
6A, blue arrow), but silver stained NuPAGE gels revealed contaminating bands (Fig.
7B, lane 5-6). The elution profile from the HyperD DEAE chromatography was
monitored by comparing the specific heme absorbance at 413 nm with the absorbance
at 280 nm, and the pure enzyme eluted at ~35 mS buffer conductivity. The first 10 ml
of the peak were of high purity as shown in silver stained gels (Fig. 7B, lane 8-9). The
fractions eluting as the first peak absorbing at 413 nm in the first gradient of the
HyperD elution (Fig. 7B, lane 8-11) were selected for co-complex formation with the
Fv fragment 18E11 and subjected to preparative size-exclusion chromatography
(Hunte et al., 2000). The highly pure crystallizable co-complex eluted as a single
symmetric peak and exhibited a ratio of AU280nm:AU413nm ~1.1 (Fig. 8B).
Fig.6 Purification of the cytochrome bc1 complex. A, FF-DEAE elution profile drawn
from the absorbance at 280 nm. The fraction containing the cytochrome bc1 complex is
marked with a blue arrow. B, difference absorbance spectra of dithionite-reduced minus
ferricyanide-oxidized samples; the solubilisate (black), pooled fractions from DEAE-FF
(blue), pooled fractions from HyperD DEAE (red).Results
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2.1.3 Destabilization of the enzyme was observed in the elution profiles
To ensure reproducibility of the preparation for 3-D crystallization, quality control
points were constructed based on the chromatographic profiles and enzyme activity.
Importantly, the membrane preparation was not stable upon long-term storage,
observed as reduced yield of isolated protein and gradual loss of measured enzyme
activity. Notably, the yield of the preparation was also highly dependent on the source
of yeast cells, demonstrating the importance of optimized growth conditions for
specific enrichment of the enzyme. Baker´s yeast (Wieninger hefe), yielded half the
quantity in mg isolated enzyme per ml membrane compared to the FGY3 strain, that
was  optimized  for  aerobic  growth  under  non-fermentable  growth  conditions
(Glycerin-EtOH).
An important quality indicator for the protein preparation was the appearance
of a second peak absorbing at 413 nm and eluting in the high salt gradient during
HyperD DEAE chromatography (Fig. 9A). The activity of the enzyme eluting at high
salt concentrations was less than half of the target peak, which elutes at ~35 mS in the
first salt gradient (150-300 mM NaCl) (Diploma thesis, Christiane Jost).
Destabilization of the enzyme was also monitored in the size-exclusion
chromatography elution profiles, manifest in a greater relative absorbance of a second
peak absorbing at 413 nm, in direct continuity of the target peak. The first 80 % of the
peak that elutes after 46 minutes or at the retention volume of ~18 ml (~500 kDa)
(Fig. 8B and Fig. 9B), contain pure homodimer with bound Fv18E11 and this material
is  suitable  for  3-D  crystallization.  Other  peaks  observed  in  the  gel  filtration
chromatograms eluted at ~22 ml and ~25 ml (Fig. 9B), the latter contained Fv
fragment (~28 kDa) alone, which was added in 1.4-fold molar excess prior to the gel
filtration run. Gel electrophoretic analysis of the peak that eluted at 22 ml in direct
continuity of the main peak, showed that it contains the cytochrome bc1 complex with
bound Fv fragment (data not shown), as expected from the observed absorbance at
413 nm. Calibration of the column with molecular mass standards in the form of
soluble proteins (see section 4.8.1) cannot be transferred directly to membrane protein
retention  volumes,  which  have  the  added  complexity  of  a  detergent  micelle
surrounding the transmembrane regions, thus adding to the apparent molecular mass.
Still,  calibration  of  the  column  demonstrated  the  resolving  power  of  this
chromatographic procedure and the retention volume at 22 ml roughly suggested aResults
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size exclusion limit of half the mass of the prominent peak. The elution profile from
the size exclusion chromatography, therefore reflects the quality of the preparation,
where the extent of the second peak absorbing at 413 nm, demonstrates the degree of
monomerization and/or subunit dissociation, i.e. destabilization of the homodimer.
Notably,  when  the  enzyme  was  isolated  from  cells,  which  do  not  synthesize
cardiolipin, this second peak was considerably more pronounced compared to wild
type preparations, even reaching the same height (i.e. measured in absorbance units)
as the target peak.
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Fig.7 Gel electrophoretic separation of the cytochrome bc1 complex polypeptides. A, the
original preparation shown in coomassie-stained Tricine SDS-PAGE using 16.5 % gels: a,
molecular mass standard; b, solubilized membrane proteins; c, pooled fractions of DEAE-
Sepharose FF; d, pooled fractions of DEAE-Hyper D; e, pooled fractions of TSK4000 size
exclusion chromatography (from Palsdottir and Hunte, 2003). B, modified preparation
analysed by separation with silver-stained Bis-Tris NuPAGE gels (4-12%): M, marker; 1-
2, solubilisate; 3 flow through FF DEAE; 4, wash FF DEAE; 5-6, pooled fractions (2x35
ml) as eluted from FF DEAE; 7, wash Hyper D DEAE, 8-9, first four 5 ml fractions of the
enzyme eluting from HyperD DEAE.Results
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Fig.8 Anion exchange and preparative size-exclusion chromatography of the cytochrome
bc1  complex.  A, HyperD  DEAE  chromatography  profile,  a  two-step  salt  gradient
(conductivity in mS as black line, right axis). The absorbance of the heme groups was
monitored by absorbance at 413 nm (red). Also depicted is absorbance at 280 nm (blue).
Contaminants are separated from the complex, as they elute at high salt concentration. B,
size exclusion chromatography of cytochrome bc1 complex with bound Fv fragment. Absolute
units for absorbance are shown (AU). These runs were carried out using the Biosys2000
system.
Fig.9  Preparation  of  the  cytochrome  bc1  complex  from  a  membrane  preparation  of
Wieninger yeast stored for 2 years at -80ºC. A, the HyperD DEAE elution profile. The
conductivity of buffers is drawn as brown lines and illustrates the two step salt gradient. The
enzyme elutes in the first and second gradient as shown by absorbance at 413 nm depicted
with the red line. For comparison, the absorbance at 280 nm is drawn in blue. B, the
TSK4000 gel filtration chromatogram shows a more pronounced relative intensity of the
second peak in direct continuity of the prominent peak when compared to Fig.8B. These
chromatographic runs were performed using the ÄKTA chromatographic system.
B A
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2.1.4 Quality checkpoints in the purification procedure
The modified preparation described here permits the purification of a more active
crystallization grade enzyme. The main adjustment with respect to the original
protocol was less exposure to detergent containing buffers (see section 4.6), which
presumably increased the lipid content of the preparation, as noticed in the refinement
of two new tightly bound phospholipids in the X-ray structures (see section 2.5). In
addition to the qualitative evaluation of the chromatographic profiles (see section
2.1.3), the quality of the preparation was also probed quantitatively by measuring
turnover  numbers  in  terms  of  mol  cytochrome  c reduced per second by mol
cytochrome b.
The final yield of isolated protein per ml membrane was 0.52 mg/ml or similar
to 0.67 mg/ml obtained in the original preparation. The specific enzyme activity
increased  during  the  preparation  from  0.5  µmol/(min*mg  protein)  to  24.8
µmol/(min*mg protein), with an enrichment factor of 49.6. The final purified enzyme
had a relative heme b concentration of 8.2 nmol per mg of protein, and a heme b to
heme c1 ratio of 1.9. These data are close to the theoretical values of 8.6 nmol
cytochrome b per mg of protein and a molar ratio of two heme b/heme c1.
Table 2 Purification table for the cytochrome bc1 complex preparation.
Yield protein
mg
heme b
nmol / mg prot.
Cyt bc1 complex
nmol
Turnover
s
-1
Specific activity
µmol / mg
 * min
Solubilized
membranes
2828
[1848 ± 504]
0.2
[0.3 ± 0.1]
336 (2.8%)
[272.3 ± 49.6](3.4%)
77
[48.1 ± 20.9]
0.5
[0.4 ± 0.1]
DEAE-Seph. FF 50
[34 ± 7]
3.6
[3.1 ± 0.2]
90 (42%)
[52.8 ± 12.3](36%)
137
[52.4 ± 2.3]
14.7
[5.0 ± 0.4]
DEAE-Hyper D 27
[18 ± 2]
5.3
[5.4 ± 0.9]
71 (63%)
[49.1 ± 7.6](64%)
111
[63.7 ± 20.9]
16.7
[12.5 ± 5.5]
TSK 4000 13
[10 ± 1]
8.2
[8.1 ± 0.3]
53 (95%)
[42.1 ± 5.9] (98%)
101
[48.8 ± 13.1]
24.8
[11.0 ± 3.3]
25 ml membranes from the FGY3-strain (stored at -80ºC for 3-days) were solubilized in 210 ml extraction buffer.
The turnover numbers present an average of 5 measurements with the intrinsic error of the assay ±15% (for
experimental details see section 4.11). The corresponding values from the original protocol are given below in
square brackets and show the average of 3 different preparations from 15 ml membranes solubilized in 210 ml
extraction buffer (from Palsdottir and Hunte, 2003). The redox properties of the b type hemes permit specific
quantification of cytochrome b content with the extinction coefficient of 28.5 mM
-1cm
-1(562-575 nm). Purity (%) is
shown as cyt b (mg) / (yield protein (mg)) x 100 (%). Specific activity was calculated as µmol cytochrome c
reduced per minute per mg total protein estimated from the BCAssay (see section 4.9.1).Results
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2.2 Fv fragment-mediated crystallization
The antibody fragment Fv18E11 has a strep-tag on the C-terminus of the heavy chain
polypeptide and was purified with streptavidin affinity chromatography, as described
by Kleymann et al. (1995). A myc-tag was placed on the light chain C-terminus in
order to permit immunodetection in Western blot analysis. A streptavidin-coupled
alkaline phosphatase served to confirm the presence of the strep-tag. Attempts to
modify the standardized purification scheme revealed structural instability of the
Fv18E11 fragment.
2.2.1 The unstable assembly of the Fv fragment 18E11
In the original protocol, slow flow CH-Sepharose 4B material was used and typically
~4.5 mg of Fv18E11 were obtained from 120 ml periplasmic extract of E. coli cells
harvested from 12 L cultures. An effort was made to speed up the purification
procedure by coupling streptavidin to a NHS-activated sepharose 4 Fast Flow resin.
However, the FF column proved not suitable for Fv18E11 purification, and the Fv
fragment eluted in two or more prominent peaks, as judged from the absorbance at
280 nm. In comparison, a single prominent peak was observed to elute from the
streptavidin-coupled CH-Sepharose 4B resin, and was followed by a second much
smaller or negligible trailing peak (Fig. 14A).  Gel electrophoretic and Western blot
analysis to detect the presence of the strep- and myc-tags demonstrated that the first
peak contained both heavy and light chain polypeptides, whereas the second peak
contained only heavy chain. Importantly, this observation demonstrated the instability
of the Fv fragment assembly.
2.2.2 Quality control of the Fv fragment
The lack of inter-chain disulfide bonds renders Fv fragments less stably folded than
Fab fragments. The observed instability of the Fv fragment assembly (see section
2.2.1) required the design of control points to qualitatively monitor its assembly in
order to ensure reproducible 3-D crystallization of the cytochrome bc1 complex.
Analytical gel filtration chromatography using Superdex75 column mounted on the
SMART system was performed for this purpose (Fig. 10). The peaks in the elution
profile were assigned based on calibration of the column by using a set of low
molecular mass standards (see section 4.8.2). Characterization of the peaks was
further confirmed by gel electrophoretic analysis of TCA precipitated fractions. AResults
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high quality Fv18E11 fragment preparation was manifest in a single prominent peak
at a retention volume of 1.2 ml (~28 kDa) (Fig. 10A). A split peak at retention
volumes in the range 1.6 ml-1.7 ml indicated dissociation of the Fv fragment into
heavy and light chain polypeptides and the relative intensity of the peaks in the
elution profile served as a reliable criteria to judge if the Fv fragment was stably
assembled (Fig. 10). In addition, this procedure permitted an estimation of the degree
of aggregation that was monitored by the extent of the peak that eluted in the void
volume of the column (marked red in Fig. 10).
2.2.3 Structural analysis of crystal contacts
In  the  Fv  fragment-mediated  3-D  crystallization  of  the  detergent  solubilized
cytochrome bc1 complex, important crystal contacts are mediated by the strep-tag,
which is located on the heavy chain of Fv18E11 (Hunte et al., 2000). Careful analysis
of  the  crystal  contacts  was  carried  out  in  order  to  explain  the  pH  sensitive
crystallization of the preparation, which only produced suitable material for X-ray
diffraction experiments in the narrow pH range of 7.5-8.5.
The antibody Fv-fragment and the acidic hinge protein (Qcr6p), which face
the intermembrane space, interact in the crystal lattice with the matrix-oriented core
Fig.10. Analytical size-exclusion chromatography of the Fv18E11 fragment. To monitor
the assembly of heavy and light chain polypeptides gel filtration was performed using a
Superdex 75 column mounted on the SMART system. The gel filtration chromatographic
profiles showed the degree of dissociation of the Fv fragment (blue) into heavy and light
chain polypeptides (light blue). The void volume is marked in red. A, freshly prepared
Fv18E11, which was immediately rebuffered and concentrated. B, Fv18E11 which shows
pronounced dissociation. This probe was incubated for more than a week in the dilute DTB
buffer as it elutes from the streptavidin column.
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proteins (Cor1p, Qcr2p) of neighboring molecules in the 3-D crystal lattice (Fig. 11).
The greatest distance between the strep-tags on either side of the homodimer is ~180
Å, whereas the largest distance from hinge-to-hinge within a homodimer is ~120 Å.
Interestingly, despite forming important crystal contacts, the strep-tag is only partially
resolved in the experimental electron density. Only the first six amino acids of the
strep tag (-SAWRHP-) were resolved and stably refined. A helical extension could be
traced in the electron density, starting from Pro127, but did not yield clear residue
assignment of the remaining four amino acids (-QFGG).
The strep-tag residue His126 forms crystal contacts to the Core 2 protein
(Qcr2p) of a neighboring dimer in the crystal lattice, with 302.7 Å
2 buried surface area
(i.e. interfacial area) of which only 27 % contribute polar interactions, as calculated
with Naccess (see section 4.13.6.3). The His126
strep side chain is within hydrogen
bond distance to the carboxylate of Asp97
Qcr2p. Moreover, a structural water molecule,
Wat313, contributes hydrogen bonds to stabilize the interaction. The strep-tag also
contacts  subunit  7  (Qcr7p)  of  the  symmetry-related  second  monomer  in  the
neighboring dimer (368.2 Å
2: 34 % polar), thus the strep-tag makes crystal contacts to
both monomers of a homodimer. More specifically, Trp124
strep contributes to crystal
contacts with hydrogen bonds from the main chain atoms to the backbone carbonyl
and nitrogen of Glu124
Qcr7p and Ser126
Qcr7p, respectively.
The acidic Hinge protein (Qcr6p),  makes  contacts  to  the  Core1  protein
(Cor1p) (560.8 Å
2: 35% polar) and the N-terminus of the Rieske protein (Rip1p)
(114.2 Å
2: 83 % polar). Importantly, the hinge Glu89
Qcr6p carboxylate is involved in
an ion pair formation with the side chain of the Rieske protein residue Arg35
Rip1p.
Furthermore, Asn187
Cor1p is hydrogen bonded to His96
Qcr6p. The latter is configured
in a plane-to-edge arrangement (<3.5 Å) with Tyr65
Cor1p.
To summarize, only a few amino acid residues contribute with relatively small
surface area to the crystal contact formation in the 3-D lattice arrangement of this
large multisubunit homodimeric membrane protein. The observation that histidines
contribute to the crystal contacts may be key to explain the apparent pH dependent
crystallization behavior. Histidines typically exhibit pKa values close to the optimal
pH  used for crystallization and this may explain the pH sensitive crystallization
behavior of the yeast cytochrome bc1-Fv co-complex (see section 2.3.2)Results
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2.2.4 Structural analysis of Fv18E11-Rieske interaction
The Rieske residues that are recognized by the Fv fragment 18E11 are not in a linear
arrangement, but form a conformational epitope (Hunte et al.,  2000).  Detailed
characterization of the atomic interactions at the Fv-epitope interface was carried out
(Table 3). This X-ray structural description of the Fv18E11 binding to its epitope
combined with a comprehensive sequence alignment of Rieske protein sequences
(carried out by O. Anderka) served as the framework for a project where grafting of
the yeast epitope onto the Rieske protein from P. denitrificans was pursued with the
aim to perform Fv-mediated 3-D crystallization of the bacterial enzyme.
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Fig.11  Crystal  packing  of  the  cytochrome  bc1  complex. A,  the  arrangement  of
homodimers  as  viewed  in  plane  ((0.5a+c),b)  -  corresponding  to  a  view  from  the
membrane plane. The different monomers in a homodimer are colored yellow and green,
respectively. This view illustrates the crystal contact made from the Fv fragment heavy
chain (red) C-terminal strep-tag to the core proteins. B, rotation around the b-axis (in
plane) produces the following view, where crystal contacts mediated by the hinge protein
(cyan) on each side of the homodimer are pointed out. C, a 90 degree rotation around the
c-axis and tilting around a-axis generates the following view to show the space occupied
per homodimer in the crystal lattice, as viewed from the matrix side. D, the polar surface
area for crystal contacts on the intermembrane side are provided by the Fv fragment
(red/magenta), and E, the hinge proteins (cyan). On the matrix side the peripheral core
proteins provide ample opportunities for crystal contact formation.Results
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Table 3. Characterization of the Fv18E11-Rieske interactions by X-ray structural analysis.
Major interactions are categorized as hydrophobic (hphop) or polar. The latter distinguished
as side chain (sc) or main chain (mc) interactions. The single salt bridge is marked in red.
FvH Type Rip1p FvL Type Rip1p
Tyr 111 hphob Gln 127 Ala 56 hphob Pro 123
Arg 98 sc-mc Asn 130 Leu 54 hphob Pro 123
Arg 98 mc-sc Asn 130 His 55 hphob Pro 123
Tyr 102 sc-sc Asn 130 Gly 57 hphob His 124
Glu 100 sc-sc Asn 130 Tyr 49 hphob Ile 126
Tyr 111 sc-sc Ser 131 Ala 56 hphob Gln 127
Tyr 27 hphob Val 132 His 55 hphob Gln 127
Ser 31 sc-sc Asp 133 Arg 53 sc-sc Asp 149
Ser 28 mc-sc Asp 133 Arg 53 sc-sc Gln 151
Ser 28 sc-sc Asp 133
Ser 31 sc-mc Met 134
Ser 31 hphob Thr 142
Tyr 33 hphob Thr 142
Tyr 102 sc-sc Asp 143
Tyr 33 sc-mc Ala 144
Tyr 102 hphob Val 147
Ser 103 sc-mc Lys 148
Val 104 sc-mc Lys 148
Tyr 102 hphob Pro 150
Thr 105 hphob Pro 150
Fig.12 The Fv18E11 binds the extrinsic Rieske domain. A, the position of the epitope
(magenta) in the Rieske protein (blue) is shown. FvH (steelblue), covers the majority of
contacts compared to FvL (green). B, the homodimer with bound Fv fragments. Cytochrome
c1  and  cytochrome  b  are  colored  cyan  and  brown,  respectively.  C,  an  extract  from  a
comprehensive multiple sequence alignment of eukaryotic and prokaryotic Rieske sequences.
Shown here are the sequences from yeast (UCRI_YEAST), P. denitrificans (UCRI_PARDE),
R. sphaeroides (UCRI_RHOSH), R. capsulatus (UCRI_CAPSU), and bovine (UCRI_BOVIN)
(alignment provided by O. Anderka).Results
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The conformational epitope resides in a non-conserved region (Pro123 to
Gln151) (Table 3, Fig. 12C) and is composed of an α-helix and a connecting loop
inserted between the more highly conserved β3 and β4 strands of the soluble Rieske
protein. Multiple sequence alignment showed that in the non-conserved epitope-
containing segment the bacterial Rieske proteins have an inserted span of amino acids
(Fig.  12C).  Homology-based  modeling  proposed  a  helical  arrangement  of  this
insertion (Xiao et al., 2004).
The majority of contacts is provided by the Fv fragment heavy chain (FvH)
(Fig.  12),  namely  CDR-H1  (residues  27-33)  and  CDR-H3  (residues  98-111).
Interactions with the light chain are confined to CDR-L2 (residues 49-57) and,
although not as many as from the heavy chain, include the only salt bridge in this
antibody-antigen recognition (Table 3). Calculations using the program Naccess
estimated that 38 % of the buried surface area is polar (see section 4.13.6.3), with
strikingly larger contribution of 12 distinct hydrogen bond pairs, compared to only
one salt bridge, i.e. Arg53
FvL and Asp149
Rip1p (Table 3). For comparison, the value
reported for the number of hydrogen bond interactions typically observed in antibody-
antigen recognition is 8.5 ± 3.5 (Lo Conte et al., 1999). Strikingly, structural water
molecules were reproducibly identified at the interface in different data sets. The
coordinated hydrogen bond network stabilizing these water molecules suggests a
contribution of water-mediated hydrogen bonds in antigen recognition by Fv18E11.
Water molecule Wat279 is for instance hydrogen bonded to the side chains of
Asp110
FvH and Glu100
FvH, as well as it is hydrogen bonded to the Asn130
Rip1p side
chain. Another example is Wat5, which is stabilized by side chain hydroxyl of
Tyr33
FvH and main chain nitrogen of Asp143
Rip1p. Non-polar interactions were mainly
mediated by tyrosine residues, which form characteristic clefts and cervices on the Fv
fragment surface.
2.2.5 Structural comparison of Fv-fragments bound to membrane proteins
The Fv-mediated 3-D crystallization of the cytochrome c oxidase was the pioneer
study to demonstrate that Fv fragments can serve as crystallization enhancers of
membrane proteins (Ostermeier et al., 1995). The second example is the Fv18E11-
cytochrome bc1 complex X-ray structure determination (Hunte  et al.,  2000).  AResults
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comparative structural study was carried out to search for common traits in these two
successful examples of Fv-mediated crystallization of membrane proteins.
Both Fv fragments form crystal contacts via the strep-tag (see Hunte and
Michel, 2002). Also, both Fv7E2 and Fv18E11 recognize discontinuous epitopes, thus
are conformation specific, consistent with their applications in X-ray structure
determination of the native protein conformation. The strep-tag is only partially
resolved  in  the  experimental  electron  density  maps  derived  from  both  Fv7E2-
cytochrome c oxidase and Fv18E11-cytochrome bc1 complex crystal diffraction, in
both cases the disorder starts from the proline. Notably, the strep- and myc-tags were
disordered in the 1.28 Å resolution X-ray structure of the Fv7E2 fragment alone
(Essen et al., 2003).
The antibody-antigen recognition is dominated by hydrogen bonds for both
Fv7E2-cytochrome c oxidase and Fv18E11-cytochrome bc1 complex. Indeed, Fv7E2
binds with 16 hydrogen bonds to its antigen and the lack of salt bridges poised the
question whether water bridges serve to enforce the binding (see Essen et al., 2003).
In comparison, the Fv18E11-Rieske protein interaction is composed of 12 hydrogen
bond pairs and one salt bridge (see Table 3). Also, structurally resolved water
molecules were observed to contribute to the network of hydrogen bond interactions
at the Fv18E11-Rieske protein interface.
A noticeable difference between these two reported cases of Fv-mediated
crystallization of membrane proteins was uncovered by the extent of buried surface
area, where the Fv18E11-Rieske interface is 1521 Å
2  or  twice  the  size  of  the
interfacial area covered by Fv7E2 (744 Å
2). The mean value for the interfacial area of
antibody-antigen complexes was calculated by Lo Conte et al. (1999) to be 1680 Å
2
(±260). Thus, the Fv18E11-antigen interaction lies within this range, whereas the
Fv7E2-antigen recognition presents an unusual exception (Essen et al., 2003).
To summarize, except for the unusually small surface area of interaction in the
case of Fv7E2, the nature of antigen recognition appears similar to the reported
antigen-antibody interactions for soluble proteins, including the distribution of polar
and non-polar forces, and the dominant role of hydrogen bond interactions (see
Davies and Cohen, 1996).Results
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2.2.6 Magnetic beads pull down assay to probe co-complex formation
Unlike the Fv7E2-cytochrome c oxidase co-complex, that was purified by preparative
streptavidin affinity chromatography (Ostermeier et al., 1995), the cytochrome bc1-
Fv18E11 co-complex could not be purified in large-scale via the strep-tag (C. Hunte,
unpublished). Analytical pull down assays using streptavidin- and streptactin-coated
magnetic beads permitted specific capture of the co-complex, but silver stained gels
of the eluted co-complex revealed increased relative intensity, i.e. enrichment of the
Rieske polypeptide, with respect to the remaining subunits, thus demonstrating
unstable integration of the Rieske protein in this type of purification scheme (Fig. 13).
As mentioned before, stigmatellin fixes the Rieske extrinsic domain in b-position, but
the yield of enzyme eluting from the beads did not change by stigmatellin addition
(data not shown).
The pull down assay appeared most efficient when the co-complex was
formed prior to incubation with the beads. The conditions for antibody-antigen co-
complex formation may be less favorable when the antibody fragment is bound to the
beads than when both proteins are free to interact in solution. Importantly, the assay
with Fv fragment alone confirmed the unstable assembly of heavy and light chain
polypeptides that was observed in large-scale streptavidin affinity purification and
analytical gel filtration chromatography (see section 2.2.1 and  2.2.2). Extensive
washing of the Fv fragment when bound to the beads increased the relative amount of
Fv heavy chain (FvH) to Fv light chain (FvL), as detected in silver stained gels of the
eluted fractions. Even complete absence of FvL was noticed after overnight washing,
meaning it was in effect ‘washed off’ the heavy chain. This was shown by gel
electrophoretic analysis and the lack of immunodetection of the myc-tag in Western
blots (data not shown).
Importantly, the magnetic beads pull down assay demonstrated the species-
specific binding of Fv18E11 that was predicted, because the epitope resides in a non-
conserved region of the Rieske protein (see Fig. 12C). This lack of cross-reactivity
was  observed  in  inefficient  pull  down  of  the  homologous  enzymes  from  P.
denitrificans (Fig. 13), bovine heart mitochondria, and R. sphaeroides (data not
shown). Candidates responsible for the observed lack of cross-species reactivity were
exposed in multiple sequence alignment, i.e. residues were identified, which are
expected to introduce electrostatic and/or steric disturbance at the binding site (Fig.
12C).  For  instance,  Asn130
Rip1p  is  replaced  with  Arg  in  the  bacterial  RieskeResults
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sequences, which is clearly electrostatically incompatible with Arg98
FvH (Table 3).
Furthermore, Ala144, Val147, and Lys148, from the yeast epitope, are replaced with
Arg, Asp and Glu, respectively, which confers further incompatibility. In contrast,
interactions could, theoretically, still be mediated by Asp133
Rip1p that is conserved in
P. denitrificans. Also, the Gln151
Rip1p side chain that interacts with the side chain of
Arg53
FvL is replaced with a Glu in the bacterial sequence, which could participate in
an ion pair interaction provided that the tertiary structure is conserved. This, however,
is unlikely because the fold of this region in the bacterial Rieske protein is expected to
be different, due to the inserted extra loop, as well as the absence of 3 prolines, which
are present in the segment containing the yeast epitope. It was therefore not surprising
to find that the bacterial enzyme was not efficiently captured by Fv18E11 in the
magnetic beads pull down assay (Fig. 13).
An attempt was made to graft the complete epitope-containing segment, i.e.
Pro123 to Gln151 (see Table 3), into the enzyme from P. denitrificans (by O.
Anderka).  This  construct  was  not  stably  assembled.  Therefore,  chimeras  were
constructed, which contained the complete soluble domain of the Rieske protein, with
and  without  the  yeast  linker  region  that  connects  the  soluble  domain  to  the
transmembrane helix. The chimeras were named Chimera(sc) and Chimera(pd),
respectively. The chimera Rieske proteins were recognized by the Fv fragment in the
pull down assay (T. Kleinschroth, Diploma thesis) (see Fig. 13). A stable co-complex
of Chimera(sc) with Fv18E11 was formed and isolated by analytical size-exclusion
chromatography and addition of 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC)
to the preparation stabilized the integration of the engineered Rieske protein in the
complex (T. Kleinschroth  and H. Palsdottir, unpublished).Results
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Fig.13 Magnetic beads pull down assay to probe co-complex formation. Silver stained
NuPAGE (4-12%) gel electrophoretic analysis of elution from beads. A, the positive
control (Pos.) shows pull down of Fv fragment alone. In the pulldown of yeast cytochrome
bc1 complex (BC1) enrichment in the relative intensity of the Rieske polypeptide (Rip1p)
with respect to the remaining polypeptides demonstrates the structural instability of the
enzyme in this type of purification scheme. Insignificant pull-down of the enzyme from P.
denitrificans illustrates the specificity of the Fv18E11 fragment for the yeast epitope. B,
the two chimeras have the soluble domain of the bacterial Rieske protein replaced by the
yeast domain. The two lanes show undiluted and five fold dilution of eluted fraction from
the beads to confirm comparative intensity of bands. Eluate from Fv18E11 pull down is
shown for of chimera (pd) with the bacterial linker, chimera (sc) with yeast linker,
“grafting” refers to insertion of the epitope containing segment into the bacterial Rieske
domain, and wildtype (WT) is shown for comparison. C, pulldown of yeast cytochrome bc1
complex. The assay was optimized to reduce unspecific binding. Addition of the 67 kDa
bovine serum albumine did not interfere with detection of the enzyme polypeptides. Lanes
marked with M contain marker. D, the probes before the assay are shown for comparison
of the relative intensity of cytochrome bc1 complex and Fv fragment polypeptides before
and after pull down.
A B
C DResults
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2.2.7 Fluorescent labeling of the Fv18E11 was hindered by its unstable assembly
Superimposition of the yeast enzyme with the X-ray structures where Rieske is found
in different positions, showed that the Fv fragment light chain C-terminus was also
rotationally displaced upon the movement from b- to c1-position. Thus, fluorescent
labeling of the Fv fragment was pursued in order to estimate the Fv fragment affinity
for the antigen by Fluorescence Correlation Spectroscopy. For this purpose an Fv
fragment with a Cys engineered at the light chain C-terminus, was labeled with
tetramethylrhodamine-5-maleimide (TMR5M). The yield of the modified Fv fragment
from the streptavidin affinity purification was dramatically reduced compared to the
wild type Fv18E11 preparation, or 5-fold less, i.e. ~800 µg from 12 L cultures of
E.coli. Furthermore, destabilization of the engineered fragment was illustrated in the
elution profile from streptavidin affinity chromatography. The second peak, marked
with arrow in Fig 14B, was shown by Western blot analysis to contain only heavy
chain (data not shown).
Fig.14 Streptavidin affinity chromatography of Fv18E11 and the variant. A, the elution
profile of WT Fv18E11 as monitored by absorbance at 280 nm. The second peak in the
elution profile is much smaller (arrow). B, elution profile of the Fv fragment variant with
a  cysteine introduced at the light chain C-terminus, before the myc-tag. The relative
intensity of the second peak (arrow) is greater compared to A. This peak was shown to
contain the heavy chain alone. The insert on the right shows gel electrophoretic analysis
to probe labeling by UV-irradiation in gels: a, negative control, WT Fv18E11; b, 5 times
dilution of a; c, Fv-TMR5M; d, 5 times dilution of c.
A B
FvH
Fv
a    b    c    dResults
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2.2.7.1 Assignment of surface accessible free thiols in the cytochrome bc1 complex
Since instability of the Fv fragment hindered its fluorescent labeling, structural
analysis was performed to evaluate the accessibility of free cysteines in the detergent
solubilized or reconstituted enzyme. The aim of this analysis was to identify targets
within  the  enzyme  for  fluorescence  or  spin  labeling  to  study  to  the  enzyme
mechanism. The majority of cysteines were observed to be buried, involved in
disulfide bond formation or other atomic interactions (SH
...O) and therefore not
accessible  for  labeling.  However,  a  few  putative  candidates  for  labeling  were
identified. Cys188
Cyt1p was appointed as the most feasible residue for labeling on the
intermembrane space side (Fig. 15). Cys188
Cyt1p is located close to the Qo site, above
the estimated bilayer. On the matrix side, Cys312
Cor1p, Cys137
Cor2p and Cys25
Qcrp7p,
appeared surface accessible and free.
FvL
FvH
188
Cyt1p
25
Qcr7p
312
Cor1p
137
Qcr2p
Fig.15. Identification of free and surface accessible cysteines in the X-ray structure. A
structural overview of potential targets for labeling. Solvent exposed and free cysteines
are depicted as magenta spheres. The C-terminus of Fv-fragment light chain (i.e. myc-tag)
is marked with yellow spheres and C-terminus of heavy chain (i.e. strep-tag) in green.
Refined lipids (yellow ball-and-stick) permit positioning of the enzyme in the bilayer and
the lipid-aqueous interface is marked with gray stipled ellipsoids.Results
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2.3 Crystallographic analysis of the binding mode of HHDBT at the Qo site
The inhibitor 5-n-heptyl-6-hydroxy-4,7-dioxobenzothiazole (HHDBT) is structurally
similar to ubiquinone, the substrate of the cytochrome bc1 complex. The similarity is
accomplished  by  a  carbonyl  and  a  hydroxy  group  on  opposite  sides  on  the
benzothiazole ring (see Fig. 17). To analyze whether hydroxydioxobenzothiazoles
compete with the substrate at the Qo site, determination of the apparent Km of the
yeast cytochrome bc1 complex for decyl-ubiquinol in the presence and absence of
HHDBT  were  performed  by  Dr.  C.  G.  Lojero  in  the  laboratory  of  Prof.  B.
Trumpower.  From  Lineweaver-Burk plot it was concluded that HHDBT is a
competitive inhibitor, which is consistent with the assumption that it is a substrate
analogue. Ubiquinone has not been detected by X-ray crystallography at the Qo site.
The binding mode of competitive inhibitors is instead assumed to provide a reliable
molecular description of the substrate binding site.
2.3.1 Crystallization with a negatively charged inhibitor bound at the Qo site
A color change from yellow to purple was observed when HHDBT (20 mM stock in
DMSO) was diluted in the buffer used for crystallization (pH ~8 at 4ºC). This color
change  is  indicative  of  ionization  of  the  6-hydroxy  group  that  was  shown  by
Trumpower and colleagues to have a pKa of 6.1 in detergent micelles. The inhibitor
was crystallized at a pHcryst > pKa and ca. 98 % of the inhibitor were calculated from
the Henderson-Hasselbach equation to be ionized in the crystallization mixture.
The absorbance maxima of the protonated inhibitor HHDBT at 241 nm, 287
nm and 445 nm have extinction coefficients of 10.6, 12.2 and 0.77, respectively (in
MeOH, acetic acid) (von Jagow and Link, 1986). Difference spectra of the yeast
cytochrome bc1 complex with bound inhibitor versus the enzyme alone at pH 6.0,
were recorded by C.G. Lojero. When the inhibitor was added in molar excess the
absorbance  maximum  shifted  to  longer  wavelengths,  whereas  when  added  in
substoichiometric amounts the spectra appeared similar to the spectra of inhibitor
alone at pH 8.7. It was therefore concluded that the inhibitor is ionized when bound to
the enzyme. These data refute previous reports that the ionized inhibitor cannot bind
at the Qo site (Zhang et al., 1999). Instead, the observed pH dependency of inhibition
is attributed to a dissociable group within the complex, namely the catalytic residue
His181 of the Rieske protein, as will be discussed in more detail below.Results
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2.3.2 X-ray structure determination of HHDBT bound at the Qo site
Because previous attempts to obtain high-resolution structures of the cytochrome bc1
complex with undecyl-HDBT (UHDBT) bound at the Qo site were not successful, the
inhibitor with shorter alkyl chain, namely heptyl-HDBT (HHDBT), was selected for
the X-ray structural studies presented here. The only difference between HHDBT and
UHDBT is the shortening of the flexible side chain from 11 to 7 C atoms, thus the
head group moiety, i.e. the functional groups which specifically bind to the enzyme,
are  the  same.  The  inhibitor  efficacy  of  UHDBT  was  shown  to  depend  on  the
oxidation-reduction poise of the catalytic subunits, demonstrated by enhanced binding
when the Rieske protein is reduced (Bowyer et al., 1982). The purified cytochrome
bc1  complex  used  in  this  study  has  a  partially  reduced  Rieske  (F.  McMillan,
unpublished) and was fully inhibited by the applied amount of HHDBT. The crystals
with HHDBT bound diffracted to 2.5 Å resolution and a model of the enzyme was
submitted to the PDB databank (PDB entry 1P84: Palsdottir et al., 2003) (Table 4).
The experimental procedures for obtaining the crystals and subsequent structure
determination are described in section 4.13.
Successful 3-D crystallization of the co-complex was restricted to the narrow
pHcryst range of 7.5-8.5 (4ºC). Crystal growth was monitored at different pH {6, 6.5, 7,
7.5, 8, 8.5}. Bis-tris-propane was used instead of Tris to buffer the precipitation
solution below pH 7.5 (RT). Lowering the pH caused a shower of minute crystals to
appear, which pointed to defect crystal contacts. Pre-formed crystals grown under
feasible conditions (pH 7.5-8, 4ºC) cracked when they were soaked to acidic pH. It
was therefore not possible to soak the crystals of the HHDBT inhibited enzymes
below pHcryst < pKa. The crystal lattice is fragile and held together by few polar
contacts of small surface area (see section 2.2.3). Importantly, structural analysis
showed that a number of histidines participate in crystal contact formation, perhaps
explaining this pH sensitive behavior in crystal formation. It is important to point out
that at the given conditions, crystallization of the enzyme without inhibitor bound at
the  Qo  site  was  not  possible  (C. Hunte,  unpublished  observations). Although
important crystal contacts are mediated by the strep-tagged  Fv18E11,  it  is  not
sufficient to support crystallization. Without Qo site inhibitor bound, the Rieske
protein may not be fixed in b-position and this lack of stabilizing interaction is
presumably the reason why the enzyme only crystallizes in the presence of inhibitor.Results
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2.3.3 Binding of HHDBT at the Qo site
The difference electron density map (Fo-Fc) calculated prior to inclusion of HHDBT
in the model clearly showed specific binding at the Qo site (Fig. 16). The asymmetric
form of the difference density for the head group moiety permitted unambiguous
orientation of the hydroxy-dioxobenzothiazole ring.
The Qo site is formed by the C-terminus of cytochrome b transmembrane (TM)
helix C
111-134, N-terminus of TM helix D
173-204, the intervening cd loop
135-173 including
two small non-transmembrane a-helices cd1
138-153 and cd2
158-166, the ef loop
246-288 with
a-helices ef1
254-257 and ef2
274-283 and the N-terminus of TM helix F
288-307 (Fig. 17). The
ef and cd loops serve as ‘lids’ from the intermembrane side and provide a narrow
opening for the Rieske cluster containing domain to access the substrate. Residues
which interact with HHDBT are confined to the cd1 helix and the ef loop (Table 5).
Table  4  Crystallographic  table. Statistics  for  two  datasets  obtained  from  the  modified
preparation (described in section 2.1) with stigmatellin and HHDBT bound at the Qo site.
Stigmatellin HHDBT
PDB entry n.s. 1P84
Space group C2
a, b, c [Å] 214.6, 164.1, 147.7 215.0, 165.1, 147.5
β [°] 117.6 117.3
atoms 18115 18069
amino acid residues 2168 2168
Non-protein molecules 13 13
solvent molecules 321 326
Data collection
Resolution range (OS) [Å] 30.0-2.5 (2.59-2.50) 25.0-2.50 (2.56-2.50)
Measured reflections 445,775 (42,078) 372,220 (20,853)
Redundancy 2.9 (2.8) 2.5 (2.3)
Unique reflections 153,177 (15,221) 149,103 (9,128)
Completeness [%] 98.3 (98.5) 92.4 (84.6)
Rmerge [%] ξ 6.8 (56.2) 6.6 (37.4)
I/s(I) < 1 20.3 (2.3) 13.4 (1.2)
Refinement
Resolution range (OS) [Å] 25.0-2.50 (2.52-2.50 ) 25.0-2.50 (2.52-2.50)
R factor [%]* 21.4 (34.6) 22.5 (40.9)
Rfree [%]# 24.1 (34.2) 25.3 (38.4)
Root mean square deviations from ideal values
Bond lengths [Å] 0.007 0.008
Bond angles [°] 1.269 1.305
Structure validation
Most favored regions [%]
Additional allowed [%]
Generously allowed [%]
Disallowed [%]
88.0
11.3
0.5
0.3
86.8
12.5
0.5
0.2
n.s.=not submitted. OS=outer shell. Diffraction data collected at ESRF, ID14-EH3 at 4°C, l
0.9299 Å, ξRmerge=ShSi|Ii(h)-<I(h)>|/ShSII(h), Ii(h): intensity of ith measurement, <I(h)>:
average  intensity  of  a  reflection,  *R  factor=Sh||F(h)obs|-|F(h)calc||/Sh|F(h)|,  #Rfree
calculated for 2.5% of reflections.Results
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Fig.17 A structural overview of the Qo site. A,the topological arrangement of a-helices in
cytochrome b. The regions which construct the Qo site are marked in red. The orange circle
points out the site. B, the binding mode of HHDBT at the Qo site (from Palsdottir et al., 2003)
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Fig.16 Crystallization of the HHDBT-Fv18E11-cytochrome bc1 co-complex. A, crystals
grown with HHDBT bound were smaller and had a purple shade compared to the B,
intensely  red  crystals  with  stigmatellin  bound.  The  black  bar  measures  1  mm.  C,
asymmetric difference electron density of HHDBT at the Qo site allows unambiguous
modeling of ligand orientation.
A
B
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2.3.4 Comparison of HHDBT and stigmatellin binding at the Qo site
The X-ray structures of the enzyme with stigmatellin (PDB entry 1KB9: Hunte et al.,
2000) and HHDBT (PDB entry 1P84: Palsdottir et al., 2003) were superimposed by
structural  alignment  using  LSQMAN.  Differences  between  the  structures  were
estimated by the root mean square deviation criteria (RMSD) in terms of atomic
positions after superimposition of the Cα atoms (see section 4.13.6.4). The resulting
values for the catalytic subunits were RMSD(all atoms)/RMSD(Cα atoms) of 0.369 Å
(3089 atoms)/0.235 Å (385 atoms), 0.272 Å (1941 atoms)/0.214 Å (246 atoms), and
0.270 Å (1411 atoms)/0.238 Å (185 atoms), for cytochrome b, cytochrome c1 and
Rieske protein, respectively.
The inhibitors, stigmatellin and HHDBT, overlap with their head groups
positioned in the tight binding pocket carved by cytochrome b residues and enclosed
by the Rieske protein, which is in b-position, and contributes a hydrogen bond via the
cluster ligand His181
Rip1p to the carbonyl and hydroxyl group of stigmatellin and
HHDBT, respectively. The larger surface area of stigmatellin, its rigid side chain, as
well as an additional hydrogen bond provided by cytochrome b residue Glu272
Cobp
confer stronger binding than for HHDBT, observed in greater inhibitor potency of
stigmatellin (Zhang et al., 1999). The side chain of HHDBT coincides and ends where
the stigmatellin side chain bends. Both inhibitor side chains extend into the gradually
opening hydrophobic cavity at the dimer interface.
The  flexible  alkyl  chain  of  HHDBT  was  defined  to  full  length  in  the
experimental difference density, demonstrating tight and specific binding. The short
heptyl  side  chain  of  HHDBT  is  stabilized  by van der Waals interactions with
cytochrome b residues: Ile147, Leu275, Met295 and Phe278. The following residues
contribute to the binding site, but are not in close contact to HHDBT (> 3.9 Å) and
therefore not listed in table 5: Ile125 (4.0 Å), Phe129 (6.0 Å), Tyr132 (5.5 Å), Leu150
(5.5 Å), Thr265 (6.0 Å), Glu272 (5.0 Å), Leu275 (4.0 Å), Leu282 (4.0 Å), Met295
(4.0 Å), and Phe296 (5.3 Å). The largest surface area at the binding site is provided by
residues: Tyr279, Met295, Val146, Ile147, and Leu275, in decreasing order of
contribution.
Stigmatellin  makes  van  der  Waals  contacts  with  a  larger  number  of
cytochrome b residues, of which nine are not involved in contacts to HHDBT:
Thr122, Ala126, Leu130, Thr148, Phe151, Leu165, Phe179, Leu182 and Val270. TheResults
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largest surface contact area to stigmatellin is provided by Tyr279, Met295, Ile147,
Phe129 and Leu275, listed with decreasing contribution.
The  conserved  and  catalytically  important  cd loop residue Trp142 (see
Brasseur  et al., 1996), discriminates between HHDBT and stigmatellin by only
contacting HHDBT. Phe129
Cobp, a side chain stabilizing ligand of stigmatellin was
observed in alternate conformations when HHDBT is bound. The short tail of
HHDBT does not extend far enough to stabilize this residue (0.3 Å
2 contact area)
compared to the greater or 45.1 Å
2 surface contact area to the stigmatellin side chain.
Variants at this position exhibit impaired ubiquinol oxidation (see Brasseur et al.,
1996), which suggests a role of this residue in stabilization of the quinone side chain,
or at least its importance for maintaining proper molecular structure at the site.
Mutagenesis studies in R. sphaeroides showed that when Phe129
Cobp was replaced
with a positively charged residue quinol oxidation was abolished. Furthermore, EPR
spectral properties of the Phe129Arg variant, suggested ion pair formation with an
anionic ubiquinone (Ding et al., 1995a).
The  aromatic  rings  of  stigmatellin  and  HHDBT  are in plane and  both
positioned at 90 degree angle to the side chain of Tyr279
Cobp (Fig. 19). The distances
between the O6 atom of HHDBT and the Tyr279
Cobp side chain atoms, Cδ1 and Cε1,
respectively, are below the sum of their van der Waals radii (dCδ1-O6=3.2 Å and dCε1-
O6=3.3 Å), indicating a weak hydrogen bond (C-H
…O) with the aromatic C-H groups
as donors. Hydrogen bond angles and bending angles at the acceptor atom (θ Cδ1-H-O6
=125 °, θ Cε1-H-O6 =113 °, φHδ1-O6-C6 =107 °, φHε1-O6-C6 =94 °) are only slightly lower
than the optimal range for non-conventional hydrogen bonds (Desiraju and Steiner,
1999). The bifurcation is not fully symmetrical as conditions for the bond involving
Cd1 are more favorable. The acidity of the aromatic C-H groups is increased, because
the hydroxy group of Tyr279
Cobp donates a hydrogen bond to the backbone oxygen of
the disulfide bridged Cys180
Rip1p (dOH-O= 2.7 Å; ϕCz-OH-O = 112°). Cys180
Rip1p
contributes to the fold of the cluster containing tip of Rieske.
B factor analysis indicates a tight binding of stigmatellin with average B
factors of 37.4 Å
2 and 35.6 Å
2 for the inhibitor and cytochrome b, respectively.
HHDBT appears less tightly bound with average B factor of 50.9 Å
2 compared to 40.2
Å
2 for cytochrome b. Kinetic studies agree that stigmatellin is more tightly bound than
UHDBT, as it is a more potent inhibitor (Zhang et al., 1999).Results
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Fig.19 Electron density and model of the Qo site viewed from the intermembrane space.
2Fo-Fc  electron density map illustrated the tight interaction of the inhibitor with the
Tyr279 side chain.
Tyr279
Cobp
His181
Rip1p
2Fe-2S
HHDBT
Distal
Proximal
Met 139
Pro 271
Gly 143
Wat518
Phe 278 Phe 298
Fig.18 Electron density map and structural model of the Qo site viewed from heme bL. A
structural water molecule (Wat518) was refined at the active site and is involved in
hydrogen bond stabilization of the ligand. The Qo  site is divided into two domains,
referred to as proximal and  distal to heme bL.Results
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2.3.5 The ionized HHDBT hydroxy group binds the protonated His181
Rip1p
Stigmatellin and HHDBT head group moieties are stabilized by a network of weak
and strong hydrogen bonds and numerous van der Waals interactions. Importantly,
the  oxygen  atom  of  the  ionized  6-hydroxy  group  (O6)  of  the  hydroxy-
dioxobenzothiazole  head  is  in  close  contact  with  the  nitrogen  atom  Nε2  of
His181
Rip1p, of which the second imidazole nitrogen coordinates the [2Fe-2S] cluster
of the Rieske protein. The distance and geometry of the interaction (dNε2-O6= 2.8 Å; θ
= 148°) are in good agreement with a conventional hydrogen bond. Likewise, the
carbonyl  (O8)  of  stigmatellin  forms  a  hydrogen  bond  to  His181
Rip1p.  When
superimposed both functional groups occupy exactly the same position (Fig. 20).
Crystallographic analysis of stigmatellin binding suggested that Nε2 is protonated at
pH 8.5, as the fixation of Rieske protein in b-position is stabilized by a hydrogen bond
between this atom and the carbonyl group of stigmatellin (Hunte et al., 2000). For
crystallization of the cytochrome bc1 complex in the presence of HHDBT the pH was
lowered by half a unit, and Nε2 is expected to be protonated under these conditions.
With both donor and acceptor of the hydrogen bond ionized, this type of a polarized
hydrogen bond provides a strong stabilizing interaction. On the other side the
carbonyl group O4 is oriented towards heme bL and forms a hydrogen bond to a
structural water molecule (Wat518) that is also stabilized by a hydrogen bond to the
backbone nitrogen atom of Glu272
Cobp (Fig. 22). The Glu272
Cobp side chain, which
was observed to form a hydrogen bond to the hydroxy group of stigmatellin (Hunte et
al., 2000), re-orients when HHDBT is bound and points out of the binding site.
Table 5 The binding mode of HHDBT at the Qo site.
Cobp Å Qo Cobp Å Qo Cobp Å Qo Rip1p Å Qo
M139(O) 3.6 C2 V146(Cγ1) 3.6 O7 P271(Cβ) 3.4 O4 C180(Cβ) 3.8 O7
W142(C) 3.9 C2 3.7 C7 3.7 C4 H181(Cε1) 3.4 O7
3.9 S1 3.6 O6 P271(Cγ) 3.6 C4 3.6 O6
W142(Cβ) 3.8 S1 3.7 C6 3.7 O4 H181(Cδ) 3.9 O6
W142(O) 3.9 S1 V146(Cγ2) 3.2 O7 3.8 C5 H181(Nε) 2.8 O6
G143(N) 3.4 C2 3.7 C7 F278(Cβ) 3.9 C12 3.5 O7
3.8 N3 I147 (Cδ1) 3.4 C9 Y279(Cδ) 3.2 O6
G143(Cα) 3.5 N3 I269 (Cδ1) 3.7 S1 3.7 C6 Water Å Qo
3.6 C2 3.6 C7A Y279(Cε1) 3.3 O6 Wat 518 2.9 O4
V146(Cβ) 3.8 O7 3.8 C7 3.7 C6
3.9 C7 3.9 O7 I299(Cδ1) 3.9 C14
A  few  polar  and  several  non-polar  interactions  stabilize  the  hydroxy-dioxobenzothiazole.  Residues  within
interatomic distances of less than 3.9 Å from inhibitor are listed (from Palsdottir et al., 2003).Results
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2.3.6 Conformational flexibility at the Qo site
Superposition of the X-ray structures of the enzyme with stigmatellin and HHDBT
bound, revealed that major conformational changes were confined to cytochrome b
residues, which form the Qo site (Fig. 21). Conformational changes illustrated Qo site
occupancy induced plasticity of the enzyme. RMSD comparison of the two structures
revealed  a  short  span  of  main  chain  displacement  and  a  few  side  chain
rearrangements. Comparison of residue accessibility did not expose large differences
between the two data sets (data not shown). Upon HHDBT binding, an expansion of
the binding pocket was noticed in a local displacement of the ef segment Cα trace,
including residues Ala267, Ser268, Ile269 and Val270, located just before the
catalytic PEWY loop (Pro271-Tyr274). The greatest Cα trace displacement was at
Ser268  (1.7  Å)  (see  also  Appendix  A4).  The  most  pronounced  side  chain
displacements were observed for His253 and Glu272 (Fig. 21).
Based on the binding mode of stigmatellin, Glu272 is proposed to be a direct
ligand of ubiquinol and a primary proton acceptor in quinol oxidation (Crofts et al.,
1999; Hunte et al., 2000). A hydrogen-bond network established by cytochrome b
residues Arg79, Tyr132, Asn256, Glu272, Tyr274, the heme bL propionate A, and
Fig.20 Comparison of stigmatellin and HHDBT binding at the Qo site. Left, when the X-
ray structures of the stigmatellin (orange) and HHDBT (purple) inhibited enzymes were
superimposed the inhibitors were found to be in plane, with the functional groups at the
same position (encircled). Middle, HHDBT is stabilized by a hydrogen bond from the
ionized hydroxy group to protonated His181 and from the carbonyl group on the other
side to Wat518. Right, Glu272 side chain rotates into the binding site to form a hydrogen
bond to the stigmatellin hydroxyl group and on the other side the carbonyl group of
stigmatellin forms   a hydrogen bond to His181. Please note that the polar interactions
from Tyr279 side chain to the backbone carbonyl of Cys180 as well as the [2Fe-2S]
cluster are not depicted in C, although present at the same position as shown in B.
polar interactions to the Rieske cluster ligand His181
Rip1p are observed in both cases. Both
inhibitor fix the Rieske protein in b-position. B,
His181
Tyr279
His181
Tyr279 His181
Glu272
Cys180
Wat518Results
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structural water molecules, was identified in the crystal structure of the yeast enzyme
with stigmatellin bound at the Qo site (see Fig. 5). In the X-ray structure of the
cytochrome bc1 complex with HHDBT bound at the Qo site, the side chain of Glu272
is rotated out of the Qo site, and forms a hydrogen bond to a structural water molecule
(Wat42) that is further stabilized by heme propionate A (L1O2A) (Fig. 22). The side
chain atoms of Glu272 occupy the previous position of two structural water molecules
(Wat428 and Wat50) that were refined in the structure of the stigmatellin inhibited
enzyme. Upon rotational displacement of the Glu272 side chain, a water molecule
Wat518 is positioned at the previous location of the carboxylate and forms a hydrogen
bond with backbone nitrogen of Glu272 and the carbonyl O4 atom of HHDBT (Fig.
22). The reorientation of Glu272 is accompanied by subsequent rearrangements in the
hydrogen bond network. His253 is rotationally displaced and forms a hydrogen bond
to the Glu272 side chain. Tyr274 remains in position and stabilizes the rotationally
displaced Glu272. Arg79 is hydrogen bonded to the heme propionate and provides a
possible proton escape route by connecting to the bulk solvent (see Fig. 22).   
Charged residues are not abundant in the membrane spanning part of integral
membrane proteins. Most of the membrane immersed titratable residues have a
functional role, for instance in stabilization of cofactors (i.e. histidines ligating
hemes), binding of substrate at the active sites (Qo and Qi site), in proton transfer
pathways, or interact with lipid phosphodiester groups. From above it is clear that
structural analysis of titratable residues close to the quinol oxidation site has been
useful in proposing possible proton escape routes from the Qo site. To summarize, in
the 8 transmembrane helix protein cytochrome b, 11.4 % of the total amino acid
residues are titratable, 3.4 % can carry a negative charge (8 Asp, 2 %; 5 Glu 1.3 %)
and the remaining 8 % (13 His, 3.4 %; 7 Lys, 1.8 %; 11 Arg, 2.9 %) can be positively
charged. Protonatable residues in the vicinity of the Qo site that were identified by
structural analysis include: Glu66, Arg70, Arg79, His253, Asp255, Glu272, Arg283,
and Lys288. Functional characterization of these residues relies on other techniques
and Fourier-Transform infrared spectroscopy can for instance provide information
about redox-induced protonation behavior of amino acid residues, as will be described
in the next section.Results
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S268
I269
Fig.21 Qo  site occupancy induced conformational changes. Structural alignment with
stigmatellin (orange, red) and HHDBT (purple, blue) bound at the Qo site revealed that
the most pronounced main and side chain displacements, as response to binding of
different ligands at the active site in the X-ray structures of the yeast enzyme, are confined
to cytochrome b residues 245-274 from the catalytic ef loop. Also shown here are heme bL
and His181 of the Rieske protein that occupy the same position in these two structures.
Fig. 22 The proton exit pathway from the Qo site. X-ray structural analysis of hydrogen
bonds pointed out a putative proton escape route. The reorientation of Glu272 side chain
is encircled. Possible proton exit via hydrogen bonds is marked with stipled lines (black).
The coordinates shown are from PDB entry 1P84, except for the position of His253,
Ser268, Glu272 and stigmatellin that are from PDB entry 1KB9 and are depicted in
orange.
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2.4 Stigmatellin and HHDBT binding probed by FTIR analysis
Based on the structural study presented here, an electrochemical and spectroscopic
study was carried out, in collaboration with Dr. P. Hellwig and Dr. M. Ritter. The aim
of this study was to address redox-dependent alterations in the protonation state of
titratable amino acids close to the Qo site in order to identify catalytically important
residues.
The binding of diverse inhibitors, including: HHDBT, Stigmatellin, Undecyl
stigmatellin (UST), 
13C-UST, Methoxyiminoacetamide (MIA), 
13C-MIA, UK2A and
antimycin, to the yeast cytochrome bc1 complex, was monitored by electrochemically
induced FTIR difference spectroscopy. The oxidized-minus-reduced FTIR difference
spectra revealed redox-induced conformational and/or protonation changes within the
enzyme. In the spectra, positive bands show signals associated with the oxidized state
of the protein, and negative signals represent the reduced state. An important outcome
of this study was that stigmatellin itself appeared to be redox-active (Ritter et al.,
2004). The effect of stigmatellin binding on the electrochemically induced FTIR
difference spectra of the enzyme is presented in Fig. 23. Compared to the native
enzyme, clear variations were observed upon binding of substoichiometric amounts of
stigmatellin to the enzyme (Fig. 23B). Even more dramatic was the spectral change
when 10-fold increase of stigmatellin was added (Fig. 23C), but this revealed an
increase in amplitude of several signals that were derived from stigmatellin itself. In
order to discriminate protein-specific variations from signals derived from the redox
active inhibitor, model compound studies in solvent with a stigmatellin derivative
(UST), having the conjugated trienes replaced by an aliphatic tail, were performed.
The carbonyl group shown in crystal structures to interact with His181
Rip1p  was
specifically 
13C-labeled. The studies with labeled (4-
13C=O) UST led to a more
detailed understanding of the electrochemically induced FTIR difference spectra
(Ritter et al., 2004).
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Fig.23  Oxidized-minus-reduced  FTIR  difference  spectra.  A, yeast cytochrome  bc1
complex with B, 1 µM or substoichiometric amount of natural stigmatellin A (black, full
line) and C, 10 µM of the inhibitor (black, full line), shown overlayed with A (gray line, B
and C) for a potential step from –0.292 to 0.708 V (vs SHE’). The insert above shows the
oxidized-minus-reduced visible difference spectra as typically monitored to control the full
reaction if the enzyme (from Ritter et al., 2004).
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Absence of quinone characteristic signals in the spectra suggested that the Qo
site is empty in the protein preparation from yeast. This interpretation is based on the
assignment of Qo site quinone signals in the cytochrome bc1 complex preparation
from P. denitrificans (Ritter et al., 2003).
To address mechanistic aspects of proton transfer and catalysis, the spectral
region above 1710 cm
-1, which is characteristic for protonated aspartic or glutamic
acids, is of interest. Comparison of the spectral region for protonated carboxylates in
the native enzyme (i.e. empty Qo site) with the spectra when stigmatellin and HHDBT
are bound at the Qo site, is shown in Fig. 24. In the absence of inhibitor, a prominent
positive peak is present at 1746 cm
-1, which points to the presence of protonated
carboxylate groups in the oxidized enzyme. Interestingly, the signal at 1746 cm
-1 is
decreased when stigmatellin is bound. This spectral change is accompanied by an
increase in signal at 1732 cm
-1 (see Fig. 24). In order to interpret the spectral changes
that occur upon stigmatellin binding, two different scenarios can be considered. One
explanation could be that the binding of inhibitor causes an environmental change of a
protonated residue, leading to weaker hydrogen bonding and inducing the downshift
of the ν(C=O) vibrational mode. Alternatively, the decrease in signal at 1746 cm
-1
could be explained by the deprotonation of an acidic residue, whereas the emerging
signal at 1732 cm
-1 would be derived from protonation of another residue. It is most
likely that Glu272 is deprotonated when rotated into the binding site as it binds the
hydroxyl group of stigmatellin. Therefore, an additional residue should be considered
to be perturbed upon binding. In Fig. 25 titratable carboxylates (i.e. Glu66, Asp255,
and Glu272) identified by structural analysis of the Qo site are pointed out.
Importantly, this FTIR spectroscopic study demonstrated that changes in
protonation state and/or conformational change of protonated carboxylates are linked
to the events, which occur upon binding of inhibitors to the Qo site of cytochrome bc1
complex from S. cerevisiae. Exact assignment of these signals in the FTIR difference
spectra needs support from site-directed mutagenesis.Results
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Fig.25 The Qo site viewed from the intermembrane space. Cytochrome b (gray) forms the
crater into which the [2Fe-2S] cluster bearing tip of the Rieske (green) docks. Stigmatellin
binding is stabilized by hydrogen bonds (dotted lines) to His181
Rip1p and Glu272
Cobp.
Acidic residues and tyrosines at the Qo site are depicted in red and orange, respectively.
The flexible ef loop is depicted in yellow.
Fig.24  Comparison  of  the  spectral  region  for  protonated  carboxylates.  Difference
spectra recorded in the presence of the inhibitors stigmatellin/UST and HHDBT were
compared with native enzyme. The difference in absorption, i.e. distance between ticks on
y-axis, equal 0.00005 absorbance units. Lack of Qo site specific quinone signals suggests
that the native preparation has an empty Qo site.
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2.5 Specific binding of phospholipids to the yeast cytochrome bc1 complex
The transmembrane helices of cytochrome b bundle up to shape the internal cavity at
the dimer interface, where the majority of tightly bound phospholipids and the refined
detergent  molecule  are  identified  in  the  structure  of  the  yeast  enzyme  with
stigmatellin at the Qo site (Lange et al., 2001). Notably, all active site occupants tail
into this cavity at the dimer interface. This is best illustrated by the side chain of
stigmatellin, which extends into the lipophilic cavity to meet the end of the isoprenoid
terminus of endogenous CoQ6, which is bound at the Qi site of the other monomer
(see Fig. 26 A). Preferential side chain stabilization of ligands at the Qo  site is
demonstrated where the full length flexible alkyl chain of HHDBT coincides with the
side chain of stigmatellin (see section 2.3.4), despite no obvious steric preferences in
the spacious distal domain of the Qo site. Another interesting observation is that close
to the end of the HHDBT heptyl chain, unresolved lipid-like density is observed to
extend  and  tail  towards  the  Qi  site  occupant.  The  position  of  this  unresolved
compound coincides with the position of the stigmatellin side chain. Obvious polar
ligands are not available and partial density does not permit identification of this
molecule. Importantly, this passage that leads to the lipid filled cavity at the dimer
interface, may serve as the substrate entrance channel to the Qo site.
The modified preparation presented here (see section 2.1) was optimized for
less  delipidation. Consistent with increased lipid content of the preparation, the
protein preparation exhibited higher enzyme activity (Table 2). Furthermore, two new
phospholipids were identified in the X-ray structures derived from this preparation
(Table 4), in addition to the detergent molecule and five previously identified
phospholipids (Lange et al., 2001). The distribution of average B factors for the
refined lipids compared to their ligating protein subunits, demonstrates their tight
binding to the complex (Table 6). The reproducibility of assigned lipid binding sites
was noteworthy and pointed to high specificity of binding, including selective
stabilization of the acyl chains. Even structural features, such as kinked side chains,
were remarkably conserved. In Fig. 26A the refined lipids are shown as they appear in
the structural context of a homodimer. Common features in stabilizing interactions
with the identified phospholipids, include stabilization of the negatively charged head
group moiety by positively charged residues (Fig. 26B), as well as aromatic residues,
such as Trp and Tyr were frequently observed to contact both acyl chains and head
groups (Fig. 26C) (see also Table A5, Appendix A5).Results
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Fig.26 Arrangement of tightly bound phospholipids in the structure of the homodimer. A,
lipids  (yellow,  cyan),  b-type  hemes  (gray),  Qi  site  CoQ6  (black),  HHDBT  (purple)  and
stigmatellin (red). The thickness of the bilayer was estimated from the distance between the
phosphate moieties of matrix leaflet lipid L4 and intermembrane space leaflet lipid L6. The
atoms P, Fe and S are marked in red, brown and green, respectively. B, surface accessible
positively charged residues, which are positioned in the lipid head group region, are depicted,
with His (magenta) and Lys/Arg (blue) (see text). C, surface exposed Tyr (brown) and Trp
(blue) (From Palsdottir and Hunte, in press).Results
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Notably, all of the identified lipids made contacts to cytochrome b (Table 6).
In Fig. 26B a cut-off criteria of > 50 Å
2 accessible surface area and 5 Å distance from
estimated polar region of the membrane plane clearly demonstrates how ‘the positive-
inside rule’ takes effect for the mitochondrial encoded 8 TM helix cytochrome b, with
enrichment of positively charged residues at the negative side of the membrane, or the
matrix side (von Heijne, 1986; von Heijne and Gavel, 1988). This is also where the
majority of refined lipid head groups is stabilized.
The distribution of the selected 41 basic residues is shown in Fig. 26B
(12His/14Lys/15 Arg): Cor1p (1/1/4), cytochrome b (4/3/4), cytochrome c1 (3/3/1),
Rieske (0/1/1), Qcr7p (2/0/0), Qcr8p (1/2/4) and Qcr9p (1/4/1).
Tyr (brown) and Trp (purple) have a proposed role of positioning the complex
by ‘anchoring’ the transmembrane region in the lipid bilayer. The applied cut-off
criteria for displaying residues in Fig. 26C is surface accessibility of more than 50 Å
2
within the bilayer embedded regions. In this way 8 Tyr and 6 Trp were selected for
each monomer, or more specifically (Tyr/Trp): cytochrome b (3/3), cytochrome c1
(1/0), Rieske (1/0), Qcr8p (3/2) and Qcr9p (0/1)
Table 6 Contacts between phospholipids and cytochrome bc1 complex subunits.
Subunits Cor1 Qcr2 Rip1 Cob Cyt1 Qcr6 Qcr7 Qcr8
B
factors
76-
79
91-
94
60-
66
37-
40
55-
59
78-
81
54-
56
75-
78
Lipid B factors Chain
length
L1 67-70 5-15 ; 13 X X
L2 64-68 16-18 ; 7 X/X*
L3 54-56 14 ; 12 X X X
L4 62-63 14 ; 16-18 X X X
L5 74 11 ; 10 ;
18; 9 X X X
L6 78-93 9-10 ; 11 X X
L7 86-88 2 ; 2 ; 2 ; 7 X X
Style of lipid designation is taken from Lange et al., 2001: L1-L5. L6 (Palsdottir et al., 2003) and L7
were identified in crystal structures from the modified preparation described here. The acyl chain
lengths show number of carbon atoms counting from the carboxy-ester bond. The side chains were
truncated according to visibility in the experimental electron density and are therefore presented as the
interval of length as refined in 3 different datasets. Likewise, the average B factors (Å
2) calculated for
subunits and ligands in the analyzed datasets are shown. Chain length gives an indication of the extent
of tight binding of acyl chains, but does not necessarily reflect the real length of the respective side
chains (from Palsdottir and Hunte, in press).Results
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2.5.1 Phospholipid that marks the intermembrane space leaflet at the Qo site
A tightly bound phospholipid (L6) was identified at the surface of the Qo  site
(Palsdottir et al., 2003). Importantly, L6 marks the intermembrane space leaflet of the
membrane (Fig. 26A). It is bound at the interface of cytochrome b (Cobp) and
cytochrome c1 (Cyt1p). A highly conserved residues, His185
Cyt1p, was observed to
stabilize the phosphodiester moiety, whereas the acyl chains interact with cytochrome
b residues. Continuous density from the phosphodiester moiety pointed to a bulky
head group, which led to the tentative assignment of a phosphatidylcholine.
The acyl chains of L6 were clearly resolved in all examined data sets and
extended to within van der Waals distance of the oppositely oriented acyl chains of a
phosphatidyl ethanolamine (L4) and cardiolipin (L5) from the matrix leaflet. The
distance between the phosphodiester groups of L6 and the oppositely oriented L4 and
L5 is 36 Å (Fig. 27). This is in good agreement with
 the experimentally determined
thickness of pure phosphatidylcholine
 bilayers with 18:1 acyl chains, where 38 Å
were measured
 between the phosphodiester groups and 27 Å for the hydrophobic
 core
(Lewis and Engelman, 1983). Accordingly, using L6 as reference and assuming
HHDBT and stigmatellin bind similarly to substrate, the position of quinol oxidation
within the membrane spanning part could be estimated. The functional groups of Qo
site occupants, such as stigmatellin and HHDBT, were observed at 6 Å below
 the
polar zone
 of the head group region.
The largest contribution made by a single residue to stabilize L6, is provided
by  the  highly  conserved  residue  Trp273
Cobp.  Other  residues  that  add  to  the
hydrophobic stabilization or create the van der Waals surface area to which the lipid
adheres include Pro219
Cyt1p and a number of cytochrome b residues: Met91, Phe94,
Thr250, Leu251, Gly252, Val270, Leu276, Pro277, Phe333, Val334, and Ala341.
Cytochrome c1 residue His185 is a direct ligand of the phosphate head group.
Also, His67
Cyt1p and Arg184
Cyt1p together with His253
Cobp, Gln338
Cobp and
His343
Cobp contribute in the immediate neighborhood to generate feasible electrostatic
environment for stabilization of the negatively charged phosphate. Strikingly, polar
contacts  are  made  to  Ser268
Cobp,  which  is  the  residue  of  major  main  chain
displacement (see section 2.3.6). The observation that the lipid interacts with the
displaced loop
 region (Ala
267–Val
270) shows that the conformational
 rearrangement of
the protein takes place in the membrane spanning region.Results
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2.5.2 A cardiolipin identified in the cavity at the dimer interface
The dianionic head group of a cardiolipin (L7), was unambiguously identified in Fo-Fc
difference density maps. L7 adheres to the protein surface in the frontal cleft at the
homodimer interface. The head group is stabilized on the matrix side via several polar
and non-polar interactions with C-terminal domain of core 1 (Cor1p) and the N-
terminal  region  of  cytochrome  b  (Cobp)  from  the  same  monomer  (Fig.  28).
Lys349
Cor1p is the primary ligand of phosphodiester group A (PA) and phosphodiester
group  B  (PB)  is  stabilised  by  polar  interaction  with  Arg4
Cobp.  Also,  backbone
nitrogens of Phe3
Cobp and Arg4
Cobp are within hydrogen bond distance to PB-O12 and
the backbone nitrogen atom of Met455
Cor1p is within hydrogen bond distance to PA-
O4´. The position of L7 at the interface of different subunits suggests a role in
structural integrity or assembly. Interestingly, the primary ligands of the polar head
group are confined to the termini of the respective polypeptides, i.e. C-terminus of
cytochrome  b and N-terminus of Cor1p. The head group stabilizing ligands are
Fig.27 Lamellar oriented tryptophan residues structure the protein surface for lipid
binding. Phospholipids L4, L5 and L6, mark the transmembrane region. The helices are
shown as white cylinders and Trp residues are painted yellow with the nitrogen depicted
in blue. L6 is for made transparent to show Trp273, a residue in the conserved catalytic
PEWY loop, which provides the largest surface area for the acyl chain stabilization at the
Qo site surface (from Palsdottir and Hunte, in press).Results
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involved in hydrogen bond networks at the Core 1 and cytochrome b interface. For
instance, Arg4
Cobp  interacts  with  Asp19
Cobp  which  binds  Arg447
Cor1p.  Also,  a
structural  water  molecule  Wat60  forms  a  hydrogen  bonded  bridge  between
Asp341
Cor1p, Asp342
Cor1p  and  Arg4
Cobp.  The  ligand,  Arg4
Cobp, is well conserved
among metazoan cytochrome b sequences where it is present as an XRK motif and X
is a hydrophobic residue (see Appendix A1).
Fig.28 The lipid filled cavity at the dimer interface. A, majority of identified lipids are
confined to the matrix leaflet of the bilayer. Lipids are shown in space-fill representation
and colored yellow, with the exception of the two cardiolipin molecules (cyan). Cofactors
and Qi site occupant (ubiquinone, Uq6) are shown as black ball-and-stick models. Helices
are depicted as cylinders and colored according to subunits: Cytochrome b (brown),
cytochrome c1 (darkgray), Rieske (green), Qcr6p (cyan), Qcr7p (midgray), Qcr8p (white),
Qcr9p (magenta), Cor1p (blue), and Qcr2p (purple). The two lipid-filled cavities are
encircled, the frontal cavity (black) and at each side of homodimer (brown, dotted line). B,
the  identified  lipid  molecules  define  the  vertical  positioning  of  the  complex  in  the
membrane. C,  the binding site of cardiolipin, L7 (cyan), at the subunit interface of
cytochrome b (brown) and Cor1p (blue). Hydrogen bonds to direct ligands (lightgray) of
the phosphodiester moieties are depicted and the neighboring lipid, L1, is shown in
yellow.  P,  O  and  N  atoms,  are  marked  in  purple,  red  and  blue,  respectively  (from
Palsdottir and Hunte, in press).
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Stabilization of several phospholipids and detergent molecules in the cavity at
the dimer interface uncovers an intricate network of polar and non-polar interactions
where the lipophilic molecules are frequently observed to share ligands. For example,
a ligating residue of L7, Phe3
Cobp, forms a hydrophobic contact to the lipid L2, which
is tightly bound by cytochrome b residues from both monomers at the dimer interface
(Cobp-Cobp*). Also, Met454
Cor1p forms a hydrophobic contact to L7 in addition to a
polar contact to the head group of a stably refined undecyl maltopyranoside (UM)
detergent molecule, which is tightly bound by Cor1p, Rip1p and Qcr9p. Furthermore,
Fig. 29 The homodimer and tightly bound lipids displayed as van der Waals spheres. A,
the intermembrane leaflet lipid L6 depicted in orange. Previously identified phosphatidyl
ethanolamine (L4, yellow) and cardiolipin (L5, cyan) that represent the matrix leaflet of
the bilayer are shown. Proposed site for supercomplex formation with COX. B, 90 degrees
clockwise rotation reveals how the second identifed cardiolipin (L7, cyan) positioned at
the  interface  of  Cor1p  and  cytochrome  b,  contributes  to  the lipophilic cavity which
presumably promotes access to the active site, as demonstrated by the isoprenoid tail of
the bound substrate UQ6, at the Qi site (black). This cavity could serve as a docking site
for  supercomplex  formation  with  SQR.  C,  the  arrangement  of  cofactors,  active  site
occupants, lipids and detergents as viewed from the matrix side. D, same as C but with
added TM helices. Color coding as in A, B.
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Met455
Cor1p forms hydrophobic contact to UM, whereas its backbone nitrogen is
hydrogen bonded to the phosphodiester group of L7. His222
Cobp, the phosphodiester
ligand of L1, an immediate neighbor of UM, contributes to hydrophobic stabilization
of L7. These molecules (L1, L2, L7, UM) are in proximity or directly contributing to
the entrance to the Qi site (Fig. 29B).
2.5.3 Conserved lipid binding sites
The current resolution of the structure of the yeast protein does not permit assignment
of unsaturated side chains. It is still valid to make the observation that some of the
refined phospholipids possess highly curved (i.e. kinked) side chains, which suggest
double bond character as supported by mass spectrometric analysis of the lipid
content in the 3-D crystals used for structure determination (C. Lange and C. Hunte,
manuscript  in  preparation). The acyl chain of L4 in the yeast cytochrome bc1
complex is reproducibly refined in several datasets to bend at a ~90° angle and extend
into  a  narrow  and  highly  hydrophobic  dent  coated  by cytochrome b residues,
including side chains of Phe94, Leu101, Ile330, and Phe278 (see Palsdottir and
Hunte, in press).
Lipid-detergent exchangeability was observed when comparing the structures
of the yeast and chicken enzymes (see C. Lange, PhD thesis). Structural alignment of
the yeast and chicken cytochrome bc1 complexes showed that a detergent molecule,
octyl glucoside is assigned to the position where the interhelical phosphatidyl inositol
(PI) (L3) is stably refined in the yeast enzyme and likewise a lipid binding site in the
structure of the chicken enzyme is occupied by a detergent, undecyl maltoside, in the
yeast enzyme.
Structural alignment with the recently determined X-ray structures from the
homologous protein, the cytochrome b6f complex (Plastohydroquinone : Plastocyanin
Oxidoreductase), showed conserved lipid-filled cavities. 3 endogenous tightly bound
lipid molecules were identified in the X-ray structure of the cytochrome b6f complex
from alga Chlamydomonas reinhardtii (Stroebel et al., 2003: PDB entry 1Q90). At
the matrix side one sulfolipid (SL) was identified (Fig. 30). Notably, it is stabilized by
three catalytic subunits, subunit IV, cytochrome f and Rieske of the cytochrome b6f
complex. The head group is stabilized by polar and non-polar interactions with Trp32
side chain of subunit IV (corresponds to C-terminus of cytochrome b). The negatively
charged sulfate is mainly stabilized by electrostatic interactions with positivelyResults
60
charged residue Lys272 from cytochrome f, which is implicated in biogenesis of the
enzyme (Stroebel et al., 2003).
On the intermembrane side, two 1,2-distearoyl-monogalactosyl-diglycerides
(DMG) were identified in a similar position like the intermembrane space lipid in
yeast (see section 2.5.1). Importantly, one of the DMGs is stabilized by subunit IV
residue Trp79, which is homologous to Trp273 (PEWY loop) (see Appendix A1).
Interestingly, Trp273 contributes the largest surface area for stabilization of the
intermembrane space lipid (L6) observed in the yeast structure (Fig. 27). Furthermore,
polar contacts with the head group are made by subunit IV residues Glu74 and
Thr148, homologous to Ser268 and Val344 in cytochrome b. The former is also a
stabilizing ligand of L6 (see section 2.5.1) and the residue where most pronounced
main chain displacement takes place, when comparing the structures with stigmatellin
and HHDBT bound at the Qo site (see section 2.3.6).
In the cyanobacterial cytochrome b6f  complex  2  exogenous  lipids  were
crystallographically resolved (Kurisu et al., 2003). Like the endogenous SL from alga,
both of the exogenous lipids were identified in the lipid enriched frontal cavity at the
dimer interface (Fig. 30). In the cyanobacterial enzyme, the intermembrane space
leaflet lipid occupies unusual position below the membrane plane similar to the
interhelical lipid (L3: Lange et al., 2001). Both exogenous lipids make contacts with
the  catalytic  subunit  Rieske,  as  well  as  cytochrome  b6  from  both  monomers,
underlining their importance in promoting structural stability of the complex, as
demonstrated by Zhang et al. (2003). Lipid-mediated stabilization of this preparation
was a prerequisite for successful structure determination (Kurisu et al., 2003).
Notably, in the X-ray structures of the homologous enzymes from yeast,
chicken, alga and cyanobacteria, tightly bound lipids were identified in the cavity at
the dimer interface. Furthermore, the acyl chains of L7 and the algal SL, provide only
fragmental density, although the head groups are well resolved. This points to
conformational flexibility of these side chains, which presumably extend into the lipid
bilayer, e.g. in structural context into the surrounding layer of detergent side chains,
rather than being fixed by tight interactions on the protein surface. The observed
mobility of these acyl chains suggests that they may participate in forming a feasible
environment to promote substrate diffusion. Structural and/or functional relevance of
the L7 binding site has to be explored by site-directed mutagenesis.Results
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L1
L2
L7
L4
L3
SL
PCC
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PEE
PEE
Fig.  30  Conserved  lipid  binding  sites  in  the cytochrome bc1  complex  and  related
enzymes. Superposition of tightly bound lipids refined in the X-ray structures of the
cytochrome bc1 complex from yeast (L1-L7, gray/cyan) and chicken (PEE, red), as well as
the photosynthetic cytochrome b6f complex from alga (SL, blue) and cyanobacteria (PCC,
magenta). Note that structurally resolved lipids are enriched at the dimer interface in all
species.Discussion
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3. DISCUSSION
3.1 Fv-mediated crystallization of a less delipidated and more active protein
The purification of the yeast cytochrome bc1 complex presented here was modified in
favor of increased lipid content by decreasing the extent of detergent exposure. This
resulted in isolation of crystallization grade enzyme with higher turnover numbers
than previously reported (Palsdottir and Hunte, 2003).
The multi-factorial procedure behind Fv-mediated crystallization and structure
determination  of  this  enzyme  is  complicated  because  of  destabilization of this
homodimeric  multisubunit  membrane  protein  (see  section  2.1.3) and unstable
assembly  of  the  Fv  fragment  (see  section  2.2.1).  To  ensure  reproducible
crystallization behavior checkpoints were designed for quality control of both the
enzyme and Fv fragment preparation. The presence of individual subunits and purity
of the preparation was analyzed by denaturing sodium dodecyl sulfate polyacrylamide
gel  electrophoresis  (SDS-PAGE).  Furthermore,  the  chromatographic  profiles
demonstrated the degree of monomerization and/or subunit dissociation. Also, the
enzyme activity was inspected by monitoring the reduction of cytochrome c. The
turnover numbers of yeast cytochrome bc1 complex can approach 200 s
-1 (Ljungdahl
et al., 1987), but are typically lower for detergent solubilized and isolated complexes
(Sidhu and Beattie, 1982; Siedow et al., 1978; Snyder and Trumpower, 1999) (see
Table 2). The specific enzyme activity of 24.8 µmol/(min*mg protein) shown here is
comparable  to  the  17.1  µmol/(min*mg  protein)  reported  for  the  Triton  X-100
solubilized yeast enzyme, which was purified by ammonium sulfate precipitation and
size exclusion chromatography (Sidhu and Beattie, 1982).
In both successful examples of Fv-mediated crystallization of membrane
proteins, the strep-tag mediates important crystal contacts and the antibody fragments
are conformation-specific (see section 2.2.5). In contrast to the strep-tag affinity
purification of the Fv7E2 cytochrome c oxidase co-complex (Kleymann et al., 1995;
Ostermeier et al., 1995), preparative streptavidin affinity chromatography proved
incompatible for purification of the Fv18E11-cytochrome bc1 co-complex (C. Hunte,
unpublished). Here, specific capture of the co-complex was, however, accomplished
in an analytical streptavidin-coated magnetic beads pull down assay (see section
2.2.6) (Fig. 13). This assay underlined the unstable assembly of the Fv fragmentDiscussion
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18E11. A quality control point was therefore designed and the stability of the Fv
fragment preparation was routinely investigated by analytical gel filtration (see
section 2.2.1).
Detailed  structural  characterization  of  the  binding  of  Fv18E11  to  the
cytochrome bc1 complex was carried out (see Table 3). Water-mediated hydrogen
bonds  and  aromatic  residues  are  postulated  to  contribute  to  antibody-antigen
interactions (see Davies and Cohen, 1996; Essen et al., 2003). Here, structural water
molecules were reproducibly identified and stabilized by hydrogen bond bridges
between the epitope and the antibody fragment. Also, a number of tyrosine residues
were observed to create a characteristic fold at the Fv fragment interface.
The epitope (Pro123-Gln151) resides in a non-conserved region of Rieske (see
Fig. 12), thus explaining the apparently yeast specific binding of Fv18E11. Based on
structural  characterization  of  the  antibody-antigen  interaction,  site-directed
mutagenesis approach was carried out to create (i.e. to graft) the yeast epitope on the
soluble  domain  of  the Rieske protein from P.  denitrificans, in order to pursue
Fv18E11-fragment mediated crystallization of the bacterial cytochrome bc1 complex
(see Diploma thesis, T. Kleinschroth). Disappointingly, even the introduction of the
entire  yeast  sequence,  which  contained  the  non-linear  segments  encoding  the
conformational Rieske epitope, did not permit efficient recognition by the antibody
fragment. The reasons for this may be two-fold. First, the engineered Rieske protein
was not stably integrated into the bacterial enzyme. Second, incompatible folding of
this non-conserved part of the Rieske protein may not permit correct tertiary structure.
In an attempt to overcome these obstacles, chimeras were constructed with the
complete extrinsic domain of the yeast Rieske protein engineered in the bacterial
enzyme. Two types of chimeras were constructed, both contained the soluble Rieske
domain from yeast, and one also included the flexible linker region from yeast.
Interestingly,  the  chimera  domains  appeared  to  fold  properly,  as  judged  from
successful recognition by the Fv18E11 in streptavidin-magnetic beads pull down
assays (Fig. 13). Subsequently, analytical gel filtration showed that the Fv-chimera
co-complex  eluted  as  a  single  symmetric  peak  and  structural  integrity  of  the
preparation  was  enhanced  by  the  addition  of  phospholipids  (i.e.  DOPC)  (T.
Kleinschroth and H. Palsdottir, unpublished). Fv-fragment mediated crystallization of
this construct will be pursued.Discussion
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Recently, the inserted extra fragment in the bacterial Rieske sequence, that
breaks up the epitope-containing region in yeast (see Fig. 12), was shown to be
important for structural stability of the enzyme from R. sphaeroides (Xiao et al.,
2004). Likewise, mutagenesis studies showed that Rieske deletion mutants Δ122-135
and  Δ138-153 were not efficiently assembled into the cytochrome bc1 complex,
despite being properly processed and imported to mitochondria. Thus, the Fv18E11
recognizes a part of the yeast Rieske protein that appears important for biogenesis of
the enzyme (Gatti et al., 1989; Obungu et al., 1998; Beattie et al., 1999).
3.2 Structural insight into the enzyme mechanism
Water-mediated hydrogen bond interactions are prominent at the Rieske-cytochrome
b interface (see Appendix A3), and also observed in ligand stabilization at the Qo site
(see section 2.3.3). Additive weak forces in transient molecular interactions are
energetically more feasible than strong atomic interactions, especially in enzyme
catalysis, where the substrate should be specifically, but still reversibly bound (see
Jiang and Lai, 2002; Sarkhel and Desiraju, 2004). Likewise, the interaction between
the catalytic interface of Rieske and cytochrome b should permit proper positioning of
Rieske to enclose the quinol oxidation site, but also allow the release and rotational
displacement of the Rieske domain. The position of the Rieske extrinsic domain has
been proposed to dictate the midpoint potential of the [2Fe2S] cluster (Darrouzet et al,
2002).  It  is  however  clear  that  not  only  position,  but  also  other  factors,  must
contribute to this effect (see Cooley et al., 2004). For instance, stigmatellin binding
raises the midpoint potential (Em) of the Rieske protein by 250 mV (von Jagow and
Ohnishi, 1985), whereas UHDBT binding causes less increase in Em (~70 mV), as
was shown for the bovine (Bowyer et al., 1982) and the yeast enzyme (T. Merbitz-
Zahradnik and B. Trumpower, unpublished). This difference in Qo site inhibitor
induced increase of the midpoint potential is not likely to be caused by the position of
the  Rieske  soluble  domain  alone,  because  the  molecular  interactions  at  the
cytochrome  b-Rieske interface were observed by X-ray structural analysis to be
almost identical when stigmatellin and HHDBT are bound, at least in the yeast
enzyme (see Appendix A3).
Structural comparison of the quinone/quinol (CoQ) binding sites shows that
water-mediated  hydrogen  bonds  are  frequently  involved  in  ligand  head  groupDiscussion
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stabilization. This is observed in stabilization of stigmatellin (Hunte et al., 2000),
HHDBT (Palsdottir et al., 2003), famoxadone (Gao et al., 2002), and NQNO (Gao et
al., 2003) at the Qo site, and also by the binding mode of native occupant at the Qi site
(Hunte et al., 2000). A common feature in stabilization of the head group of CoQ and
derivatives are polar interactions of the functional groups with titratable residues,
frequently histidines, which serve as primary ligands and proton acceptors. In the
structures of the bacterial reaction center, a menaquinone is hydrogen bonded to
His217
M, and the non-heme iron ligand His190
L is hydrogen bonded to the carbonyl
group of a truncated quinone at the QB site (Deisenhofer et al., 1988). The latter
binding mode was reproduced for stigmatellin (Lancaster and Michel, 1997). Link
(1997) transferred this information of coinciding substrate and stigmatellin binding
sites to the Qo site of the cytochrome bc1 complex and suggested that the complex
between stigmatellin and Rieske mimics the reaction complex between protonated
semiquinone and the reduced Rieske protein.
The observed binding mode and orientation of stigmatellin and HHDBT at the
Qo site provide an important foundation for modeling the substrate in the active site.
In  agreement  with  EPR  studies  and  kinetic  characterization  of  variants,  X-ray
structural analysis revealed that HHDBT and stigmatellin binding sites coincide.
Furthermore, superimposition of the X-ray structures showed that the inhibitor ring
systems are in plane (Fig. 20). Interestingly, the inhibitors are oriented with their
functional groups at the same distance and geometry to the Rieske [2Fe-2S] cluster
ligand His181. More specifically, the oxygen atom O6 of the ionized hydroxy group
of HHDBT is at the same position as the carbonyl oxygen atom O8 of stigmatellin,
allowing in both cases for a hydrogen bond to the Nε2 atom of a protonated His181.
Importantly, the residues involved in binding of the hydroxy-dioxobenzothiazole and
stigmatellin head groups are highly conserved (see Degli-Esposti et al., 1993). Kinetic
characterization of variants has shown that the following residues, which interact with
the head groups: Trp142, Gly143, Ile269, Pro271, and Tyr279, have phenotypes of
disturbed ubiquinol occupancy and/or oxidation (see Brasseur et al., 1996; Crofts et
al., 2000), suggesting that the inhibitors bind at the substrate binding site. Based on
these data and structural resemblance to the substrate, the competitive inhibitors,
HHDBT and stigmatellin, are here regarded as substrate analogs and their binding
mode will be discussed as resembling the binding of CoQ. Recent EPR studiesDiscussion
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support this assumption. Samoilova et al. (2002) detected the product of Qo site
catalysis and reported similar interactions with the reduced Rieske cluster, as in the
case when stigmatellin was bound. The X-ray crystallographic analysis of stigmatellin
binding suggests single occupancy with ubiquinol hydrogen bonded to His181
Rip1p
and Glu272
Cobp side chains (Hunte et al., 2000). In this way, the Enzyme-Substrate
(ES) complex was created by docking ubiquinol into the X-ray structure of the yeast
enzyme. The substrate was modeled in plane with stigmatellin and HHDBT, with the
functional  groups  coinciding  accordingly  (Hunte  et  al.,  2003).  After  energy
minimization the quinol hydroxyl groups were at a distance of ~2.1 Å and ~2.4 Å to
the putative primary proton acceptors, the imidazole nitrogen of His181
Rip1p  and
carboxylate of Glu272, respectively (Fig. 31).
Single occupancy models comprise either simultaneous or sequential electron
transfer at the Qo site. For the latter, a proton-gated affinity change mechanism claims
the presence of a relatively stable semiquinone intermediate with the rate-limiting step
at the second electron transfer (Link, 1997). Since a semiquinone radical has not been
detected  at  the  Qo  site,  this  has  been  explained  away  by  an  EPR  silent  anti-
ferromagnetically coupled semiquinone-[2Fe-2S]
reduced pair (Link, 1997; Jünemann et
al., 1998). Based on kinetic considerations, another explanation for the undetectable
semiquinone is provided by Crofts and colleagues, who suggest rapid dissociation of
the product after the first electron transfer and movement of the semiquinone within
the bilobal Qo binding pocket to allow fast reduction of heme bL (Hong et al., 1999).
A third reaction mechanism suggests a concerted reaction and is based on the kinetic
interpretation that the midpoint potentials of the b type hemes control the rate of
cytochrome c1 reduction (Snyder et al.,  1999;  Snyder et  al.,  2000).  In  such  a
mechanism the concentration of semiquinone is so low as to be almost non-existent.
Still, the structural study presented here clearly illustrates the possibility of stabilizing
a negatively charged ligand at the Qo site.
The identification of a backwards operating cytochrome bc1 complex in the
acidophilic chemolithotrophic organism Acidithiobacillus ferrooxidans was a topical
finding (Elbehti et al., 1999; Brasseur et al., 2002). This observation formed the basis
for reaction schemes that stress the reversibility of the enzyme mechanism (Osyczka
et al., 2004). Based on kinetic characterization of cofactor knockouts, the reversibility
of electron transfer in quinol oxidation is suggested to be key in eliminating short-Discussion
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circuits. The bypass reactions, that have to be avoided to prevent short-circuits in
quinol oxidation, comprise the oxidation of ubiquinol by sequential electron transfer
to the Rieske and oxidation of heme bL by the unstable Qo site semiquinone. The O2
respiring mitochondria are the main location for production of reactive oxygen
species (see Crofts, 2004). If a semiquinone is formed at the Qo site, the necessity to
stabilize it is illustrated by these two potentially harmful events, which would
promote damaging superoxide production: 1. Escape of the semiquinone from the Qo
site and 2. Reduction of O2 by an unstable semiquinone. Experimental conditions
aimed  to  accumulate  semiquinone  at  the  Qo  site  cause  enhanced  superoxide
production, whereas Qo site inhibitors block superoxide production either partially or
completely depending on their inhibitory characteristics (Müller et al., 2003; Sun and
Trumpower, 2003).
The reversible reaction scheme, proposed by Osyczka et al. (2004), fails to
discriminate between concerted and sequential reactions. The latest mechanistic
model proposed by P. Rich (2004) suggests that, the coupling of the protonation state
of primary proton acceptors to the redox state of the cofactors is the crucial event in
Qo site catalysis. FTIR analysis may be the most suitable technique to address redox-
dependent protonation behavior of catalytic residues.
Fig.31 The enzyme-substrate complex at the Qo site. Ubiquinol truncated to the first two
isoprenoid repeats was modeled into the active site according to the observed binding
mode for stigmatellin. The distances to the proposed primary proton acceptors His181
Rip1p
and Glu272
Cobp after energy minimization are depicted (from Hunte et al., 2003).Discussion
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The double occupancy model suggests synergistic interaction between two
substrate molecules, which occupy the Qo site simultaneously (Ding et al., 1992; Ding
et al., 1995a; Brandt et al., 1996; Bartoschek et al., 2001). Interpretation of EPR
lineshapes even suggested different affinities of these two occupants, with a strong
and weak CoQ binding site (Ding et al., 1992). All reports on double occupancy are,
however, based on indirect observations. Although the Qo site is divided into two
spacious domains, X-ray structural analysis has shown that the binding sites of bulky
Qo site inhibitors overlap and the substances compete with each other and substrate in
kinetic studies. Moreover, the proposed tightly bound CoQ has not been detected by
other methods than interpretation of EPR lineshapes. Modeling of two CoQ at the site
requires considerable structural distortion. Furthermore, energetic considerations
speak in favor of single-occupancy models (see Crofts, 2004). In addition, reports on
crystallographic analysis of a truncated quinone, CoQ2, partially resolved at the Qo
site, does neither reveal strong binding, nor two molecules at the site (Gao et al.,
2003). So far, the latter is true for all crystallographically resolved Qo site inhibitors.
The observation that UHDBT did not inhibit the cytochrome bc1 complex
efficiently at alkaline pH was explained by restricted access of an ionized compound
to  the  Qo  site  (Zhang et  al., 1999). The study shown here presents contrasting
evidence to this assumption and a dissociable group within the complex, namely
His181
Rip1p, is instead suggested to cause the observed pH dependency of UHDBT
inhibition. The apparent pKa of 7.5 for inhibitor efficacy is more alkaline than the pKa
of alkyl-HDBT (~6.1), whereas it closely matches the pKa ~7.5 suggested for the
imidazole nitrogen (Nε) of His181 of the oxidized Rieske protein (Link et al., 1992).
Spectroscopic evidence and the crystal structure of the enzyme with HHDBT bound at
pH  > pKa demonstrate that this alkyl-hydroxyquinone derivative is bound in the
ionized form and is proposed to be stabilized by a polarized hydrogen bond to the
protonated His181
Rip1p (Palsdottir et al., 2003). This is consistent with the observation
that His181
Rip1p donates a hydrogen bond to the carbonyl group of stigmatellin at pH
~8.5 or half a pH unit above that used for HHDBT crystallization.
Considering  the  possibility  that  at  least  a  transiently  stable,  anti-
ferromagnetically coupled semiquinone is formed (Link, 1997; Jünemann, 1999),
stigmatellin binding would mimic the binding of a protonated semiquinone, whereas
HHDBT resembles the deprotonated form, i.e. the semiquinone anion.Discussion
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Based  on  the  structural  considerations  presented  here,  snapshots  of  the
reaction mechanism can be discussed (Fig. 32). Reversible gating would permit
sequential electron transfer through a semiquinone and prevent short circuits only if
the [2Fe-2S] cluster and the heme bL have the same redox state (Osyczka et al., 2004;
Rich, 2004). If both cofactors are oxidized, His181
Rip1p and Glu272
Cobp should be
deprotonated. When ubiquinol enters the binding site, the deprotonated Glu272 side
chain re-orients to ligate the hydroxyl group on one side and the oxidized Rieske is
captured in a hydrogen bond between His181
Rip1p and the other hydroxyl group (Fig.
32: Panel 2-3). The weak hydrogen bond interactions from the Tyr279
Cobp side chain
position the hydroxyl group of ubiquinol for optimal interaction with His181
Rip1p and
thus efficient electron-proton transfer to the Rieske. Reduction of the oxidized [2Fe-
2S] cluster occurs as a first step after formation of the ES-complex, and involves
coupled electron-proton transfer to the Rieske similar to when stigmatellin is bound
(Fig. 32: Panel 4). After coupled electron-proton transfer to the Rieske, Glu272
accepts a proton from the singly protonated semiquinone and re-orients towards heme
bL and the resulting negative charge is stabilized as in the case of HHDBT (Fig. 32:
Panel 5). Conformational gating is accounted for in that the reduced Rieske protein is
firmly held in b-position by interactions with the reaction intermediate in a polarized
hydrogen bond. After the second electron reduces heme bL the destabilized product
leaves the binding site and allows for increased mobility of the highly conserved
Tyr279 side chain. Kinetic characterization of Tyr279 variants supports its importance
in the catalytic cycle (see section 3.4.1). Tyr279 responds to Qo site occupancy by
rotating into the binding site in the absence of ligand, as shown in the structures of the
enzyme with empty Qo site (Crofts et al., 1999a) (Fig. 32: Panel 6). When the
substrate leaves the active site, the soluble domain of the Rieske protein is released
from docking position on cytochrome  b because the hydrogen bond to Qo  site
occupant and the hydrogen bond from Tyr279
Cobp to Cys180
Rip1p is broken.
If reversibility of quinol oxidation is taken into account, a feasible mechanistic
coupling to prevent short circuits would be the redox-governed protonation state of
the primary ligands, namely His181 and Glu272 (Osyczka et al., 2004; Rich, 2004).
Thus, substrate binding should only occur when the enzyme is redox poised to accept
electrons from both sides. The redox dependent protonation behavior of His181
Rip1p is
accounted for in a bulk of experimental and theoretical studies that assume coupled
electron-proton transfer to the Rieske and pKa values estimated for the reduced RieskeDiscussion
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cluster are much higher than for the oxidized Rieske (Link et al., 1992; Ullmann et
al., 2002; Zu et al., 2003). Still, the question whether protonation state of Glu272 is
coupled to heme bL redox state remains to be addressed.
Fourier transform infrared (FTIR) spectroscopy is a feasible technique to
address  this  question.  The  initial  findings  from  the  redox-induced  FTIR  study
presented here (see section  2.4 and PhD thesis, M. Ritter). Differences in redox
induced spectra were observed when the enzyme with empty Qo site was compared to
the enzyme with HHDBT and stigmatellin bound. The study of the binding of 
13C-
labeled stigmatellin, demonstrated that changes in conformation and/or protonation
state of acidic residues, such as Glu or Asp, take place when the inhibitors bind to the
Qo site of cytochrome bc1 complex from S. cerevisiae (Ritter et al., 2004). Ongoing
studies, especially the spectral characterization of variants, are needed for exact band
assignment.
Fig.32 Structure-based snapshots of the reaction mechanism. The oxidized [2Fe-2S] is
indicated with black circles, the reduced in grey. Hydrogen bonds stabilizing the enzyme-
substrate complex are indicated with dotted lines. 1. Empty Qo site with Glu272 oriented out
of the binding pocket. 2. Initial stabilization of ubiquinol by cytochrome b residues. 3. The
enzyme-substrate complex with the Rieske protein docked in the b-position. 4. Coupled
electron-proton transfer to the Rieske protein. 5. Stabilization of the anti-ferromagnetically
coupled ubisemiquinone anion and rotational displacement of protonated Glu272. 6. Release
of the reduced and protonated Rieske protein and of the oxidized ubiquinone accompanied by
rotational displacement of Tyr279 into the binding site (from Palsdottir et al., 2003).Discussion
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3.3 Proton transfer pathways
Molecular  dynamics  simulation  studies  using  the  3  Å  X-ray  structures  of  the
cytochrome bc1 complex from chicken were first to propose a proton exit pathway
from the Qo site via the Glu272 carboxylate and heme bL propionate (Izrailev et al.,
1999; Crofts et al., 1999c). The first experimental support for this proposed pathway
emerged with improved resolution, which permitted the refinement of structural water
molecules at 2.3 Å resolution in the yeast enzyme (Hunte et al., 2000). In the X-ray
structure of the HHDBT inhibited enzyme, the hydrogen bond network revealed that a
single water molecule connects the reoriented Glu272 carboxylate to the heme bL
propionate A (Fig. 22). The protein-stabilized hydrogen bond network from heme bL
propionate to outside was shown in the structure, including crystallographic water
molecules and cytochrome b residues: Arg79, Asn256, Glu66 and Arg70. Arg79,
Glu272, and Tyr274 are highly conserved in mitochondrial cytochrome b supporting
their importance for the catalytic mechanism (Degli-Esposti et al., 1993).
The functional importance of Glu272 is shown in a number of mutagenesis
and kinetic studies (Brasseur et al., 1996; Covian and Moreno, 2001). Mutation to
Asp or Gly causes decreased rates of quinol oxidation, whereas exchange with a Gln
renders the enzyme inactive. The shorter side chain of Asp could still fulfill the role in
proton  transfer,  although  not  as  efficiently  due  to  non-optimal  hydrogen  bond
geometry and in the case of a small side chain, such as Gly, it is conceivable that a
water molecule migrates to the site to mediate hydrogen bonds to outside.
In addition to the main pathway proposed for proton conduction, alternative
and less effective proton exit pathways may exist in the cytochrome bc1 complex.
This is suggested by the functional analysis of Glu272 variants, where smaller side
chains are tolerated. Furthermore, rearrangements in hydrogen bond networks have
been shown to accommodate for loss of catalytic residues in other energy transducing
enzymes. For instance, formation of an alternative proton transfer pathway was
demonstrated in variants of the bacterial reaction center, where inhibited proton
uptake at the QB site in Asp213Asn
L variant was restored by second site revertants
(Xu et al., 2004).
Interestingly,  in  some  microorganisms,  such  as  the  chemolithotrophic
acidophilic bacteria Acidithiobacillus ferrooxidans, Glu272 is replaced with a Pro
(PPWY) (Brasseur et al., 2002). Brasseur and colleagues found that Pro was also
present in the cytochrome bc1 complex of the hyperthermophilic aerobic craenarchaeDiscussion
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Aeropyrum  pernix  and  acidophilic  obligate  aerobic Sulfolobus  acidocaldarius.
Another deviation from the conserved PEWY loop is replacement with Val observed
for instance in the neutrophilic chemolithotrophic bacteria Nitrosomonas europea.
However, these organisms have an inserted span of amino acids in this region of the
enzyme and an upstream acidic residues may therefore be repositioned within the
binding site and provide the necessary ligand and proton acceptor to compensate for
the missing function of Glu272. Also, in the X-ray structures of the cytochrome b6f
complex, the complement of non-homologous small subunits changes the molecular
architecture at the site. In this case, structural analysis suggests different proton exit
pathway than that proposed for the cytochrome bc1 complex, such as a hydrogen
bonded water chain, which was structurally resolved in cytochrome f (see Ponamarev
and Cramer, 1998; Stroebel et al., 2003).
The conformational changes described for the side chains of Glu272 and
His253 (Fig. 33) invite the following speculations: Does the rotational displacement
of the Glu272 side chain induce rotational displacement of the His253 side chain,
which in turn releases Ser268 and subsequently causes relaxation of the span of
residues within the ef loop which are observed to be displaced? Is the observed
conformational change of functional importance? Does it present an event in relaying
a signal to the surface which senses Qo site occupancy?
The observed conformational changes can be put into mechanistic context.
Once ubiquinol binds, rotational displacement of the Glu272 side chain to bind the
substrate may release the His253 side chain to rotate away from the binding site and
form a hydrogen bond to the main chain atom of Ser268 (Fig. 33). This cycle is
repeated when the substrate is oxidized and Glu272 rotates away from the binding
site. In this way a domino-like cascade of hydrogen bond rearrangements and subtle
conformational changes may serve to sense Qo site occupancy and perhaps relay
signals to the surface, which capture or release the Rieske protein.
The observed rotational displacement of His253 and the contact it makes to
the head group of the intermembrane space lipid (L6) (see section 2.5.1) may as well
provide an alternative proton exit pathway? Although His253 is not a completely
conserved residue it must not be excluded that it has at least secondary roles in proton
escape pathways from the site, and it should be pointed out that it is partially
conserved, at least in fungi, parasites and some bacteria R. sphaeroides and P.
denitrificans (see Appendix A1).Discussion
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3.4 Structural analysis assists functional interpretation of mutagenesis data
The prokaryotic origin of mitochondria presumes that much of the information
retrieved from massive efforts by mutagenesis studies on the bacterial cytochrome b,
may be transferred to eukaryotes. However, although highly conserved, the enzymes
are not fully conserved and careful inspection of sequence similarities is required
when interpreting functional aspects in structural context . Recent technical advances
based on biolistic transformation allow genetic manipulation of mitochondrial DNA
(mtDNA) and subsequently data is accumulating about functional effects in yeast
(Fisher and Meunier, 2001; Kessl et  al.,  2003;  Kessl et al., 2004). In general,
nonsense and frameshift mutations are observed to affect assembly, conformation and
stability of the enzyme. Missense mutations are more difficult to interpret. The
molecular structures provide a necessary fundament to discuss the molecular reasons
for  the  observed  phenotypes.  The  Qo  site  and  heme  surroundings  are  highly
susceptible to amino acid replacements. Variations in the van der Waals surface area
and changes in electrostatic properties are typically not tolerated and frequently even
conservative substitutions may cause inhibitor resistance and/or impaired quinol
Fig.33 Qo site occupancy dependent conformational switch? When stigmatellin is bound
at the Qo site (left) Glu272 carboxylate is hydrogen bonded to the hydroxyl group of
stigmatellin. When HHDBT is bound (right) His253 rotates to form a hydrogen bond to
Glu272.Discussion
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oxidation reaction (Bruel et al., 1995; Saribas et al., 1995; Saribas et al., 1997; Fisher
et al., 2004a). Cytochrome b residues described as susceptible to variation with
respect to Qo site occupancy and catalysis are clustered mainly on the cd or ef
segment of cytochrome b including residues: F129, Gly131, Gly137, Met139, Trp142,
Thr145, Thr148, Asn256, Ile269, Pro271, Glu272, Trp273, Tyr274, Leu282, Lys288,
Gly291, and Val292 (summarized by Brasseur et al., 1996).
Temperature sensitive yeast mutants with Thr85
Rip1p  replaced  by  an  Ile
showed hypersensitivity to UHDBT in addition to slower rates of ubiquinol oxidation
(Ljungdahl  et  al.,  1989).  Before  the  structural  data  was  available  original
interpretation for this effect was a proposed enrichment of hydrophobicity at the site
leading to stronger binding of UHDBT. Another explanation was based on a model
with Thr85
Rip1p involved in catalysis. However, structural analysis renders these
previous interpretations obsolete and inspection of the structure reveals more likely
reasons for this phenotype. Thr85
Rip1p is located in the flexible linker region of the
Rieske (see Table A3). Several studies have shown that the length of the linker region
is important for quinol oxidation. Insertion or deletion of amino acids in the linker
region disturbs catalysis and changes sensitivity to inhibitors presumably because of
improper positioning of the Rieske soluble domain on the catalytic interface of
cytochrome b (Tian et al., 1998; Tian et al., 1999; Darrouzet et al., 1999; Obungu et
al., 2000; Nett et al., 2000). Furthermore, Thr85
Rip1p side chain and main chain atoms
are hydrogen bonded to Asp87
Rip1p side chain and Val88
Rip1p main chain, respectively.
Thr85
Rip1p therefore also contributes indirectly to intersubunit interactions, where
Asp87
  Rip1p is observed to stabilize a structural water molecule Wat104, which is
hydrogen bonded to cytochrome c1 residues Ser152
 cyt1p and Arg113
cyt1p. Accordingly,
in  addition  to  hypersensitivity  to  UHDBT,  the  T85I  variant  exhibits  reduced
thermostability possibly derived from destabilized subunit association. The functional
importance of the network of interactions at the cytochrome b and Rieske interface in
proper positioning of Rieske soluble domain for Qo site catalysis is further illustrated
in recent mutagenesis studies. Functionally impaired mutants in the Rieske linker
region were rescued by suppressor mutations in cytochrome b (cd and ef loops) and
vice versa (Darrouzet and Daldal, 2003; Brasseur et al., 2004).Discussion
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3.4.1 Human diseases derived from defect Qo site and impaired catalysis
The yeast S. cerevisiae has been used as a model system to study diseases derived
from Qo site deficiency in humans (Fisher and Meunier 2001; Fisher et al., 2004b;
Brasseur et al., 2004).
The deletion of cytochrome b residues 252-259 (Δ252-259) causes myopathy
and the mutation inserted in yeast inactivates the enzyme. In the same segment
another disease in man, histiocytoid cardiomyopathy, corresponds to point mutation
G252D
Cobp. Interestingly, when introduced in yeast it does not display immediate
pathogenic  effects  (Fisher  et  al.,  2004b).  Meunier  and  Brasseur reported that
purification  of  this  variant  yielded  highly  unstable  and  less  active  enzyme
(unpublished observation). They proposed that introduction of Asp at position 252
interferes with the binding of the structural lipid close to Qo site (see Fig. 34 and
section 2.5.1). Although the G252D variant showed wild type behavior in yeast under
standard conditions it was found to exhibit disturbed respiratory function when cells
were grown at 36°C and biogenesis was negatively affected observed as reduced
levels of Qcr9p. Furthermore, Qcr9p was found to be essential for enzyme activity at
28°C for this mutant. A compensating mutation P174T
Cobp was identified which
alleviated this effect (Saint-Georges et al., 2002). It was concluded that Qcr9p
contributes to thermal stability of the enzyme. Phospholipids are highly sensitive to
temperature, therefore the phenotype may also be a result of enhanced delipidation at
the protein surface due to electrostatic repulsion of the lipid. It is here important to
point out that the next neighbor to this point mutation is not conserved when
comparing mammals (Asp 253) and fungi (His 253) (see Appendix A1). This may
indeed explain why the human phenotype is more dramatic than in yeast. In yeast, the
presence of His253 may partially compensate for the introduction of a negative charge
at position 252, whereas in man Asp253 would repulse negative charge at position
252.  Hence,  the  human  G252D  variant  could  prevent  binding  of  the  anionic
phospholipid, but also overall conformational changes at this site may be expected.
Clearly, this case study underlines how subtle differences in genotype may have
dramatic effects on phenotype.
The mutation Y279C is found in human diseases such as exercise intolerance
and multiple system disorder. Introduction of this mutation in yeast yielded a less
active enzyme (Fisher et al., 2004b). Structural analysis showed direct interactions ofDiscussion
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Tyr279 with Cys180
Rip1p that contribute to Rieske stabilization in b-position. The
functional importance of this residue in positioning Qo site ligand was proposed
(Palsdottir et al., 2003, see Fig. 34). EPR spectra
 showed an altered signal, indicative
of lower occupancy of
 the Qo site. To further analyze substitutions at position 279,
Ala and Trp were introduced. The latter completely inactivated the complex. When
substituted with Cys or Ala, the Rieske protein was integrated and the phenotype was
judged from EPR to be derived from impaired Qo site occupancy, which in the case of
Y279A caused more than 4-fold reduction of enzyme activity. Together with lower
Km values this indicated lower quinol on-rate. These studies supports the role of
Tyr279 for proper positioning of substrate in the active site (see Fig. 34), as observed
in the weak hydrogen bond interactions with stigmatellin and HHDBT. Functional
importance of this highly conserved residues is also supported by mutagenesis in
bacteria (R. sphaeroides) where mutation of the homologous residue Tyr302 caused
3-, 40- and 50-fold reduced rates of quinol oxidation when replaced with a Leu, Gly,
and Gln, respectively (Crofts et al., 2000).
Fig.34 Residues at the Qo site implicated in human diseases. G252D (cardiomyopathy),
Δ252-259 (myopathy) and Y279C (multiple system disorder) are depicted in magenta.
Also shown is the intermembrane space lipid L6 (yellow) and the stabilizing ligand
His185 from cytochrome c1  (blue).  The  Rieske  (green)  is  in  b-position  and  His181
interacts with stigmatellin (orange) and HHDBT (purple).
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3.5 Modeling of atovaquone binding to the Qo site
The  Qo  site  is  a  target  of  many  compounds  of  agricultural  or  pharmaceutical
importance. These compounds utilize subtle molecular differences at the active sites
to  bind  target  in  a  species-specific  manner.  Atovaquone  is  a  substituted  2-
hydroxynaphthoquinone that is
 used therapeutically to treat malaria, pneumonia, and
toxoplasmosis and targets the Qo site of the corresponding pathogens, the parasites
Plasmodium and Toxoplasma and the opportunistic fungi Pneumocystis. Atovaquone
(AtQ) has structural similarity to both HDBT and stigmatellin. Based on this analogy
AtQ was modeled into the Qo site of the structure of yeast cytochrome bc1 complex
(Kessl et  al., 2003). Sequence comparison and structural analysis suggested the
reasons for differential efficacy of AtQ inhibition in the pathogens and mammalian
enzymes. The molecular reasons for selectivity of the drug are exposed by the
emergence of resistant strains. Pathogens frequently become desensitized to drugs
which bind cytochrome b due to the inherently higher mutation rates in mtDNA
compared to nucleus. AtQ resistant strains have been cultivated in vitro, generated in
mice as well as isolated from human hosts. Importantly, natural selection propagates
viable and drug resistant variants, thus the pathogen has to compromise the need for
rejecting the drug, but still allow binding of substrate and effective catalysis at the Qo
site. Studies of AtQ binding have therefore functional perspectives, in addition to the
important medical impact.
AtQ was shown to inhibit the
 yeast cytochrome bc1 complex (Kessl et al.,
2003). EPR lineshapes were consistent with distal occupancy of the Qo site and
similar to when HHDBT is bound, AtQ binding raised the midpoint potential of the
Rieske  iron-sulfur  protein  from  285
  to  385mV.  The  interaction  of  AtQ  with
cytochrome bc1 complex from S. cerevisiae was simulated by modeling this substance
into the active site based on the binding mode observed for HHDBT. The AtQ head
group, including the position of the hydroxyl group, was presumed to be oriented like
in the case of HHDBT (Kessl et al., 2003). The observed rotational displacement of
Glu272 when HHDBT is bound was used in the modeling studies by relaxing the
constraints on the Glu272 side chain and a water molecule was modeled into the site.
Also the conformational flexibility of the ef loop provided important basis for the
molecular  dynamics  studies,  because  constraints  were  introduced  that  allowed
relaxation of this region. The results from the molecular dynamics simulationsDiscussion
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revealed a very similar binding mode as observed for HHDBT, including a water-
mediated hydrogen bond to Glu272.
The computed
 energy-minimized structure suggested that the Phe at position
275 of
 cytochrome b in the bovine enzyme, instead of Leu
 at the equivalent position in
the yeast and parasite enzyme, is responsible
 for decreased sensitivity of the bovine
cytochrome bc1  complex.  The  L275F  mutation  was  introduced
  into  the  yeast
cytochrome b, and accordingly AtQ sensitivity decreased drastically. Seven of the
mutations from AtQ-resistant fungi P. jirovecii
 were introduced in the cytochrome b
gene from yeast (Kessl et al., 2004). Three (I147V, L150F, and L275F) are expected
to interact directly with
 AtQ. Other two, T148I and S152A, are in the cd1
 helix.
Turnover rates were not affected in the T148I and L275 variants, whereas the I147V,
L150F, S152A and P266L, displayed disturbed quinol oxidation.
The  important  role  of  Tyr279  in  stabilizing  ligands  at  the  Qo  site  is
demonstrated by the mutation Y279S that is the most frequent cause of in vivo
treatment failure, because the parasites that carry this mutation are resistant. This
observation underlines the importance of Tyr279 in stabilizing the drug at the binding
site. Resistant P. yoelii lines generated upon drug exposure in infected mice included
a substitution of Y279 with Cys, which caused nearly 2000 fold increase in AtQ IC50
(Srivastava et al., 1999). Also, L282V and I269M, and the non-conserved positions
278 and 283 were mutated. AtQ resistant lines of P. falciparum generated in vitro,
exhibit  similarly  variants  at  positions  139,  283,  286,  291,  279,  291  and  295
(Korsinczky et al., 2000; Fivelman et al., 2002, Gil et al., 2003). Interestingly, initial
mutation in the cd loop of the conserved Met139 exhibited low resistance, which was
enhanced by additional mutations in the ef region from 283 to 290. Similarly, three
mutations in Plasmodium  berghei  lines associated with resistance to AtQ, were
identified as M139I, L150S and the non-conserved position 295 (Syafruddin et al.,
1999). Mutations conferring AtQ resistance typically result in loss-of-fitness in terms
of impaired respiratory growth (Kessl et al., 2004). Based on structural and functional
analysis tailor-made drug development is now feasible. Consistent with conservation
of the mechanism for active site catalysis, the homologous mammalian cytochrome b
protein differs from that of the malaria parasite only in a few of the amino acids at Qo
site. To summarize, the highly conserved residues, which affect AtQ binding include
F129, G137, M139, I147, T148, L150, I269, Y279, L282, and G291.Discussion
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  The ef segment exhibits more pronounced sequence differences than the cd
loop  and  non-conserved  positions  are  observed  to  mutate  in  resistant  strains,
especially at position 283 and 295. Furthermore, the L275F mutation in AtQ resistant
fungi P. jiroveci, was pointed out as position for drug selectivity (Kessl et al., 2004).
However, in Plasmodium strains position 275 is a Phe like in humans. The drug
selectivity  in  parasites  must  therefore  be  derived  from  another  loci.  Based  on
sequence and structural comparison a putative candidate could be at position 283.
Arg283 is highly conserved in mammalian enzymes, whereas in the Plasmodium
strains this residue is replaced with a Lys. In P. jiroveci a Trp occupies this position
(see Appendix  A1).  Structural  analysis  shows  that  Arg283  interacts  with  the
functionally relevant Tyr279. Furthermore, Arg283 is within van der Waals sphere of
cytochrome b residues Ile269, Ala280, Pro286, Gly340, His343, Val344, Tyr348 and
Val349 and makes close contacts to Leu282, Ser284, Ile285 and Cys342. When the
Qo site is empty and Rieske is in c-position Tyr279 is rotated into the binding site and
the interatomic contacts made to Arg283 change accordingly, with 4.6 Å separating
the Tyr279 hydroxyl group and the sidechain NH1 atom of Arg283 instead of 3.2 Å
observed when Rieske is in b-position. Similar to the L275F mutation in fungi, the
resistant K283R mutant presents another example for pathogen mimicking the host
genotype to alleviate drug effects. Better understanding of the binding mode of
atovaquone to the Qo site is expected to aid in strategies for drug design to overcome
the emerging resistance to this compound.
Fig.35 Energy-minimized structure of atovaquone modelled at the Qo  site. A, AtQ
binding site viewed from the lipid filled cavity. The steric hindrance to atovaquone binding
that results from the amino acid replacement is illustrated by the van der Waals surfaces
for Leu275 (blue) and Phe275 (magenta). The chloride atom on the atovaquone side chain
is colored in yellow. B, the structure viewed from the intermembrane side. Cytochrome b is
shown in cyan, and Rieske cluster containing tip in orange. Leu275 and Glu272 in the ef
loop of cytochrome b are also shown. AtQ is hydrogen-bonded to His181 of the Rieske
protein and to a water molecule that forms a hydrogen bond bridge to the Glu272 side
chain (from Kessl et al., 2003).
A BDiscussion
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3.6 Tightly bound lipids in the X-ray structure of cytochrome bc1 complex
Increased  lipid  content  of  the  protein  preparation  was  illustrated  in  two  new
structurally resolved tightly bound phospholipids, which were included in the model
and refined. The relative orientation of integral membrane proteins with respect to the
bilayer can be roughly estimated from hydropathy plots and structural features, such
as  the  arrangement  of  transmembrane  α-helices,  distribution  of  refined  water
molecules and configuration of aromatic residues. The bilayer must have regional
differences in thickness depending on its protein complement, as demonstrated by
variable thicknesses shown for transmembrane regions of different integral membrane
proteins (see Lee, 2003). The membrane spanning part dictates bilayer morphology
and the bilayer exerts lateral pressure which presumably affects structural integrity of
membrane proteins. These interactions between lipids and the highly structured
protein surface support a sealed integration of the protein in the bilayer. The observed
destabilization upon detergent solubilization, may be derived from decreased lateral
pressure  accompanied  by  increased  conformational  freedom  of  the  protein.
Importantly, lipids refined in membrane protein structures may aid in assigning the
annular bilayer. A phospholipid stabilized at the Qo site surface gave first reliable
estimation of the intermembrane space (IMS) leaflet of the bilayer and together with
previously identified lipids from the matrix side allowed vertical positioning of the
complex in the membrane (Fig. 26 and Fig. 28). Based on the position of the IMS
leaflet lipid the observed main chain displacement of the ef loop at the Qo site surface
was shown to extend into the lipid phase.
Cardiolipin (L5) binding on both sides of the complex, together with the
neighboring phosphatidyl ethanolamine (L4) are proposed to provide a feasible
docking site for supercomplex formation with cyt c oxidase (Pfeiffer et al., 2003). The
recently assigned intermembrane space lipid (L6), contributes to this lipid filled cavity
on each side of the homodimer (Fig. 27).
Interestingly, in the cavity at the dimer interface (Fig. 28), the isoprenoid tail
of  native  Qi  site  occupant refined in  the  X-ray  structures  extends  to  meet the
stigmatellin side chain that is bound at the Qo site of the other monomer of the
homodimer (Fig. 26). This observation triggers ideas based on intermonomer cross-
talk, as suggested by models based on alternating half-of-the-sites mechanism and
observed anti-cooperativity of inhibitor binding (Gutierrez-Cirlos et al., 2002; Covian
et al., 2004), suggesting that regulatory mechanisms may be related to active siteDiscussion
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occupancy. This cavity is discussed as substrate entry point where substrate may
diffuse from the membrane into the active sites. Also, the product from Qo site may
turn in the lipophilic cavity at the dimer interface to find its way into the Qi site
without leaving the complex, as an internal substrate tunneling event.  It  is  also
conceivable that this lipid rich interface provides a docking site for supercomplex
formation, where substrate tunneling from for instance, succinate dehydrogenase
(succinate:quinone oxidoreductase) and cytochrome bc1 complex, could occur.
The majority of tightly bound lipids with strongly stabilized head groups is
bound on the electronegative side of the membrane (n side), i.e. the mitochondrial
matrix  side.  This  is  consistent  with  the  asymmetric  charge  distribution  on  the
membrane  protein  surface,  where  the  mitochondrial  encoded  8  TM  helix  of
cytochrome  b is noticed to have enrichment   of positive charges at the n side,
consistent with the ‘positive-inside rule’ (von Heijne, 1986; Gavel and von Heijne,
1988). Importantly, all identified phospholipids in the X-ray crystal structure make
contacts  to  cytochrome  b (table  6),  which  is  the  host  of  both  active  sites  of
cytochrome bc1 complex. The assigned phospholipids are positioned at subunit
interfaces,  pointing  to  a  structural  role  in  assembly  and/or  stability  of  this
multisubunit complex. In the structure, arginine and lysine residues are prevalent at
the level of the phosphodiester groups on the matrix side, whereas the ratio is shifted
to histidine residues on the side of the intermembrane space (Fig. 26B). Aromatic
residues are frequently observed in lipid binding, including stabilization of acyl chain
and interacting with the head group region. Tyrosines are observed with their side
chains at the level of the phosphodiester groups at both sides of the membrane domain
surface (Fig. 26C).
To summarize, lipid phosphodiester groups are often stabilized by two or more
residues, with non-linear motifs typically combining a positively charged and polar
ligands (see Table A5). Also, head group ligands were frequently observed to be from
different subunits, further illustrating that structure-based and not sequence-based
searches are required to identify lipid binding sites in silico. The majority of identified
lipids in membrane protein structures are endogenous and reproducibly co-purified
with  the  protein  despite  exhaustive  purification  procedures  based  on  detergent
extraction of the proteins. Interestingly, endogenous lipids have been reproducibly
refined in conserved positions in both detergent solubilized protein crystallization and
under  conditions  of  lipidic  cubic  phase  crystallization,  as  observed  forDiscussion
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bacteriorhodopsin (see Cartailler and Luecke, 2003) and the bacterial reaction center
(Katona et al., 2003), demonstrating specific stabilization of certain lipid species
despite different purification and crystallization conditions.
Ordered and reproducible binding of the described lipids is demonstrated in
their average B-factors, which are similar to the values obtained for the membrane
spanning region of the protein (table 6). In comparison, an average B-factor of 27 Å
2
of the protein model in contrast to 57 Å
2 of the lipid phytanyl chains were observed
for the 1.55 Å resolution structure of bacteriorhodopsin (Luecke et al., 1999). In
addition to reproducible B-factor distribution when comparing different datasets, an
impressive superimposition of the phospholipid binding sites in the yeast cytochrome
bc1 complex was observed, including head group specificity and structurally resolved
length of acyl chains. Even inter-species conserved ‘kinks’ of tightly bound acyl
chains were demonstrated when comparing the lipids identified in the X-ray structures
of the bovine enzyme with yeast (Fig. 30). This reproducibility of lipid binding
clearly indicates tight and specific protein-lipid interactions. Furthermore, the primary
ligands of phospholipids head groups in the yeast cytochrome bc1 complex are highly
conserved (see Lange et al., 2001, Palsdottir et al., 2003), supporting a functional role
of these lipid binding sites.
Interestingly,  the  identified  lipid  filled  cavities  coincide  with  those
demonstrated in the photosynthetic cytochrome b6f complexes (Kurisu et al., 2003;
Stroebel et al., 2003) and even homologous primary ligands of the lipid head groups
were identified. Conserved features were especially observed in the cavity at the
dimer interface (Fig. 29 and Fig. 30), including truncated acyl chains, in contrast to
well defined head groups as illustrated by the binding mode of an endogenous
sulfolipid in the structure of the photosynthetic cytochrome b6f complex from alga
(Stroebel et al., 2003), which coincides with the binding site the cardiolipin (L7)
described here (see section 2.5.3) (Fig. 30).
The unresolved density in the structure of the enzyme with HHDBT bound at
the Qo site provokes speculations (see section 2.5). It could be derived from a lipid
fragment sticking there, because no high affinity substance is there to replace it. The
specific stabilization of the stigmatellin side chain would replace any non-specifically
adhering substance. Similarly, in the structure of CoQ9 depleted RC with empty QB
site a detergent molecule was found to bind at the isoprenoid tail binding site
(Lancaster  and  Michel,  1997).  Importantly,  these  observations  provoke  theDiscussion
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conclusions drawn from inhibitor titration studies to estimate Qo site occupancy
(Bartoschek et al., 2001). The observation that Qo site specific inhibitor replaces
substrate molecules does not prove that they were replaced from the active site, as the
structures show ample opportunities for substrate molecules to bind in the lipophilic
cavity at the dimer interface.
The importance of this lipid enriched cavity for structural integrity of the
homodimer  is  illustrated  in  the  structure  determination  of  the  homologous
cyanobacterial enzyme (Kurisu et al., 2003). The stability of this preparation was
enhanced by addition of exogenous lipids (Zhang et al., 2003), two of which were
retained and refined in this cavity. Also, studies on R.  sphaeroides showed that
extensive delipidation and concomitant substrate depletion induced monomerization
of the enzyme, which could be derived from a collapse of the delipidated frontal
cavity (Montoya et al., 1999).
The observed lipid-detergent exchangeability (see section 2.5.3) provokes
conflicting views. It is well known that excess detergent destabilizes membrane
proteins. However, individual detergent molecules may assume a role of stabilizing
interactions, as illustrated in the detergent-lipid exchangeability of the interhelical
lipid, which has a proposed structural role for stable integration of Rieske in the
complex (Lange et al., 2001). The observed lipid-detergent exchangeability could
indicate that lipid binding sites of high and low affinity and different degree of
specificity exist? The low affinity/specificity binding sites would be exposed in the
much  higher  detergent  concentration  surrounding  the  transmembrane  region  in
classical detergent solubilized purification-crystallization procedure.
The stably refined lipids in the structures could then present high affinity
binding sites? It can be concluded that sites with affinity for lipid molecules exist,
where specific binding is illustrated in reproducibly identified and even cross-species
conserved  lipid  binding  sites.  The  controversial  questions  about  the
functional/structural role of tightly bound phospholipids awaits further analysis
through for instance structure-based-mutagenesis approach.Discussion
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3.7.Concluding remarks
X-ray  structural  analysis  of  the  cytochrome  bc1  complex  from  the  yeast
Saccharomyces cerevisiae with the inhibitor HHDBT bound at the quinol oxidation
site was carried out. Previous crystallographic studies on UHDBT binding were not
successful in providing high resolution structural information (Kim et al., 1998). A
shorter chain variant of UHDBT, heptyl-HDBT, was here successfully co-crystallized
and a 2.5 Å crystal structure was obtained (Palsdottir et al., 2003). Importantly,
HHDBT binds in its ionized form in contrast to previous reports claiming that an
ionized compound cannot bind at the active site (Zhang et al., 1999).
Structural resemblance and competitive inhibition of Qo site catalysis by
HHDBT support its recognition as a substrate analog. The binding mode of this
hydroxyquinone-derivative  was  therefore  discussed  in  functional  context.  The
observed binding mode of stigmatellin (Hunte et al., 2000) and HHDBT, support a
single  occupancy  model  for  ubiquinol  oxidation  (Hunte  et  al.,  2003).  FTIR
spectroscopic analysis was initiated to address functional aspects of the proposed
mechanistic  models  (Ritter  et al.,  2004).  Preliminary  results  from  theoretical
investigation of protonation probabilities of catalytic residues are presented (see
Appendix A2).
Importantly, the yeast S. cerevisiae was selected as a model system, because
this organism permits site-directed mutagenesis approaches to address the enzyme
mechanism in molecular detail. Understanding the relationships between structure and
function of the cytochrome bc1 complex is not only of fundamental research interest
in  the  field  of  cellular  bioenergetics,  it  is  also  of  medicinal  and  agricultural
importance. Certain human diseases are caused by molecular defects of this central
enzyme in energy transduction. The catalytic subunits of the enzyme are highly
conserved and these human mutations may therefore be modeled into the yeast
enzyme to permit kinetic characterization of variants (Fisher et al., 2004).
A number of compounds block the catalysis of this vital enzyme in a species-
specific manner. For instance, the hydroxynaphthoquinone derivative atovaquone is
used therapeutically to treat Plasmodium falciparum malaria, Pneumocystis carinii
pneumonia,  and  Toxoplasma  gondii  toxoplasmosis.  Atovaquone  binds  more
efficiently to the cytochrome bc1 complex of the respective pathogens and blocks their
function, while not disturbing the activity of the human enzyme. Atovaquone is
structurally similar to HHDBT and stigmatellin. The orientation of these inhibitors inDiscussion
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the  X-ray  structures,  as  well  as  the  observed  Qo  site occupancy-induced
conformational flexibility of the enzyme, therefore served as criteria to model the
binding of the drug at the Qo site, thus providing the first molecular description of
atovaquone  binding  to  the  cytochrome  bc 1  complex  (Kessl  et  al.,  2003).
Subsequently, the molecular basis for acquired resistance to atovaquone in fungal
pathogens that cause pneumonia was investigated (Kessl et al., 2004).
Finally, a structural analysis of lipid binding to the cytochrome bc1 complex
was performed. The protein purification scheme was modified to enrich the lipid
content  of  the  preparation.  Accordingly,  the  isolated  enzyme  exhibited  higher
turnover numbers and two new phospholipids were identified in the X-ray structure,
in addition to previously assigned tightly bound lipids (Lange et al.,  2001).  A
phospholipid stabilized at the surface of the Qo site marks the intermembrane space
leaflet of the lipid bilayer. Together with the previously identified matrix leaflet lipids
this lipid permitted vertical positioning of the enzyme in the membrane. Notably, the
tightly bound lipids were strategically positioned at subunit interfaces pointing to a
structural role in gluing this multisubunit enzyme. Also, the lipids were reproducibly
identified in data sets derived from different preparations, even faithfully reproducing
the acyl chain lengths resolved in the electron density maps. Strikingly, cross-species
conserved lipid binding sites and cavities provoke ongoing research regarding the
structural and functional roles of tightly bound lipids in membrane protein structures.Materials and Methods
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4. MATERIALS AND METHODS
4.1 Suppliers
Amersham Biosciences (http://www.amershambiosciences.com)
Biomol (http://www.biomol.de/inhalt.php)
Biosepra (http://www.ciphergen.com/products/biosepra)
Biotrace/Difco (http://www.intlbioproducts.com/FrameSet.htm)
Calbiochem (http://www.emdbiosciences.com/html/CBC/home.html)
Gerbu (http://www.gerbu.de)
Invitrogen (http://invitrogen.com)
Merck KGaA (http://www.merck.de)
Roth (http://www.carl-roth.de)
Sigma-Aldrich & Fluka (http://www.sigmaaldrich.com)
4.2 Chemicals
2-(N-morpholino) ethane sulfonic acid (MES)  Biomol
3-(N-morpholino)propane sulfonic acid (MOPS) Biomol
5-Brom-4-Chlor-3-indolyl-phosphate (BCIP) Biomol 
Bovine Serum Albumin (BSA) Biomol 
Calcium chloride (CaCl2) Roth
D-biotin Sigma
Desthiobiotin Sigma
Dimethylsulfoxide (DMSO) Biomol
di-Potassiumhydrogenphosphate trihydrate (K2HPO4
.3H2O)Roth
di-Sodium hydrogen phosphate dihydrate (Na2HPO4
.H2O) Roth
Ethylenediamine-tetraacetic acid disodium salt(EDTA) Gerbu
Formaldehyde, 36.5 % Fluka
Glutaraldehyde, 25 % Sigma
Hydrochloric acid (HCl) (37%) Roth
Lithium dodecyl sulfate (LDS)  Sigma
n-dodecyl-b-D-maltopyranoside (DDM)  Glycon
Nitro Blau Tetrazolium (NBT) Biomol 
n-undecyl-b-D-maltopyranoside (UM) GlyconMaterials and Methods
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Phenyl-methyl-sulfonyl fluoride (PMSF) Gerbu
Polyethylene glycol 4000 (PEG4000) (50 % w/v) Hampton research
Polyoxyethylene-sorbitan-monolaurate (Tween20) Koch
Potassiumdihydrogenphosphate (KH2PO4) Merck
Silver nitrate (AgNO3) Roth
Sodium azide (NaN3) Merck
Sodium carbonate (Na2CO3) Merck
Sodium chloride (NaCl) Gerbu
Sodium dodecylsulfate (SDS) Gerbu
Sodium hydroxide (NaOH) Merck
Sodium thiosulphate 5-hydrate (Na2S2O3
.5H2O) Sigma-Aldrich
Sucrose (purity 97.995 %)  Gerbu
Tetramethylrhodamine-5-maleimide (TMR5M) Molecular Probes
Tris-hydroxymethyl-9-aminomethane (Tris) Roth
4.2.1 Chromatography materials
Activated thiol sepharose 4B  Amersham Biosciences
CH activated sepharose 4B Amersham Biosciences
Diethylaminoethyl (DEAE) Fast flow sepharose  Amersham Biosciences
HyperD Diethylaminoethyl (DEAE) Biosepra
NHS activated sepharose Fast Flow (FF) Amersham Biosciences
PD10 (Sephadex G-25) Amersham Biosciences
Superdex 75 PC 3.2/30 Amersham Biosciences
Superose 6 PC 3.2/30 Amersham Biosciences
TSK4000 TosoHaas
4.2.2 Proteins
Anti-myc-tag monoclonal antibody 9E10 hybridoma supernatant
Avidin Fluka
Cytochrome bc1 complex  from R. capsulatus Prof. F. Daldal
Cytochrome bc1 complex from bovine heart Prof. U. Brandt
Cytochrome bc1 complex from P. denitrificans Prof. B. Ludwig
Cytochrome c from horse heart Sigma-Aldrich
Gel filtration HMW calibration kit Amersham BioscienceMaterials and Methods
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Gel filtration LMW calibration kit Amersham Bioscience
Goat anti-mouse IgG alkaline phosphatase conjugate Sigma-Aldrich
LMW calibration Kit for SDS Amersham Bioscience
Pre-stained protein marker Invitrogen
Streptavidin-coupled alkaline phosphatase Amersham Bioscience
4.2.3 Strains
Bacteria
E. coli-K12 JM83 transformed with pASK6818E11 Dr. C. Hunte
E. coli-K12 JM83 transformed with pASK6878+79
Yeast
FGY3 wildtype S. cerevisiae  Prof. M. Greenberg
Baker’s yeast Wieninger
4.2.4 Inhibitors
Undecyl stigmatellin (UST)  Dr. H. Miyoshi
13C-UST
Methoxyiminoacetamide (MIA)
13C-MIA
Stigmatellin  Sigma-Aldrich
Ubiquinone-2
5-n-heptyl-6-hydroxy-4,7-dioxobenzothiazole (HHDBT)  Prof. B. Trumpower
4.2.5 Other materials
MPG
® Streptavidin coated magnetic beads   CPG Inc.
Step-tactin coated magnetic beads 5% IBA
Bicinichoninic acid (BCA) Assay Reagent A and B Uptima
Streptavidin coated M-PVA SAV2 Dynabeads Chemagen
NuPAGE® 4-12% Bis-Tris Gel Invitrogen
EXtrelutNT1 glass column  MerckMaterials and Methods
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4.3 Solutions
Gel electrophoresis and staining
20x Running buffer for NuPAGE Novex precast gels (pH 7.3): 1.0 M MES, 1.0 M
Tris, 69.3 mM SDS and 20.5 mM EDTA
LDS Sample Buffer for gel electrophoresis: 3 % LDS, 10 % (w/v) glycerol, 50 mM
Tris (8.5), 0.075 % (v/v) Serva Blue-G250, 0.025% (v/v) Phenol Red, 50 mM
dithiothreitol
Coomassie stain solution: 0.25 % (w/v) Coomassie Brilliant Blue R250, 50 % (v/v)
methanol and 10 % (v/v) acetic acid
Coomassie destaining: 40 % (v/v) methanol, 10 % (v/v) acetic acid
Storage solution: 7 % (v/v) acetic acid, 2 % (v/v) glycerin
Silver stain fixation solution: 30% ethanol and 10% acetic acid
Silver  stain  conditioning  solution:  0.5  M  sodiumacetate  trihydrate,  0.01  M
Na2S2O3
.5H2O, 0.125 % glutaraldehyde and 30 % ethanol
Silver stain solution: 6 mM AgNO3  and 0.025 % formaldehyde
Silver stain developing solution: 0.24 M Na2CO3 and 0.04 % formaldehyde
Western blotting
Phosphate buffered saline (PBS) buffer : 2.7 mM KCl, 1.5 mM KH2PO4, 13 mM
Na2HPO4 and 13.7 mM NaCl
PBS-T buffer: PBS containing 0.1 % Tween20
Semi-dry transfer buffer: 1x running buffer with 20 % methanol
Blocking buffer: PBS with 0.5% (v/v) Tween20 and 20 µg/ml avidin.
Washing buffer: PBS with 0.1% (v/v) Tween20
Color development solution: 33 µl NBT and 66 µl BCIP in 10 ml of 100 mM
Tris/HCl(9.5), 100 mM NaCl, 5 mM MgCl2
Fv fragment preparation
LB medium(1L): 10 g NaCl, 10 g bactotryptone, 5 g yeast extract
Periplasmic extraction buffer: 0.5 M sucrose, 100 mM Tris(8.0), 1 mM EDTA
Equilibration buffer: 0.05 M Tris(8.0)
Elution buffer: 0.05 M Tris(8.0), 2.5 mM desthiobiotin
Column storage buffer: 0.02% NaN3, 1 mM EDTA
Column cleaning-in-place solution: equilibration buffer with 0.02% SDSMaterials and Methods
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Fluorescent labeling of Fv
Labeling buffer: 50 mM KPi (7.0) (carefully deoxygenated)
Magnetic beads pull down assay
Assay buffer: add 0.1% BSA (w/v) to SEC buffer (20 mM KPi(7.5), 250 mM NaCl,
0.05% UM)
Elution buffer: 20 mM biotin in SEC buffer
Enzyme activity assay
Activity assay buffer:  250 mM sucrose, 50 mM KH2PO4/K2HPO4 at pH 7.3 - i.e. 50
mM KPi(7.3), 0.2 mM EDTA, 1 mM NaN3, 0.1 % BSA, 0.05% UM
Membrane preparation
Sorbitol solution: 1.2 M D-sorbitol, 0.01 M CaCl2
.2H2O, 0.1 M Tris, adjust pH with
HCl to 7.5 and used immediately
Mannitol buffer: 50 mM KPi(7.4), 650 mM D-mannit, 5 mM EDTA, and 2 g/L BSA
Solubilization buffer: 50 mM KH2PO4/K2HPO4 KPi(7.3), 325 mM NaCl, 1.5 % DDM,
0.01 % PMSF
DEAE FF chromatography
Equilibration buffer: 50 mM KPi(6.9), 350 mM NaCl, 0.015% DDM
Gradient high salt: 50 mM KPi(6.9), 500 mM NaCl, 0.015% DDM, 0.01 % PMSF
Gradient low salt: 50 mM KPi(6.9), 380 mM NaCl, 0.015% DDM, 0.01 % PMSF
Wash buffer: 10 mM KPi(7.3), 1 M NaCl, 0.015% DDM
Storage buffer: 20 mM KPi(7.3), 0.02 % NaN3
Sample dilution buffer: 50 mM KPi(6.9), 0.015% DDM
HyperD DEAE chromatography
Column packing buffer:  0.1 M KPi(6.8), 0.25 M NaCl
Equilibration buffer: 50 mM KPi(6.9), 150 mM NaCl, 0.015% DDM
Gradient high salt: 50 mM KPi(6.9), 1 M NaCl, 0.015% DDM
Gradient low salt: 50 mM KPi(6.9), 0.015% DDM
Storage buffer: 20% ethanol, 1 M NaClMaterials and Methods
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Size exlusion chromatography (SEC)
SEC buffer: 20 mM KPi(7.5), 250 mM NaCl, 0.05% UM
3-D crystallization
Inhibitor stock solutions: Inhibitors were dissolved to 20 mM in DMSO
Solution  for  crystallization:  100  mM  Tris/HCl(8.5/8.0  at  4°C),  0.05%  UM,
PEG4000(6-12%), x µM inhibitor
Reservoir solution: 100 mM Tris/HCl(8.5/8.0 at 4°C), 0.05% UM, PEG4000(5%)
Crystal  storage  solution:  100  mM  Tris/HCl(8.5/8.0  at  4°C),  0.05%  UM,
PEG4000(8%), x µM inhibitor
Solution for cryoprotection: 0.2-1.2 M sucrose, 100 mM Tris/HCl(8.0), 0.05% UM,
PEG4000(8-14%)
4.4 Equipment
ÄKTA purifier updated as explorer Amersham Biosciences
Analytical SMART station Pharmacia Biotech 
Avanti J-20XPI Beckmann Coulter
Biosys2000 Beckmann Instruments
Centricon (2 ml), Centriprep (15 ml) Amicon
Centrisart (1.5 ml) Sartorius AG
Desintegrator S   Bernd Euler
Diode array spectrophotometer Agilent
Dual-wavelength UV/ vis Lambda40 Perkin-Elmer
DYNO-MILL  W. A. Bachofen AG
ELISA reader PowerWave X, Bio-Tek Inst.
Eppendorf microfuge 5415C Eppendorf
NuPAGE Novex XCell Mini Cell Invitrogen
Sorvall RC-5B (rotors SS34 and GSA) Du Pont de Nemours
Table centrifuge 4 K 10 Sigma-Aldrich
Ultrospec2100 UV/visible Amersham pharmacia
UZ Optima LE-80K (rotor Ti45) Beckmann Coulter
Vivaspin Vivascience
Western blot apparatus “semi-dry” system at MPIMaterials and Methods
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4.5 Software
Windows,  UNIX  and  SGI  platforms.  Windows  based  software  for  graphical
presentation and curve fitting of kinetic data was Origin 7 (http://www.originlab.com)
and KaleidaGraph (http://www.synergy.com), respectively. Unicorn software for
Windows was used to control the ÄKTA purifier. Image processing, data scaling and
reduction of X-ray data was performed with the HKL suite of programs. Refinement
and model building was performed with CNS1.0 and Program O, respectively.
Coordinate analysis, structural alignment, estimation of accessibility and evaluation of
atomic contacts were performed with diverse program packages from the Uppsala
Software Facility (http://xray.bmc.uu.se/usf). Other programs used were Naccess,
LSQMAN, Profit, and HBPlus. For graphical presentation of X-ray structures,
Ligplot, Molscript, Bobscript, and Raster3D were used.
4.6 Preparation of crystallization-grade material of the cytochrome bc1 complex
All procedures were carried out at 4°C to prevent proteolytic degradation and
denaturation of the probes. Preparation the cytochrome bc1 complex was performed as
described (Palsdottir and Hunte, 2003), with adjustments to the procedures listed
below.
4.6.1 Preparation of membranes from Saccharomyces cerevisiae
The preparation was scaled up to accommodate more material by breaking the cells in
the large DYNO-MILL (W. A. Bachofen AG, Maschinenfabrik). The yeast cells were
either baker´s yeast (prepare by Wieninger, i.e. “fresh” supermarket yeast stored at
4°C) or FGY3 strain Saccharomyces cerevisiae (stored at  -80 °C). 1,350 g of yeast
cells were resuspended in 4 L of 10 mM EDTA and sedimented by spinning at 5000
rpm (7300 g) for 10 min in an Avanti J-20 centrifuge. The cells were resuspended in 4
L sorbitol solution. After second round of sedimentation, the wet weight of the cell
sediment was estimated (ca. 1 kg). Effective cell breakage was ensured under
hypertonic conditions where a 35 % (w/v) suspension of cells was carefully adjusted
in mannitol buffer. To avoid clogging, the cell suspension was filtered through a
nylon cloth (200 µm), prior to loading into the glass bead mill. The serine protease
inhibitor phenylmethylsulfonyl fluoride (PMSF) was pre-dissolved in a small volume
of dimethylsulfoxide and added to the suspension at a final concentration of 1 mM.
The cell suspension was pumped through the mill at an approximate flow rate of 20Materials and Methods
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ml/min and the stirring adjusted to 2000 rpm. Successful cell breakage was monitored
by microscopic analysis of the resulting specimen. More than 50% of the cells should
be disrupted after the first run. The passage was repeated 3 times for complete
disruption with addition of PMSF before every round of cell breakage. After diluting
the broken cells with mannitol-free extraction buffer [1:10 (v/v)], cell debris and
residual intact cells were sedimented 6200 rpm (5900 g) for 25 min using GSA rotor.
The supernatant was subjected to ultracentrifugation at 43,000 rpm (~150,000 g) for
90 min. The membrane preparation was frozen at -80°C and was not stable for long
term storage as noticed in reduced yield and enzyme activity of preparations stored
for more than 6 months.
4.6.2 Solubilization of membranes
Resuspend 25 ml of crude membranes in 1.5 % n-dodecyl-b-D-maltoside (DDM), 350
mM NaCl, 50 mM KPi 7.3, and 0.01% PMSF in a final volume of 210 ml. After
incubation  with  stirring  for  45  minutes,  the  solubilisate  was  subjected  to
ultracentrifugation at 150,000 g for 35 minutes.
4.6.3 Anion exchange chromatography
Purification of the enzyme is based on two consecutive chromatographic steps using
the  weak  anion  exchanger  diethylaminoethyl  (DEAE)-material,  in  line  with
moderately acidic average pI of the extramembraneous subunits (see Table 1). The
intrinsic absorbance of cytochromes in the visible range assists in their detection
during purification. Distinct dark red fractions clearly distinguished the target protein
from the green-yellowish cytochrome c oxidase eluting in neighboring fractions. The
multiple wavelength systems provided by the ÄKTA and Biosys chromatography
systems permitted monitoring of the absorbance at 280 nm for total protein content
and at 413 nm to specifically monitor heme absorbance. The membrane extract was
loaded on a DEAE fast flow (FF) CL-6B resin and the eluted fractions were applied to
the ceramic HyperD DEAE column.
4.6.3.1 DEAE FF anion exchange chromatography
The DEAE FF column (~100 ml, diameter of 5 cm) was operated by a peristaltic
pump and equilibrated with several column volumes (CVs) of equilibration buffer.
After loading the sample, the majority of weakly bound contaminants was removed
by applying 1.5 CVs equilibration buffer. An elution gradient of 380-500 mM NaCl inMaterials and Methods
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equilibration buffer was applied.The pooled fractions were diluted 2.4-fold with salt-
free  elution  buffer  to  ensure  efficient  binding  to  the  next  anion-exchange
chromatography column.
4.6.3.2 HyperD DEAE anion exchange chromatography
The capacity of the second anion exchange step was increased by scaling up the
geometry of the column. The hyperdiffusion ceramic HyperD DEAE resin (50 µm
bead size) was packed in high-pressure-resistant empty column holder. To recreate
identical operating conditions, the linear flow rate was changed according to the
increase in inner diameter of column and length. The chromatographic run was
operated using the ÄKTA system at a flow rate of 4.5 ml/min. The scaled up column
with a size of 7 cm x 10 mm permitted the purification of up to 40 mg of the
cytochrome bc1 complex. The resin was equilibrated with several CVs of buffer. A
detergent exchange step from DDM to UM (3 CV) was performed. For elution a two-
step salt gradient was applied: 150-300 mM NaCl (3 CVs), hold step (3 CVs), and
300-500 mM NaCl (8 CVs). The target protein eluted at ~35 mS in the first gradient.
The cytochrome bc1 complex containing fractions were pooled and concentrated using
ultrafiltration devices with a molecular mass cut-off at 30 kDa. Notably, the chosen
cutoff value of 30 kDa confers enrichment of the detergent. To ensure reproducible 3-
D crystallization of this membrane protein preparation, the subsequent steps for
protein concentration were standardized with respect to buffer volumes and choice of
ultrafiltration devices.
4.7 Preparation and isolation of the Fv fragment 18E11
Fv fragment production was performed using a bacterial periplasmic expression
system. Periplasmic expression of the Fv fragment was made in E. coli-K12 strain
JM83 transformed with pASK68, as described by Kleywegt et al. (1995). A C-
terminal strep-tag on Fv fragment heavy chain was used in one step streptavidin
affinity chromatography, as described (Schmidt and Skerra, 1994; Kleymann et al.,
1995; Voss and Skerra, 1997). For immunodetection in Western blots C-terminal
myc-tags were inserted in the Fv fragment light chain. Streptavidin-coupled alkaline
phosphatase permitted enzymatic detection of heavy chain.Materials and Methods
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4.7.1 Streptavidin preparation
Streptavidin was prepared in inclusion bodies as described (Schmidt and Skerra,
1994). Correctly folded material was monitored by running SDS PAGE of reduced
and non-reduced material. The latter was separated in the gel as a tetramer (4 x 13.3
kDa). The yield from one preparation was 720 mg/10 L culture in a spectroscopic
determination where streptavidin has an extinction coefficient of ε280 35.6 mM
-1cm
-1
for monomer. The BCAssay for total protein content yielded 960 mg/10 L culture.
Streptavidin  was  coupled  to  the  column  material  according  to  manufacturers
instructions.
4.7.2 Streptavidin affinity chromatography
The periplasmic extract was avidin-treated to block biotinylated proteins: 40 µl
avidin/10 mL periplasma, 30 min incubation at 4°C and centrifugation at 17000 rpm
SS34 for 30 min. The streptavidin coupled columns were equilibrated with Tris-HCl
(pH 8.0).The streptavidin coupled CH activated sepharose 4B was operated at a flow
rate of 0.7 ml/min. The NHS activated sepharose FF material was operated at 1.3
ml/min. After loading with periplasmic extract, the equilibration buffer applied and
this step was strictly monitored and stopped when 10 % of the peak height was until
baseline. Elution was performed with 2.5 mM desthiobiotin (DTB) in equilibration
buffer. After purification, the Fv fragment was concentrated to 1 ml using a vivaspin
(15 ml) ultrafiltration device with molecular mass cut off at 10 kDa, washed with 2 x
5 ml Tris-HCl (pH 8.0) and finally concentrated to < 500 µl (~10 mg/ml), sterile
filtered and 1 mM EDTA was added to the probe. A typical yield from wildtype
Fv18E11 preparation was ~ 4.5 mg/120 mL periplasmic extract, as estimated by the
BCAssay. The estimated shelf-life of functional Fv-fragment was ~3 weeks at 4°C.
Notably,  O/N  incubation  in  diluted  state  in  the  DTB  elution  buffer  caused
destabilization and disassembly of the preparation. Therefore, immediate rebuffering
and concentration of Fv fragment was required.
4.7.3 Fluorescent labeling of Fv fragment with engineered cysteine
The Fv18E11 plasmid was modified by introducing a cysteine on the light chain C-
terminus  just  before  the  myc-tag,  pFv6oligos  78+79  (provided  by  D.  Vinzens)  for
fluorescent  labeling  with  thiol  reactive  probes.  All  buffers  were  carefullyMaterials and Methods
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deoxygenated to prevent oxidation of the free sulfhydryl groups. In this light sensitive
labeling procedure the reaction tubes were wrapped in aluminium foil. Both a 20- and
a 2-fold molar excess of 10 mM TMR-5M stock solution in DMSO were added to 1
mg/ml solution of the protein in 50 mM KPi (7.0). After 1 hour incubation at RT (or
O/N at 4°C) the reaction was stopped by adding 1 mM N-Acetylcysteine. Excess label
was removed by PD10-Sephadex G-25 desalting column. Labeling efficiency was
probed spectrophotometrically and was in the range of 20-40 % mol dye/mol protein.
Tetramethylrhodamine-5-maleimide (TMR-5M) in 20 mM MOPS (adj. w. NaOH to
7.0) has an extinction coefficient of ε541 91mM
-1cm
-1.
4.8 Size-exclusion chromatography (SEC)
The isolated enzyme is a homodimer with a molecular mass > 500 kDa (i.e. Mr 233.4
kDa per monomer plus detergent micelle). The co-complex with Fv fragment for 3-D
crystallization of the detergent solubilized enzyme was formed with excess Fv
fragment at a molar ratio of 1:1.4, as described (Hunte et al., 2000).
4.8.1 Isolation of the Fv-cytochrome bc1 co-complex
For  preparative  size  exclusion  chromatography  the  high-resolution  silica-based
column material TSK-G4000SW (0.75 cm x 60.0 cm, Toso Haas) was equilibrated
with SEC buffer at a flow rate of 0.45 ml/min. The pooled and concentrated fractions
of the DEAE-HyperD eluate were loaded and separated using the same buffer. The
capacity of the column allowed maximum of five mg of protein in 1 mL injected
volume per run. The co-complex eluted with a retention time of ~46 minutes at a flow
rate of 0.45 ml/min. The retention volumes for thyroglobulin (669 kDa), ferritin (440
kDa), catalase (232 kDa), and aldolase (158 kDa) were 16.9 ml, 20.3 ml, 21.6 ml, and
21.9 ml. Chymotrypsinogen (25 kDa) co-eluted with ribonuclease (13.7 kDa) at 25.5
ml. The elution volume for 1 mg/ml Blue dextran was used to estimate the void
volume of  ~12 ml.
4.8.2 Analytical gel filtration of Fv fragment
The Fv fragment assembly was monitored by gel filtration chromatography using
Sephadex  75  column  mounted  on  the  SMART  system.  This  method  permits
separation at analytical scale or ~50 µg protein. A single symmetric elution peakMaterials and Methods
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indicated purity and stability of the sample. The column was operated at a flow rate of
50 µl/min in 50 mM Tris (pH 8.0). The column was calibrated as follows: Albumin
(67 kDa) eluted in the void volume. Ovalbumin (43 kDa), chymotrypsinogen (25
kDa), and ribonuclease (13.7 kDa) eluted at 1.1 ml, 1.3 ml, and 1.5 ml, respectively.
The void volume was estimated at 0.9 ml with blue dextran.
4.8.2.1 TCA precipitation
TCA precipitation was performed for gel electrophoretic detection of the eluted
fractions  with  AU280  <  0.1.  The  probe  was  vortexed  and  incubated  in  1%
deoxycholate for 15 min at RT, after which it was incubated for 20 min in 12 % TCA
(4°C) and spun down at 13,000 RPM in a table centrifuge. The pellet was solubilized
by shaking in 20-100 µl 2.5% SDS at 37° C for 10 min.
4.9 Protein Determination
Determination of protein content was performed for the total protein content of probe
using the BCAssay or specifically for the b-type hemes by taking advantage of the
redox-properties of the heme cofactors for spectral characterization.
4.9.1 BCAssay
The total protein content was estimated using a modified Lowry procedure, the
BCAssay protein quantification kit, according to instructions. This colorimetric assay,
which  is  read  at  562  nm-595  nm,  is  based  on  the  bicinchoninic  acid  method
introduced by Smith (Smith et al., 1985) and is especially suitable for measuring
protein concentration in detergent containing samples.
4.9.2 Spectroscopic Quantification
The extinction coefficient for cytochrome b with respect to the difference absorption
spectra of the dithionite-reduced minus the ferricyanide-oxidized sample is 28.5 mM
-
1cm
-1(562-575 nm) (Vanneste, 1966). The concentration of cytochrome bc1 complex
equals half the concentration calculated for heme b. Cytochrome c1 concentration was
determined by difference absorption spectra of the ascorbate-reduced minus the
ferricyanide-oxidized sample using an extinction coefficient of 17.1 mM
-1 cm
-1 (553-
540 nm) (Yu et al., 1974).Materials and Methods
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4.10 SDS-PAGE Analysis
Ready-made polyacrylamide gels (4-12 % BisTris NuPAGE gel) of the Invitrogen
system were used. Samples were prepared in LDS sample buffer and incubated for 30
min at 40°C. The moderate heat treatment is important to prevent the hydrophobic
subunits from aggregating. The precast gel was fixed in the electrophoresis chamber
XCell sureLock and filled with MES running buffer until the gel tray was covered. 20
µl sample was loaded per well and the gel run at 100-125 mA constant current per gel
for 1 hour. The more soluble LDS in sample buffer, instead of SDS, yielded less
diffusion and better focusing of bands.
4.10.1 Gel staining
For Coomassie staining the gel was incubated for 1 hour in stain solution and then
destained for few hours or until background was colorless. Sensitivity of this staining
procedure depends on the dye-binding capacity of the protein (>1 µg). For increased
sensitivity silver staining permits detection of nanogram amounts of proteins. The gel
was soaked in silver stain fixation solution for 15 min, after which it was incubated
for 15 min in conditioning solution. After incubating (3 x 5 min) with dH2O,
incubation for 20 min in silver solution was followed by a short incubation (3 x 10 s)
in dH2O. Addition of developing solution yielded rapid detection of bands (< 5 min)
and was stopped by washing with dH2O and incubating with 5% acetic acid.
4.10.2 Western Blot
The protein transfer from the gel onto a nitrocellulose membrane was performed by
semidry blotting. The transfer took 1 hour with 50 mA at 4°C. The membrane was
incubated with blocking buffer for 30 minutes at RT (or O/N at 4°C) in order to
reduce non-specific interactions and then washed with the same buffer (3 x 5
minutes). For strep-tag detection a streptavidine conjugated alkaline phosphatase
(1:1000 in washing buffer) was incubated for one hour at 4°C, followed by washing
(3 x 10 min). For myc-tag detection, the mouse monoclonal antibody 9E10 was used
as primary antibody and the alkaline phosphatase conjugated polyclonal goat anti-
mouse  IgG  as  secondary  antibody.  Substrates  for  alkaline  phosphatase  (i.e.
BCIP/NBT)  were  used  for  color  development  and  the  enzymatic  reaction  was
visualized in a purple stained bands.Materials and Methods
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4.11 Determination of cytochrome bc1 complex activity
For  steady-state  activity  determination  the  reduction  of  cytochrome  c  by  the
cytochrome bc1 complex was followed with a spectrophotometric assay at 550 nm.
The extinction coefficient of cytochrome c is 18.5 mM
-1cm
-1 (550-540 nm) (Clejan
and Beattie, 1986). The assay was performed according to (Snyder et al., 2000) with
slight modifications. An assay volume of 1 ml was used. The reaction mixture
contained  ~1  nmol  cytochrome  bc 1  complex,  estimated  by  spectroscopic
quantification of the b type hemes (see section 4.9.2), and 50 nmol horse cytochrome
c in assay buffer (50 mM KPi 7.3, 0.2 mM EDTA, 1mM NaN3, 250 mM sucrose, and
0.05 % UM). The reaction was started by addition of 80 nmol decylubiquinol. The
reaction was followed for 1-3 min at 550 nm. The activity was calculated from the
initial linear reduction rate of cytochrome c. The background of non-enzymatic
cytochrome c reduction was subtracted. Turnover numbers refer to mol cytochrome c
reduced per mol cytochrome bc1 complex per second under conditions of continuous
turnover, where the catalytic reaction is zero order with respect to decylubiquinol and
cytochrome c. Specific activity was calculated as µmol cytochrome c reduced per min
per mg total protein.
4.11.1 Procedure for the two-electron reduction of decylubiquinone
The chemically inert and pH resistant (1-13) EXtrelut columns consist of a wide-pore
kieselguhr and are therefore ideal for analysing lipophilic substances. This procedure
avoids the time-consuming use of a separatory funnel and permits one step liquid-
liquid extraction, with minimized sample loss. The principle of separation is as
follows, the aqueous solution acts as stationary phase and elution takes place in
organic  solvent  (cyclohexane)  which  is  non-miscible  with  water.  150  mg  Na-
Dithionite (Na2S2O4) were dissolved in 1 ml degassed N2-saturated water and applied
to the column, which was equilibrated for 10 min. 10 mg of substrate were dissolved
in 1 ml of N2-saturated cyclohexane. The substrate solution was reduced during flow
through (~1 ml) and for quantitative recovery the column was incubated with at least
4-5 ml of cyclohexane. A color change from yellow (oxidized) to colorless ubiquinol
roughly reflected the extent of reduction. The eluted sample was dried by flushing
with N2. A 20 mM stock solution was prepared in ethanol with 10mM HCl and stored
at -80ºC.Materials and Methods
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4.12 Magnetic beads assay
The streptavidin/streptactin-magnetic beads assay was optimized for efficient pull
down of Fv18E11-cytochrome bc1 complex. All steps were carried out at 4°C. The
assay is based on the strep-tag technology. Here, strep-tag I was irreversibly replaced
by biotin elution buffer. Streptactin is optimized for efficient interactions with strep
tag II, but successful pulldown of strep tag I coupled to Fv18E11 is also feasible.
Typically, 100 µl beads suspension (50 mg/ml) were used per assay tube. The
theoretical capacity of beads is typically ~100 pmol/mg or 500 pmol strep tag II
fusion protein per assay tube, which means that the sensitivity of the assay for co-
complex pulldown is >10 µg Fv18E11. A comfortable working range was ~10-fold
higher or 100 µg Fv18E11 and 400 µg bc1 complex. The assay buffer was the same as
used in size-exclusion chromatography of the co-complex, i.e. SEC buffer, and was
supplemented with 0.1% BSA to reduce unspecific binding. The molecular mass of 67
kDa for BSA, does not interfere with detection of cytochrome bc1 polypeptides in gel
electrophoretic analysis. Beads were activated and washed with 4 x 1 mL assay buffer
and equilibrated on ice for 15 min. 250 µl of pre-formed co-complex (~2 mg/ml) was
incubated with beads for at least 1 hour, gently dispersing beads every 10 minutes. 4 x
500 µl washing within a time span of 10 minutes, was followed by elution with 25 µl
elution buffer.
4.13 Structure determination of cytochrome bc1-Fv co-complex with inhibitors
Co-crystallization with HHDBT bound at the Qo site was successful and led to X-ray
structure determination at 2.5 Å resolution.
4.13.1 Crystallization with HHDBT
HHDBT (20 mM DMSO) was added in ~30 fold molar excess to the diluted enzyme
or a final concentration of 100 µM in 3 ml solution of 3.6 µM enzyme. The Fv-
enzyme-inhibitor co-complex was subsequently concentrated to ~200 µM (50 mg/ml)
for 3-D crystallization. The amount of stigmatellin (20 mM DMSO) applied for co-
crystallization was a factor of 10 less, due to its comparatively stronger inhibitory
potency. The crystals
 were obtained in a hanging drop arrangement by vapor diffusion
against 5 % polyethylene glycol 4000 at 4°C in 24-well Linbro plates. Larger size
crystals were obtained by microseeding in a sitting drop arrangement. The proteinMaterials and Methods
101
solution
 (50 mg/ml) was mixed in a ratio of 2 volumes protein solution per 1 volume
precipitating agent (5% polyethylene
 glycol 4000, Tris-HCl pH 7.5 (adjusted at RT),
0.05% UM, 10 µM HHDBT). Final conditions in crystallization drop: 17 mM Tris
(pH 8.0, 4 °C), 33 mM KPi (pH 7.5), 167 mM NaCl, and 0.05% UM, or a 0.5 pH unit
lower than the
 conditions where the crystals of the stigmatellin-inhibited enzyme were
obtained (Hunte et al., 2000). For structural comparison, a data set with stigmatellin
bound was collected at the same pH.
4.13.2 Cryoprotection trials
Conditions for cryoprotection of the crystals were probed. Among additives tested for
suitability were lithium salts (LiCl, LiSO4 and LiCHO2), PEG400, glycerol, DMSO
and sucrose. Sucrose turned out to be the most successful candidate for further
optimization. Sucrose enhances solubility of the protein and therefore the amount of
precipitating agent had to be increased accordingly. Screens were made to monitor the
feasibility of growing crystals in sucrose containing buffers at final concentration of
250 mM and 500 mM. Subsequently, stepwise soaking with the aim to increase
sucrose content was found to confer successful cryoprotection. The first images of a
cryoprotected yeast cytochrome bc1 complex were obtained at the DESY beamline
(Hamburg). Although not of sufficient quality for data collection these trials provided
useful hints for future directions in development of cryoconditions (S. Solmaz and C.
Hunte, work in progress).
4.13.3 X-ray data collection
Diffraction data was collected at The European Synchrotron Radiation Facility,
Grenoble, France (http://www.esrf.fr). A charge-coupled device detector (marCCD,
mar USA, Evanston, IL) was used to register the reflections and the ProDC program
was used to control the goniometer and detector through Spec and the MAR software,
respectively. The HHDBT data set was collected at 180 mm detector-to-crystal
distance, permitting theoretical resolution of 2.18 Å, using wavelength ~0.92994 Å at
ID14EH3, ESRF (Grenoble). Data collection was performed at 4°C. To minimize
radiation  damage  the  beam  intensity  was  attenuated  (~2-5  photons/sec).  Data
collection was optimized for 20 seconds per pass and 3 passes/frame, meaning
exposure time of 1 minute per frame in the oscillation range of Δϕ of 1 degree.Materials and Methods
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4.13.4 X-ray data processing
Data were processed with the program DENZO and merged using SCALEPACK
from the HKL package (HKL Research, Charlottesville, NC) (Otwinowski and Minor,
1997). DENZO and XdisplayF were used to visualise, index, integrate diffraction
maxima and refine crystal and detector parameters. SCALEPACK was used for
finding relative scale factors between measurements and for merging and statistical
analysis of measurements. Large crystals (>0.5 mm side length) permitted translation
of the crystal in steps of 0.1 mm. The best dataset of the stigmatellin inhibited enzyme
from  the  modified  preparation  was  obtained  from  a  single  crystal  with  final
dimensions of  ~ 1 x 0.5 x 0.5 mm
 side lengths. The crystal was translated along the
longest axis (1 mm). Data collection was performed in regulated steps of irradiation
followed by translation from one end to the other, leaving mosaics of 0.05 mm areas
not targeted by the beam. In this way more than 100 % completeness from one crystal
was obtained. However, the last set of reflections were of low intensity and for
refinement the data were truncated to 98% completeness to ensure quality of the
experimental density map (Table 4). The crystals of the HHDBT inhibited enzyme
were smaller and 7 crystals had to be scaled together to reach more than 90%
completeness of data of acceptable quality.
4.13.5 Refinement and model building
Energy minimization and B-factor refinement
 were performed using the CNS program
package (version 1.0) (Brunger et al., 1998) and applying the maximum likelihood
function  as  the  target
  for refinement. The high resolution stigmatellin-inhibited
enzyme  was  in  used  as  a  model
  (PDB entry 1KB9), excluding all non-protein
molecules. Phospholipids, Qo and Qi site ligands, water molecules and the detergent
molecule were independently added in stepwise rounds of refinement. Subsequently,
stepwise improvement of the model was observed as decreasing R/Rfree factors. The
model was improved based on Fo-Fc and 3Fo-2Fc electron density maps, using the
program
 O (version 8.0.4). Simulated annealing omit maps were calculated in the
areas of interest. Amino acid displacements were manually
 adjusted and in 1P84.pdb a
displaced loop segment was manually repositioned based on the difference density,
followed by a refinement cycle. Topology
 and parameter files were generated using
the program Xplo2d
 and torsion data blocks prepared with the program Moleman2
 (X-Materials and Methods
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UTIL package) (Kleywegt and Jones, 1997). The difference electron density map (Fo-
Fc) confirmed the presence of 5 previously assigned tightly bound phospholipids
 and
detergent molecule (Lange et al., 2001) and importantly two new phospholipids were
identified and refined. Water
 molecules were included according to peaks observed in
the Fo-Fc electron density map contoured at 3s. New water molecules were numbered
as starting from Wat
500.
 Assignment of flexible and poorly resolved side chains was
aided by alanine substitution using Program O, followed by a refinement cycle. At the
given resolution the refinement of alternate conformation was not suitable. The side
chains of buried Asn, Gln, and His were oriented as judged from hydrogen bond
criteria (McDonald and Thornton, 1995). The estimation of acyl chain lengths was
based on the extent of visibility in the experimental difference electron density (Fo-Fc)
maps.
4.13.6 Coordinate analysis
4.13.6.1 Hydrogen bond analysis
Here, hydrogen bond angle is denoted as θ (X-H
…A) and the bending angle at the
acceptor atom as φ (H
…A-C). The program HBPlus was to analyse neighboring atoms
and hydrogen bond interactions (McDonald and Thornton, 1994). Atomic contacts
were evaluated based on contact legitimacy of hydrophobic-hydrophilic properties of
the interacting atoms using the Ligand-Protein Contacts (LPC) software link from the
Protein Databank (http://www.rcsb.org/). For the identification of weak hydrogen
bonds estimation of hydrogen atom position was made by generating a structural
model with hydrogens added using CNS (v.1.0) (Brunger et al., 1998). Criteria for
identifying weak hydrogen bonds were extracted from Desiraju and Steiner (1999).
PROCHECK (v.3.2) analysis verified the stereochemical quality of the coordinates
(Laskowski et al., 1993).
4.13.6.2 Estimation of surface accessible residues
Estimation of accessibility of amino acid residues in the X-ray structures and buried
surface calculations were performed using the program NACCESS (Hubbard et al.,
1991)(http://wolf.bms.umist.ac.uk/naccess/).
4.13.6.3 Buried surface area calculations
The calculated interfacial area in Fv-epitope and cytochrome b-Rieske interactions is
the  area  of  accessible  surface  area  on  both  interaction  partners,  that  becomesMaterials and Methods
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inaccessible to solvent due to protein-protein contacts (Lo Conte et al., 1999).
Interfacial surface area was calculated with NACCESS by calculating accessibility of
the interacting polypeptides A and B as a complex (AB), as well as for A and B
separately and according to the equation: A+B-AB. In this way an estimation of
buried surface area (Å
2), i.e. interfacial area, was carried out. Accordingly, the
distribution of polar and non-polar interactions could be estimated.
4.13.6.4 Structural alignment
Differences between two homologous protein structures were estimated by the root
mean  square  deviation  criteria  (RMSD,  Å)  in  terms  of  atomic  positions  after
superimposition of the Cα atoms. The structures were superimposed using explicit
least squares option in LSQMAN (Dejavuu package) and inspected in Program O.
Analysis of RMSDall of the X-ray structures from the yeast enzyme (i.e. PDB entries
1KB9  and  1P84)  with  ProFit  V2.2  (http://www.bioinf.org.uk/software/profit).
Stigmatellin-inhibited enzyme was crystallized at the same pH as the HHDBT
containing enzyme. The control data-set was collected with 2.8 Å resolution, 93 %
completeness and Rsym 5.8 %. Refinement resulted in final R factor of 20.8 % and
Rfree 24.5 %. Lowering the pH by 0.5 unit did not affect the structure of the catalytic
subunits of the stigmatellin inhibited enzyme, as judged by positional root mean
square  deviation  (RMSD,  Å)  of  superimposed  atoms  with  LSQMAN  yielding
RMSDall/RMSDCa of 0.142/0.098, 0.175/0.118 and 0.204/0.133 for cytochrome b,
cytochrome c1 and the Rieske protein respectively.
4.13.7 Graphical presentation of results
Figures were prepared using the programs O (Jones et al., 1991), LIGPLOT version
4.0 (Wallace et al., 1995), MolScript version 1.4 (Kraulis, 1991), BobScript (Esnouf,
1999), and
 Raster3D (Merritt and Murphy, 1994).
4.14 Multiple sequence alignment of cytochrome b
Multiple  sequence  alignment  was  performed  with  the  BCM  search  launcher
(http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html) and ClustalW1.8
using default parameters. For presentation of the alignment, the amino acid sequences
were  shaded  according  to  similarity  using  the  BOXSHADE  3.21  server
(http://www.ch.embnet.org/software/BOX_form.html) (see Appendix A1). ConsensusMaterials and Methods
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symbols  were  displayed  by  default.  Sequences  were  retrieved  from  ExPASy
Molecular  Biology  Server  (http://www.expasy.org/)  for  Homo  sapiens
(CYB_HUMAN),  Bos  taurus  (CYB_BOVIN),  Saccharomyces  cerevisiae
(CYB_YEAST),  Plasmodium falciparum (CYB_PLAFA),  Plasmodium bergheii
(CYB_PLABE), Rhodobacter sphaeroides (CYB_RHOSH), Rhodobacter capsulatus
(CYB_RHOCA), Paracoccus denitrificans (CYB_PARDE). The sequence for Gallus
Gallus cytochrome b was taken from PDB entry 1BCC.pdb. Likewise, sequences for
cytochrome b6 and subunit IV of cytochrome b6f complexes (Plastohydroquinone :
Plastocyanin Oxidoreductase) were used as submitted with the PDB entries from
Chlamydomonas Reinhardtii (1OQ9.pdb) and Mastogladicus Laminosus (1UM3.pdb).
Given the number of a residue in the yeast sequence (used throughout text), the
number of the corresponding residue in chicken (i.e. G. gallus) is found by adding 2 if
the number is less than 114. For residues 114 and later, the numbering is the same.
The  number  of  the  corresponding  residue  in  the  bovine  sequence  is  found  by
subtracting 1 from the number in the chicken sequence after the first five residues. For
comparative analysis of parasite and yeast cytochrome b subtraction of 6 residues in
the cd loop and subtraction of 11 residues in the ef loop generates the corresponding
position in the Plasmodium sequences.
4.15 FTIR Spectroscopy of the yeast cytochrome bc1 complex
To supplement the X-ray structural data, mechanistic insight into redox dependent
protonation behaviour of the sample, was pursued with Fourier-Transfer Infrared
Spectroscopy (FTIR). The FTIR spectra were recorded by Dr. Michaela Ritter and
interpretation of data was carried out under the supervision of Dr. Petra Hellwig.
4.15.1 Preparation of protein sample
The cytochrome bc1 complex eluting from the HyperD DEAE column was used for
measurements. The detergent exchange buffer (300 mM NaCl, 50 mM KPi (pH 6.9),
0.05% UM) was used as working buffer in the electrochemical and spectroscopic
studies. Inhibitors (e.g. HHDBT, stigmatellin, UST, 
13C-UST, MIA, 
13C-MIA and
UK2A) were added at a final concentration of 1 µM to the cytochrome bc1 complex in
diluted state of the protein of ~ 30 µM. After adding the inhibitors the enzyme was
concentrated in a centrifugal spin device with molecular mass cutoff of 30 kDa to a
final concentration of 0.3-0.5 mM.Materials and Methods
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4.15.2 FTIR measurements
FTIR and UV/vis difference spectra were simultaneously recorded as a function of the
applied potential using a setup combining an IR beam from the interferometer
(modified IFS 25, Bruker, Germany) for the 4000-1000 cm
-1 range and a dispersive
spectrometer for the 400-900 nm range as described (see M. Ritter, PhD thesis). First,
the protein was equilibrated at an initial electrode potential and a single-beam
spectrum was recorded. Then the final potential was applied, and a single-beam
spectrum was again recorded after equilibration. Equilibration generally took less than
4 min for the full potential step from -0.292 to +0.708 V as followed by the difference
signals in the visible spectral range. Infrared difference spectra as presented here were
calculated from two single-beam spectra, with the initial spectrum taken as reference.References
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ABBREVIATIONS
µM micromolar
A absorption
AC ADP/ATP carrier
ATP adenosine triphosphate
AU absolute units
B6F  cytochrome b6f complex
BC1  cytochrome bc1 complex
BCA bicinichoninic acid
BCIP  bromochloroindolyl phosphate
bH  high potential b-type heme
bL  low potential b-type heme
BR  bacteriorhodopsin
BSA bovine serum albumin
CDR complementarity determining region
CL  cardiolipin
Cobp cytochrome b
CoQ coenzyme Q
Cor1p core 1 protein
COX cytochrome c oxidase
CV  cyclic voltammetry
Cyt1p cytochrome c1
ddH20 doubly distilled water
DDM  n-dodecyl-β-D-maltopyranoside
DEAE diethylaminoethyl
DG  phosphatidylglycerophospholipid
DMSO dimethylsulfoxide
DNA deoxyribonucleic acid
E. Escherichiae
EDTA ethylene diamine tetraacetic acid
EPR  electron paramagnetic resonance
ESR  electron spin resonance
Fdh-N formate dehydrogenase N
FTIR Fourier transform infrared
Fv antibody fragment, variable
FvH Fv fragment heavy chain
FvL Fv fragment light chain
g gram
IMM inner mitochondrial membrane
IMS intermembrane space
kDa kilodalton
kg kilogram
Mr molecular mass
nm nanometer
NMR  nuclear magnetic resonance
O/N overnight
OMM outer mitochondrial membrane
P. Paracoccus
PA phosphatidic acid128
PAGE polyacrylamide gel electrophoresis
PC  phosphatidyl choline
PDB protein databank
PE phosphatidyl ethanolamine
PG phosphatidyl glycerol
PI phosphatidyl inositol
PMF  protonmotive force
PS phosphatidylserine
PSI  photosystem I
Q quinone
QCR10p subunit 10
QCR2p core 2 protein
QCR6p subunit 6, hinge protein
QCR7p subunit 7
QCR8p subunit 8
QCR9p subunit 9
QH2 quinol
Qi site   quinone reduction site
Qo site  quinol oxidation site
R.  Rhodobacter
RC  reaction center
Rip1p Rieske
RMSD root mean square deviation
RPM rotations per minute
RT room temperature
s seconds
S.  Saccharomyces
SEC size exclusion chromatography
SHE‘  standard hydrogen electrode (for pH 7)
SL  sulfolipid
SQR  Succinate:Quinone Oxidoreductase
UM n-undecyl-β-D-maltopyranoside
UQ6 coenzyme Q6
UST undecylstigmatellin
UV/vis  ultraviolet/visible
w/v weight per volume (g/100 ml)
WT wildtype
ε extinction coefficientAppendix 1
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APPENDIX 1
A.1. Multiple sequence alignment of cytochrome b
Multiple amino acid sequence alignment was performed as described in section 4.14.
Careful analysis of regions of homology provided the necessary fundament for discussing
cross-species structural differences. The sequence-based structural differences were
discussed with respect to the binding behavior of ligands targeted to the active site.
A.1.1.  Sequence  alignment  of  mitochondrial,  bacterial  and  photosynthetic  enzymes.  The
mitochondrial  (H.  sapiens,  B.  taurus,  G.  gallus,  S.  cerevisiae,  P.  jiroveci,  P.  berghei,  P.
falciparum) and bacterial (P. denitrificans, R. sphaeroides, R. capsulatus) cytochrome b were
aligned  with  cytochrome  b6  and  subunit  IV  (the  first  10  amino  acids  underlined)  from
cyanobacteria (M. laminosus) and thylakoids of alga (C. reinhardtii).
H.sapiens          1 --------------MTPMRKINPLMKLINHSFIDLPTPSNISAWWNFGSLLGACLILQIT
B.taurus           1 --------------MTNIRKSHPLMKIVNNAFIDLPAPSNISSWWNFGSLLGICLILQIL
G.gallus           1 -------------MAPNIRKSHPLLKMINNSLIDLPAPSNISAWWNFGSLLAVCLMTQIL
S.cerevisiae       1 ---------------MAFRKSNVYLSLVNSYIIDSPQPSSINYWWNMGSLLGLCLVIQIV
P.jiroveci         1 ------------------------------------------YLWNYGSLSGLCLIIQII
P.denitrificans    1 MAGIPHDHYEPKTGFERWLHRRLPIVSLVYDTLMIPTPKNLNWWWIWGIVLAFCLVLQIA
R.sphaeroides      1 -SGIPHDHYEPRTGIEKWLHSRLPIVALAYDTIMIPTPRNLNWMWIWGVVLAFCLVLQIV
R.capsulatus       1 -SGIPHDHYEPKTGIEKWLHDRLPIVGLVYDTIMIPTPKNLNWWWIWGIVLAFTLVLQIV
P.berghei          1 -------------------MNYNSINLVKTHLINYPCPLNINFLWNYGFLLGIIFFIQIL
P.falciparum       1 -------------------MNFYSINLVKAHLINYPCPLNINFLWNYGFLLGIIFFIQII
C.reinhardtii      1 -----------MSKVYDWFEERLEIQAIADDITSKYVPPHVNIFYCIGGITFTCFLVQVA
M.laminosus        1 -----------MANVYDWFQERLEIQALADDVTSKYVPPHVNIFYCLGGITLTCFLIQFA
consensus          1               .  . . .. . ..   .. .. . ........* ........*..
H.sapiens         47 TGLFLAMHYSPDASTAFSSIAHITRDVNYGWIIRYLHANGASMFFICLFLHIGRGLYYGS
B.taurus          47 TGLFLAMHYTSDTTTAFSSVTHICRDVNYGWIIRYMHANGASMFFICLYMHVGRGLYYGS
G.gallus          48 TGLLLAMHYTADTSLAFSSVAHTCRNVQYGWLIRNLHANGASFFFICIFLHIGRGLYYGS
S.cerevisiae      46 TGIFMAMHYSSNIELAFSSVEHIMRDVHNGYILRYLHANGASFFFMVMFMHMAKGLYYGS
P.jiroveci        19 TGVTLAMHYIPSIDLAFLSVEHIMWDVNYGWLIRYIHSNTASFFFLFVYIHIAWGIYYGS
P.denitrificans   61 TGIVLVMHYTPHVDLAFASVEHIMRDVNGGYMLRYLHANGASLFFLAVYIHIFRGLYYGS
R.sphaeroides     60 TGIVLAMHYTPHVDLAFASVEHIMRNVNGGFMLRYLHANGASLFFIAVYLHIFRGLYYGS
R.capsulatus      60 TGIVLAMHYTPHVDLAFASVEHIMRDVNGGWAMRYIHANGASLFFLAVYIHIFRGLYYGS
P.berghei         42 TGVFLASRYSPEISYAYYSIQHILRELWSGWCFRYMHATGASLVFFLTYLHILRGLNYSY
P.falciparum      42 TGVFLASRYTPDVSYAYYSIQHILRELWSGWCFRYMHATGASLVFLLTYLHILRGLNYSY
C.reinhardtii     50 TGFAMTFYYRPTVAEAFASVQYIMTDVNFGWLIRSIHRWSASMMVLMMVLHVFRVYLTGG
M.laminosus       50 TGFAMTFYYKPTVTEAYASVQYIMNEVSFGWLIRSIHRWSASMMVLMMILHVFRVYLTGG
consensus         61 **. ....*.. ...*. *. ........*...*..*...**.... ...*. .......
H.sapiens        107 FLYS--ETWNIGIILLLATMATAFMGYVLPWGQMSFWGATVITNLLSAIPYIGTDLVQWI
B.taurus         107 YTFL--ETWNIGVILLLTVMATAFMGYVLPWGQMSFWGATVITNLLSAIPYIGTNLVEWI
G.gallus         108 YLYK--ETWNTGVILLLTLMATAFVGYVLPWGQMSFWGATVITNLFSAIPYIGHTLVEWA
S.cerevisiae     106 YRSPRVTLWNVGVIIFTLTIATAFLGYCCVYGQMSHWGATVITNLFSAIPFVGNDIVSWL
P.jiroveci        79 YRTPRILVWSIGVVIFLIMIVTAFLGYVLPFGQMSLWGATVITNLMSAIPWIGNDIVNFI
P.denitrificans  121 YKAPREVTWIVGMLIYLMMMGTAFMGYVLPWGQMSFWGATVITGLFGAIPGVGEAIQTWL
R.sphaeroides    120 YKAPREVTWIVGMLIYLAMMATAFMGYVLPWGQMSFWGATVITGLFGAIPGIGHSIQTWL
R.capsulatus     120 YKAPREITWIVGMVIYLLMMGTAFMGYVLPWGQMSFWGATVITGLFGAIPGIGPSIQAWL
P.berghei        102 LYLP--LSWISGLIIFALFIVTAFIGYVLPWGQMSYWGATVITNLLSGIP----SLVIWL
P.falciparum     102 MYLP--LSWISGLILFMIFIVTAFVGYVLPWGQMSYWGATVITNLLSSIP----VAVIWI
C.reinhardtii    110 FKRPRELTWVTGVIMAVCTVSFGVTGYSLPWDQVGYWAVKIVTGVPDAIPGVGGFIVELL
M.laminosus      110 FKKPRELTWISGVILAVITVSFGVTGYSLPWDQVGYWAVKIVSGVPEAIPVVGVLISDLL
consensus        121 .. .. ..*..*.............**.....*...*........ ..** ..  .. ..Appendix 1
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H.sapiens        165 WGGYSVDSPTLTRFFTFH-FILPFIIAALATLHLLFLHETGSNNPLGITSHS--------
B.taurus         165 WGGFSVDKATLTRFFAFH-FILPFIIMAIAMVHLLFLHETGSNNPTGISSDV--------
G.gallus         166 WGGFSVDNPTLTRFFALH-FLLPFAIAGITIIHLTFLHESGSNNPLGISSDS--------
S.cerevisiae     166 WGGFSVSNPTIQRFFALH-YLVPFIIAAMVIMHLMALHIHGSSNPLGITGNL--------
P.jiroveci       139 WGGFSVNHATLNWFFSLH-YLLPFVLLALVVAHLISLHVHGSSNPLGVTGNS--------
P.denitrificans  181 LGGPAVDNPTLNRFFSLH-YLLPFVIAALVVVHIWAFHTTGNNNPTGVEVRRG-------
R.sphaeroides    180 LGGPAVDNATLNRFFSLH-YLLPFVIAALVAIHIWAFHSTGNNNPTGVEVRRT-------
R.capsulatus     180 LGGPAVDNATLNRFFSLH-YLLPFVIAALVAIHIWAFHTTGNNNPTGVEVRRT-------
P.berghei        156 CGGYTVSDPTIKRFFVLH-FILPFVALCIVFIHIFFLHLHGSTNPLGYDTAL--------
P.falciparum     156 CGGYTVSDPTIKRFFVLH-FILPFIGLCIVFIHIFFLHLHGSTNPLGYDTAL--------
C.reinhardtii    170 RGGVGVGQATLTRFYSLHTFVLPLLTAVFMLMHFLMIRKQGISGPLMSVTKKPDLSDPVL
M.laminosus      170 RGGSSVGQATLTRYYSAHTFVLPWLIAVFMLLHFLMIRKQGISGPLMATLKKPDLSDPKL
consensus        181  **..*.. *. .....* ...*.........*.. .. .*...*......
H.sapiens        216 --------DKITFHPYYTIKDALGLLLFLLSLMTLTLFSPDLLGDPDNYTLANPLNTPPH
B.taurus         216 --------DKIPFHPYYTIKDILGALLLILALMLLVLFAPDLLGDPDNYTPANPLNTPPH
G.gallus         217 --------DKIPFHPYYSFKDILGLTLMLTPFLTLALFSPNLLGDPENFTPANPLVTPPH
S.cerevisiae     217 --------DRIPMHSYFIFKDLVTVFLFMLILALFVFYSPNTLGHPDNYIPGNPLVTPAS
P.jiroveci       190 --------DRLPFHPYFSFKDLVTVFLFLLALSFFVFYAPNVLGHSDNYIMANPMATPPS
P.denitrificans  233 -SKEEAKKDTLPFWPYFVIKDLFALAVVLVVFFAIVGFMPNYLGHPDNYIEANPLVTPAH
R.sphaeroides    232 -SKAEAQKDTVPFWPYFIIKDVFALAVVLLVFFAIVGFMPNYLGHPDNYIEANPLSTPAH
R.capsulatus     232 -SKADAEKDTLPFWPYFVIKDLFALALVLLGFFAVVAYMPNYLGHPDNYVQANPLSTPAH
P.berghei        207 ---------KIPFYPNLLSLDVKGFNNILILFLIQSIFGVIPLSHPDNAIVVNTYVTPLQ
P.falciparum     207 ---------KIPFYPNLLSLDVKGFNNVIILFLIQSLFGIIPLSHPDNAIVVNTYVTPSQ
C.reinhardtii    230 KAKLAKGMGHNTYGEPAWPNDLLYMFPVVILGTFACVIGLSVLDPAAMGEPANPFATPLE
M.laminosus      230 RAKLAKGMGHNYYGEPAWPNDLLYVFPVVIMGTFACIVALSVLDPAMVGEPANPFATPLE
consensus        241         ..... .... .*.... ......  ........*....... .*.. ** .
H.sapiens        268 IKPEWYFLFAYTILRSVPN------------------KLGGVLALLLSILILAMIP----
B.taurus         268 IKPEWYFLFAYAILRSIPN------------------KLGGVLALAFSILILALIP----
G.gallus         269 IKPEWYFLFAYAILRSIPN------------------KLGGVLALAASVLILFLIP----
S.cerevisiae     269 IVPEWYLLPFYAILRSIPD------------------KLLGVITMFAAILVLLVLP----
P.jiroveci       242 IVPEWYLLPFYAILWSISN------------------KLFGVVAMLAAILILFVLP----
P.denitrificans  292 IVPEWYFLPFYAILRAFTADVWVVMLVNWLSFGIIDAKFFGVIAMFGAILVMALVP----
R.sphaeroides    291 IVPEWYFLPFYAILRAFTADVWVVQIANFISFGIIDAKFFGVLAMFGAILVMALVP----
R.capsulatus     291 IVPEWYFLPFYAILRAFAADVWVVILVDGLTFGIVDAKFFGVIAMFGAIAVMALAP----
P.berghei        258 IVPEWYFLPFYAMLKTIPS------------------KNAGLVIVIASLQLLFLLAEQRN
P.falciparum     258 IVPEWYFLPFYAMLKTVPS------------------KPAGLVIVLLSLQLLFLLAEQRS
C.reinhardtii    290 ILPEWYFYPVFQILRVVPN------------------KLLGVLLMAAVPAGLITVP----
M.laminosus      290 ILPEWYLYPVFQILRSLPN------------------KLLGVLLMASVPLGLILVP----
consensus        301 *.****.......*.....                  *. *.... . .... ...
H.sapiens        306 ILHMSKQQSMMFRPLSQSLYWLLAADLLILTWIGGQPVSYPFTIIGQVASVLYFTTILIL
B.taurus         306 LLHTSKQRSMMFRPLSQCLFWALVADLLTLTWIGGQPVEHPYITIGQLASVLYFLLILVL
G.gallus         307 FLHKSKQRTMTFRPLSQTLFWLLVANLLILTWIGSQPVEHPFIIIGQMASLSYFTILLIL
S.cerevisiae     307 FTDRSVVRGNTFKVLSKFFFFIFVFNFVLLGQIGACHVEVPYVLMGQIATFIYFAYFLII
P.jiroveci       280 FVDLSWIWGSAFRPLSKFFFWIFVTNFFLLMFVGSQHVEEPFVTLGQYATFFYFFYFLVV
P.denitrificans  348 WLDTSRVRSGQYRPLFKWWFWLLAVDFVVLMWVGAMPAEGIYPYIALAGSAYWFAYFLII
R.sphaeroides    347 WLDTSPVRSGRYRPMFKIYFWLLAADFVILTWVGAQQTTFPYDWISLIASAYWFAYFLVI
R.capsulatus     347 WLDTSKVRSGAYRPKFRMWFWFLVLDFVVLTWVGAMPTEYPYDWISLIASTYWFAYFLVI
P.berghei        300 LTTIIQFKMVFSAREYSVPIIWFMCSFYALLWIGCPLPQDIFILYGRLFIILFFSSGLFS
P.falciparum     300 LTTIIQFKMIFGARDYSVPIIWFMCAFYALLWIGCQLPQDIFILYGRLFIVLFFCSGLFV
C.reinhardtii    328 FIESINKFQNPYRRPIATILFLLGTLVAVWLGIGSTFPIDISLTLGL-------------
M.laminosus      328 FIENVNKFQNPFRRPVATTIFLFGTLVTIWLGIGAALPLDKTLTLGLF------------
consensus        361 ... .  ..  ....    .....  .......*..  . ... .. ...  ..   ...
H.sapiens        366 MPTISLIENKMLKWA-----------------------
B.taurus         366 MPTAGTIENKLLKW------------------------
G.gallus         367 FPTIGTLENKMLNY------------------------
S.cerevisiae     367 VPVISTIENVLFYIGRVNK-------------------
P.jiroveci       340 IPLVGII-------------------------------
P.denitrificans  408 LPLLGIIEKPDAMPQTIEEDFNAHYGPETHPAE-----
R.sphaeroides    407 LPILGAIEKPVAPPATIEEDFNAHYSPATGGTKTVVAE
R.capsulatus     407 LPLLGATEKPEPIPASIEEDFNSHYGNPAE--------
P.berghei        360 LVQNKKTHYDYSSQANI---------------------
P.falciparum     360 LVHYRRTHYDYSSQANI---------------------
C.reinhardtii        --------------------------------------
M.laminosus          --------------------------------------
consensus        421 .. .. ..      . .Appendix 2
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APPENDIX 2
A.2. Theoretical investigation of the Qo site mechanism
In this study the protonation behavior of the yeast cytochrome bc1 complex was
investigated by continuum electrostatics calculations. This work was carried out by
diploma student Astrid Klingen under the supervision of Prof. Dr. Matthias Ullmann
using the atomic models of the HHDBT (pdb entry 1P84) and stigmatellin (pdb entry
1KB9) inhibited cytochrome bc1 complex (see diploma thesis, Astrid Klingen).
A.2.1. Protonation probabilities of catalytic residues
The transmembrane part of the enzyme was estimated from the position of tightly
bound phospholipids in the X-ray structures. The titration behavior of enzyme
residues was investigated before and after adding the membrane model. It was not
surprising to find that addition of the membrane model affected the protonation
probabilities  of  residues  located  at  the  membrane-aqueous  interface.  More
specifically, 29 of 550 titratable residues per monomer displayed different titration
behavior upon addition of the membrane. Calculations were also carried out on the
structures with and without the antibody fragment Fv18E11 bound. The protonation
behavior of the residues Asp133
Rip1p and Asp149
Rip1p was affected by removal of
Fv18E11. These residues were shown by structural analysis to participate directly in
antibody-antigen interactions (see Table 3, section 2.2.4).
Protonation probabilities of residues in the X-ray structures of the enzyme
with stigmatellin or HHDBT bound at the Qo site were compared. Initial calculations
showed that, except for the catalytic residue Glu272, the other residues suggested in
the proposed proton exit pathway from the Qo site (see section 3.3) did not change
their protonation pattern. Furthermore, the heme bL propionate A was found to be
deprotonated in the oxidized enzyme. Interestingly, the titration behavior of the
structurally resolved phospholipids, suggested that the phosphates stably carry a
negative charge and the lipid head groups did not appear to titrate.
The titration behavior of the catalytic residue Glu272, the primary ligand of
stigmatellin, was highly sensitive to Qo site occupancy. The protonation probability of
Glu272 was lower when it was rotated into the binding site to form a hydrogen bond
to stigmatellin. In the stigmatellin inhibited enzyme, Glu272 titrated with a pKa of 6.8Appendix 2
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and the protonation profile was not influenced by addition of the membrane model.
On the other hand, in the HHDBT inhibited enzyme, the carboxylate side chain of
Glu272 is rotated away from the active site and points towards a more hydrophilic
environment, where it forms a hydrogen bond to the imidazole ring of His253.
Without the membrane model, Glu272 was found to be deprotonated and His253
titrated with a pKa of ~11. However, after adding the membrane, the protonation
probability of Glu272 increased, whereas His253 appeared stable in the singly
protonated imidazolate form.
Furthermore, Qo site occupancy affected the titration behavior of His343
Cobp
that  was  especially  sensitive  to  the  exchange  of  HHDBT  against  the  modeled
substrate, ubiquinol. In structural context, His343
Cobp is close to the Qo site and forms
contacts to cytochrome c1 residues. Interestingly, His343
Cobp is within van der Waals
distance to Ser268
Cobp, which is in contact with the intermembrane space lipid (L6)
(see section 2.5.1).
In agreement with spectroscopic and X-ray structural evidence (Palsdottir et
al., 2003), the titration curve of HHDBT when bound at the Qo site showed that it is
likely to be deprotonated at all the investigated pH values.
A.2.2. Theoretical treatment of the reaction mechanism
Studies on model compounds suggest that oxidation of QH2 to QH2
+ or deprotonation
of QH2 to QH
- (pKa ~ 11.3) are unlikely first events in catalysis at the Qo site (Rich,
1984). In contrast, the ubisemiquinone radical (QH
.) appears readily deprotonated
(pKa~5.9) to form the ubisemiquinone anion (Q
. -), which is a strong reductant.
Here, reaction energies for the first events in quinol oxidation were calculated
at pH 8.0. Ubiquinol was modeled into the site based on the mechanistic scheme of
single  occupancy  (see  Hunte  et  al.,  2003).  Preliminary  results  showed  that
stabilization of a fully deprotonated semiquinone anion (Q
.  -)  at  the  Qo  site  is
energetically feasible. The binding mode of HHDBT at the Qo site is proposed to
mimic this reaction intermediate (Palsdottir et al., 2003).
The obtained reaction energies will serve as inputs for Marcus theory based
methods to obtain rate constants for the reactions involved in Qo site catalysis (A.
Klingen, in progress).Appendix 3
133
APPENDIX 3
A.3 Structural analysis of the Rieske-cytochrome b interface in the yeast X-ray
structures
A structural study of the catalytically important interface of cytochrome b and Rieske
was carried out to characterize the atomic interactions within and between monomers
A and B of the functional homodimer (A-B).
Comparison of the Rieske-cytochrome b interfaces in the structures of the
HHDBT (PDB entry 1P84) and stigmatellin (PDB entry 1KB9) inhibited enzymes
showed no major differences in the outcome of buried surface area calculations (see
section 4.13.6). The area of Rieske-cytochrome b interaction within monomer A, was
1135.9 Å
2 for the stigmatellin inhibited enzyme and roughly the same, or 2.3 Å
2
greater  when  HHDBT  was  bound.  The  surface  area  of  interaction  between
cytochrome  b from monomer A and Rieske protein from the other monomer B
(Rieske*) was 2292.0 Å
2 when stigmatellin was bound, and similar or 46.5 Å
2 greater
when HHDBT was bound. This is still a negligible difference and corresponds to half
the surface area of a free Gly residue (80 Å).
Table A3 Structural study of polar interactions between Rieske and cytochrome b. Rieske
and cytochrome b residues from the same monomer (A-A) contact at the „linker“, i.e. a
stretch of amino acids that connects the Rieske soluble domain to its transmembrane region.
Polar interactions between cytochrome b from monomer A and Rieske* from the other
monomer B in a homodimer (A-B), i.e. in a functional unit, occur both at the docking
interface that is called „crater“ on cytochrome b (the site of quinol oxidation), as well as at
the linker where Rieske is tethered in the enzyme. Structural water molecules (Wat) that form
hydrogen bond bridges at the interface are marked with the arrow pointing to cytochrome b
residues (>).
Monomer A Monomer A Monomer B Monomer A
Rieske linker Cytochrome b (Pivot point) Rieske* Cytochrome b (Crater)
Thr77(O) Asn74(Nδ2) Cys159(O) Wat338>Wat383>Lys288(Nz)
Ser80(Oγ) Asn74(Nδ2) His161(O) Lys288(Nz)
Ser81(O) His53(Nε2)>Wat17 His161(Nε2) Wat16>Lys288(O)
Wat66>His73(N) Leu162(O) Asn149(Nδ2)
Ser81(O) Wat66>His73(Nε2) Val165(N) Thr265(Oγ1)
Thr83(O) Wat66>His73(N) Cys180(O) Tyr279(OH)
Thr83(Oγ1) His73(Cδ2) Pro195(O) Wat292>Lys288(N)
Thr85 (N) Wat262>Wat15 Wat16 Wat264>Leu282(O)
Thr85 (Oγ) Wat15>Wat17 Wat16 Wat264>Ile285(O)
Asp84(O) His73(Nε2) Rieske*linker Cytochrome b (Pivot point)
Ala86(N) Asp71(O) Ile79(O) Trp164(Nε1)
Asp87(Oδ1) His67(Cε1)>Wat17 Met82(O) Arg178(NH1/NH2)
Wat17 Wat53>Met52(O) Ala84 (N) Wat252>Ser163(O)Appendix 3
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The interface of cytochrome b from one monomer (A) and Rieske* from the
other monomer (B) in a functional unit is characterized by a number of nonpolar
forces and a few polar interactions (Table A3) contributed by residues that reside in
two regions of catalytic importance, namely the cd loop (W142, T145, V146, N149,
L150, W164, G167, F169, R178) and the ef loop (P262, L263, T265, P266, A267,
I269, Y279, L282, R283, P286, K288, V344) of cytochrome b. The Rieske* residues
that contribute at the interface are either in the linker region (I79, M82, A84, A90,
M91) or at the tip of the soluble domain that encloses the site of quinol oxidation
(P115, T160, H161, L162, G163, C164, V165, I167, P179, C180, H181, G194, P195).
Particularly interesting at the catalytic cytochrome b-Rieske* interface are the
polar interactions of Cys180
Rip1p* and the [2Fe-2S] cluster ligand His161
Rip1p* with
cytochrome b residues. The conserved Cys180
Rip1p* is involved in the disulfide bond,
which stabilizes the fold of the Rieske domain (Cys180~Cys164) at the [2Fe-2S]
cluster containing tip. Disruption of that disulfide bond is detrimental to quinol
oxidation reaction.Appendix 4
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APPENDIX 4
A.4 Structural comparison of cytochrome bc1 complex from bovine and yeast
Structural alignment of the high resolution X-ray structures of the cytochrome bc1
complex from yeast (Hunte et al., 2000; Palsdottir et al., 2003) and bovine (Gao et al.,
2002; Gao et al., 2003) was carried out. For comparison of main chain displacements,
superimposition of the Cα trace was performed. Based on sequence alignment, species-
specific structural differences were distinguished from ligand induced conformational
changes (see sequence alignment in Appendix A.1). The highly conserved cd (residues
138-166) and ef (residues 246-288) loops display Qo site occupancy-induced structural
differences in their main chain conformation (Fig. A4). The polypeptide region from
residues ~200-250, on the other hand, probably exhibits species-specific structural
differences, due to a less conserved stretch of amino acids, and the fact that the residues
in this segment do not directly contact the Qo site occupant. Interestingly, the flexible
loop, which exhibits greatest displacement when comparing the structures of the HHDBT
and stigmatellin inhibited yeast enzymes (see section 2.3.6), also turns out to be the site
of major displacement in this cross-species structural comparison.
Structural alignment of the bovine enzymes with different ligands and substrate
analogs  bound,  showed  that  Qi  site  occupancy  did  not  markedly  induce  great
conformational changes. For instance, structural alignment of native (i.e. Qo site empty)
and antimycin inhibited bovine enzymes, showed a displacement of ~1.1 Å at His267
(corresponds  to  Ser268  in  yeast)  and  His221  (His222  in  yeast).  Likewise,  when
comparing the structures of the bovine enzyme with antimycin and CoQ2 bound, the only
pronounced displacement was ~1.2 Å for these same residues. Comparison of the native
bovine enzyme to the structure of the enzyme with NQNO bound, revealed displacements
in the conserved residues: Val145, Ile146, and His221 (bovine numbering).
In  the  case  of  the  Qo  site  occupied  with  CoQ2  and  NQNO,  respectively,
displacements were observed at the conserved cd loop residues: Val145 and Leu149.
Residues that contact NQNO are the conserved residues: Met138, Gly142, Leu145,
Ile146, Pro270 and Phe274. These residues all contact HHDBT and stigmatellin, in theAppendix 4
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structures  of  the  yeast  enzyme  (see  section  2.3.3).  Interestingly,  comparison  of
famoxadone inhibited and native bovine structures (RMSDCα 0.508Å
2) shows greatest
main chain displacement at Gly251-Asn255 and His267-Glu271. The latter region of
conformational flexibility coincides with the most pronounced main chain displacement
when comparing the structures of the stigmatellin and HHDBT inhibited yeast enzyme
(Fig. 21). Notably, the greatest side chain displacement when comparing native and
famoxadone inhibited bovine enzyme was observed for Asp252, which corresponds to
yeast residue His253 (see Appendix  A.1). Strikingly, His253 also shows the most
pronounced side chain displacement when comparing the structures of stigmatellin and
HHDBT inhibited yeast enzymes (Fig.21).
The key conclusion from this comparative X-ray structural analysis is that the
regions of greatest main chain and also the most pronounced side chain displacements
coincide.  Thus,  these  observations  point  to  conserved  features  in  conformational
flexibility of the enzyme.
Table A4 Main chain displacements in structural alignment of cytochrome b
PDB entry
* Inhibitor Å RMSD (Å
2) Main chain displacement (max Å)
S.cerevisiae
1KB9 Qo, stigmatellin 2.3 - -
1P84 Qo, HHDBT 2.5 0.234 A267-V270 (1.7)
B.Taurus
1LON Native 2.6 0.790 V146-T148(1.7), V157(1.8), I161-S170(1.9),
L230-T232(1.4), H253-N256(3.3), A267-
P271(2.5), L302-L305(1.1), E345-Y348(1.4),
A361-L364(1.7), P367-P368(1.6)
1LOL Qo, famoxadone 2.4 0.693 G143-T148(1.2), I154-V157(1.5), F169-
V171(1.5), G260(1.9), S268-I269(2.8), 304-
F307(1.4), A361-F363(1.6)
1NTM Native 2.4 0.716 V146-Thr148(1.4), I154-G158(1.5), V162-
W164(1.0), F169(1.7), L238-L240(1.7), S268-
P271(1.9), L300-L302(1.1), H343-P347(1.9),
A361-L364(1.8)
1NTK Qi , antimycin 2.6 0.757 V146-T148 (1.6), I154-G158(1.3),  F169(1.7),
L238-L240(1.5), A267-P271(3.0), L303-
L305(1.3),H343-Y348(1.6)
1NTZ Qo/Qi, CoQ2
(partial)
2.6 0.728 V146-T148(1.2), V162-W164(1.1), F169(2.0),
L230-T232(1.1), I239(1.7), S268-P271(2.3),
A341-P347(2.0), A361-L364(1.7)
1NU1 Qo/Qi, NQNO
(partial)
3.2 0.755 P155-G158(1.5), F169 (1.5), L230-T232(1.3),
L238-242(1.9), A267-V270(2.1), L300-
D309(1.5), E345-V346(2.1), A361-L364(1.9)
Differences are displayed according to the criteria of spatial separation of more than 1 Å over a span of more than 2
amino acids, except where single residue Cα-trace displacement exceeds 1.5 Å. *1KB9: Hunte et al., 2000; 1P84:
Palsdottir et al., 2003; 1LOX: Gao et al., 2002; 1NXX: Gao et al., 2003.Appendix 4
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Fig. A4 Conformational flexibility of cytochrome b. Cα trace displacement is depicted as RMSD
(Å
2) for the span of residues from cytochrome b amino acids 50-300. The observed differences in
main chain conformation may be derived from ligand induced changes shown as brown columns
for  the  structural  comparison  of  stigmatellin  and  HHDBT  inhibited  yeast  cytochrome  bc1
complex. Cross-species comparison has to take into account sequence specific variations. Shown
here is structural superimposition of the stigmatellin inhibited yeast enzyme with the X-ray
structures from the bovine enzyme, drawn as lines (see Table A4 for details); magenta (native),
red (antimycin), green (CoQ2), and blue (NQNO). Note that only partial occupancy was obtained
for CoQ2 and NQNO.
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APPENDIX 5
A.5 Stabilizing interactions with the phosphodiester moiety of tightly bound
phospholipids identified in X-ray structures of integral membrane proteins
Preferential stabilization of phospholipids at the negative side of the membrane was
observed. A first attempt to identify lipid head group specific binding motifs was
made (from Palsdottir and Hunte, in press).
Table A5 Ligands of the anionic head group of tightly bound phospholipids in X-ray
structures  of  integral  membrane  proteins.  Amino  acid  side  chains  that  contact  the
phoshodiester  group  of  tightly  bound  phospholipids  are  shown.  Residues  within  4.5  Å
distance from the phosphodiester group are listed. Primary ligands with atomic contacts at a
distance of less than 3 Å are marked with bold. The abbreviations n and p denote the negative
and positive leaflet of the bilayer, respectively. Also shown are ligands of a sulfolipid (SL).
Lipid Amino acid Protein Species PDB entry Res.(Å)
PE KT BC1 n, annular G.gal. 1BCC 3.2
PE YQT BC1 n, same binding site as L4 G.gal. 1BCC 3.2
PE YNYQK BC1 n, annular, L4 S.cer. 1KB9 2.3
PE N BC1 n, dimer interface, L2 S.cer. 1KB9 2.3
PE(4) RHS;RW;R;
K
COX n R.sph. 1M56 2.3
PE(2) R; KR COX n B.tau. 1V54 1.8
PE KYR RC n T.tep. 1EYS 2.2
PE KK SDH n E.col. 1NEK 2.6
PE(2) QHK; YQ COX p R.sph. 1M56 2.3
PE(1) T COX p B.tau. 1V54 1.8
PC S BC1 n, cavity at dimer interface, L1 S.cer. 1KB9 2.3
PC RHE COX n P.den. 1QLE 3.0
PC H COX n B.tau. 1V54 1.8
PC(3) T AC n B.tau. 1OKC 2.2
PC HS BC1 p S.cer. 1P84 2.5
PC RD COX p P.den. 1QLE 3.0
PI KST BC1 p, integral protein lipid, L3 S.cer. 1KB9 2.3
PG(3) RHS; RW COX n B.tau. 1V54 1.8
PG(3) RNRD; RS PSI n S.elo. 1JBO 2.5
CL K, RH BC1 n, cavity at dimer interface, L7 S.cer. Here 2.5
CL KYK, YHN BC1 n, near Qi site (proton uptake), L5 S.cer. 1KB9 2.3
CL RKYD, HKK COX n B.tau. 1V54 1.8
CL HR, KW RC n R.sph. 1M3X 2.55
CL HRN, WH RC n, lipidic cubic phase R.sph 1OGV 2.4
CL(2) S AC n B.tau. 1OKC 2.2
CL NDY, HN COX p B.tau. 1V54 1.8
CL NT, NS FDH p, interface of adjacent monomers E.col. 1KQF 1.6
DG KS BR n, important for trimer formation H.hal. 1BM1 3.5
SL RKN B6F n, sulfolipid, cavity at dimer
interface, same position as L1 and
L4
C.rei. 1Q90 3.1
Resolution, Res.; Cytochrome bc1 complex, BC1; Cytochrome b6f complex, B6F; Cytochrome c oxidase, COX;
Photosynthetic reaction center, RC; Photosystem I, PSI; Bacteriorhodopsin, BR; ADP/ATP carrier, AC; Formate
dehydrogenase, FDH; Succinate dehydrogenase, SDH; Phosphatidyl ethanolamine, PE; Phosphatidyl choline,
PC; Phosphatidyl inositol, PI; Phosphatidyl glycerol, PG; Cardiolipin, CL; Phosphatidylglycerophospholipid,
DG; Phosphatidic acid, PA; phosphatidylserine, PS; sulfolipid, SL.Lebenslauf
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